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figure represents an individual participant. The three horizontal bars represent the median value 
(middle bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.4.2: Comparison of the quantities of L. gasseri (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, between 
hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test.  Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.4.3: Comparison of the quantities of L. jensenii (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, between 
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hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.4.4: Comparison of the quantities of L. iners (copies/ng DNA) measured in the DNA 
extracted from vaginal lateral wall swabs from participants in the WISH study, between 
hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.4.5: Comparison of the quantities of G. vaginalis (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, between 
the hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value comparisons 
were based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the 
figure represents an individual participant. The three horizontal bars represent the median value 
(middle bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.5A: Box-plot of the absence of any one STI for L. gasseri (red), L. jensenii (orange), 
L. crispatus (green), L. iners (blue), and G. vaginalis (purple). The ‘box’ component of each plot 
indicates the interquartile range (IQR) of the data set and the ‘whiskers’ which are the two lines 
(bottom and top) extending from the box component of each block that end with a horizontal 
stroke, indicate the range from the smallest and largest non-outliers to the 25% and 75% 
percentile components, respectively. The middle line indicates the median value for each data 
set. 
Figure 4.3.5B: Box-plot of the presence of any one STI for L. gasseri (red), L. jensenii (orange), 
L. crispatus (green), L. iners (blue), and G. vaginalis (purple). The ‘box’ component of each plot 
indicates the interquartile range (IQR) of the data set and the ‘whiskers’ which are the two lines 
(bottom and top) extending from the box component of each block that end with a horizontal 
stroke, indicate the range from the smallest and largest non-outliers to the 25% and 75% 
percentile components, respectively. The middle line indicates the median value for each data 
set. 
Figure 4.3.5.1: Comparison of the quantities of L. crispatus (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on absence or presence of any one of the WISH cohort STIs 
present. All p-value comparisons were based on an unpaired, non-parametric Mann-Whitney t-
test statistic. Each point in the figure represents an individual participant. The three horizontal 
bars represent the median value (middle bar), upper interquartile range (top bar) and lower 
interquartile range (bottom bar). 
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Figure 4.3.5.2: Comparison of the quantities of L. gasseri (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on absence or presence of any one of the WISH cohort STIs 
present. All p-value comparisons were based on an unpaired, non-parametric Mann-Whitney t-
test statistic. Each point in the figure represents an individual participant. The three horizontal 
bars represent the median value (middle bar), upper interquartile range (top bar) and lower 
interquartile range (bottom bar). 
Figure 4.3.5.3: Comparison of the quantities of L. jensenii (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on absence or presence of any one of the WISH cohort STIs 
present. All p-value comparisons were based on an unpaired, non-parametric Mann-Whitney t-
test statistic. Each point in the figure represents an individual participant. The three horizontal 
bars represent the median value (middle bar), upper interquartile range (top bar) and lower 
interquartile range (bottom bar). 
Figure 4.3.5.4: Comparison of the quantities of L. iners (copies/ng DNA) measured in the DNA 
extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on absence or presence of any one of the WISH cohort STIs 
present. All p-value comparisons were based on an unpaired, non-parametric Mann-Whitney t-
test statistic. Each point in the figure represents an individual participant. The three horizontal 
bars represent the median value (middle bar), upper interquartile range (top bar) and lower 
interquartile range (bottom bar). 
Figure 4.3.5.5: Comparison of the quantities of G. vaginalis (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on absence or presence of any one of the WISH cohort STIs 
present. All p-value comparisons were based on an unpaired, non-parametric Mann-Whitney t-
test statistic. Each point in the figure represents an individual participant. The three horizontal 
bars represent the median value (middle bar), upper interquartile range (top bar) and lower 
interquartile range (bottom bar). 
Figure 4.3.6.1: Comparison of the quantities of L. crispatus (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on none, one, two (or more <) of the WISH cohort Bacterial 
(B) versus Viral (V) STIs being present. All p-value comparisons were based on an unpaired, 
non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents an 
individual participant. The three horizontal bars represent the median value (middle bar), upper 
interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.6.2: Comparison of the quantities of L. gasseri (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
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samples have been separated based on none, one, two (or more <) of the WISH cohort Bacterial 
(B) versus Viral (V) STIs being present. All p-value comparisons were based on an unpaired, 
non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents an 
individual participant. The three horizontal bars represent the median value (middle bar), upper 
interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.6.3: Comparison of the quantities of L. jensenii (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on none, one, two (or more <) of the WISH cohort Bacterial 
(B) versus Viral (V) STIs being present. All p-value comparisons were based on an unpaired, 
non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents an 
individual participant. The three horizontal bars represent the median value (middle bar), upper 
interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.6.4: Comparison of the quantities of L. iners (copies/ng DNA) measured in the DNA 
extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on none, one, two (or more <) of the WISH cohort Bacterial 
(B) versus Viral (V) STIs being present. All p-value comparisons were based on an unpaired, 
non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents an 
individual participant. The three horizontal bars represent the median value (middle bar), upper 
interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.6.5: Comparison of the quantities of G. vaginalis (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, where the 
samples have been separated based on none, one, two (or more <) of the WISH cohort Bacterial 
(B) versus Viral (V) STIs being present. All p-value comparisons were based on an unpaired, 
non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents an 
individual participant. The three horizontal bars represent the median value (middle bar), upper 
interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.7A: Box-plot of the negative HPV group for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple). The ‘box’ component of each plot 
indicates the interquartile range (IQR) of the data set and the ‘whiskers’ which are the two lines 
(bottom and top) extending from the box component of each block that end with a horizontal 
stroke, indicate the range from the smallest and largest non-outliers to the 25% and 75% 
percentile components, respectively. The middle line indicates the median value for each data 
set. 
Figure 4.3.7B: Box-plot of the low risk HPV group for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple). The ‘box’ component of each plot 
indicates the interquartile range (IQR) of the data set and the ‘whiskers’ which are the two lines 
(bottom and top) extending from the box component of each block that end with a horizontal 
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stroke, indicate the range from the smallest and largest non-outliers to the 25% and 75% 
percentile components, respectively. The middle line indicates the median value for each data 
set. 
Figure 4.3.7C: Box-plot of the high risk HPV group for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple). The ‘box’ component of each plot 
indicates the interquartile range (IQR) of the data set and the ‘whiskers’ which are the two lines 
(bottom and top) extending from the box component of each block that end with a horizontal 
stroke, indicate the range from the smallest and largest non-outliers to the 25% and 75% 
percentile components, respectively. The middle line indicates the median value for each data 
set. 
Figure 4.3.7.1: Comparison of the quantities of L. crispatus (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, between 
the negative, low risk and high risk HPV groups. All p-value comparisons were based on an 
unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents 
an individual participant. The three horizontal bars represent the median value (middle bar), 
upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.7.2: Comparison of the quantities of L. gasseri (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, between 
the negative, low risk and high risk HPV groups. All p-value comparisons were based on an 
unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents 
an individual participant. The three horizontal bars represent the median value (middle bar), 
upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.7.3: Comparison of the quantities of L. jensenii (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, between 
the negative, low risk and high risk HPV groups. All p-value comparisons were based on an 
unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents 
an individual participant. The three horizontal bars represent the median value (middle bar), 
upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.7.4: Comparison of the quantities of L. iners (copies/ng DNA) measured in the DNA 
extracted from vaginal lateral wall swabs from participants in the WISH study, between the 
negative, low risk and high risk HPV groups. All p-value comparisons were based on an 
unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents 
an individual participant. The three horizontal bars represent the median value (middle bar), 
upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Figure 4.3.7.5: Comparison of the quantities of G. vaginalis (copies/ng DNA) measured in the 
DNA extracted from vaginal lateral wall swabs from participants in the WISH study, between 
the negative, low risk and high risk HPV groups. All p-value comparisons were based on an 
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unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure represents 
an individual participant. The three horizontal bars represent the median value (middle bar), 
upper interquartile range (top bar) and lower interquartile range (bottom bar). 
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Abstract 
Young, reproductive-aged women are at highest risk of acquiring human-immunodeficiency 
virus (HIV). The Women’s Initiative in Sexual Health (WISH) study was designed to investigate 
potential biological reasons for this high risk in HIV negative, South African adolescent females. 
Little is known about the ‘normal’ microbiome of this population. As such, the aim of this sub-
study was to quantify specific bacterial species (L. crispatus, L. jensenii, L. gasseri, L. iners, G. 
vaginalis and P. bivia) by quantitative real time PCR (qPCR) from adolescent female lateral 
vaginal wall swabs, and to assess associations between the quantities of these bacteria and 
bacterial vaginosis (BV) status, inflammation levels, age, hormonal contraceptive usage, and 
sexually transmitted infections (STIs). Samples were collected from 143 participant adolescent 
females in total, aged between 16 and 22 years of age, with a median of 18 years of age, from the 
Masiphumelele Youth Clinic in Cape Town, South Africa.  
Bacterial DNA was extracted from lateral vaginal wall swabs using the MoBio Powersoil® DNA 
Isolation Kit after enzymatic digestion. Positive bacterial reference strains were cultured in MRS 
buffer and Schwedler’s broth, after which the DNA was extracted using the Qiagen Blood and 
Tissue DNA Maxi Extraction Kit. The quality and concentration of the DNA was confirmed 
using Qubit technology. The positive control DNA was amplified with PCR using species 
specific primers and the product run on an agarose gel to confirm primer specificity. The positive 




 copies/µL to form a standard curve for 
absolute quantification through qPCR. Multiple steps were taken in order to optimize the qPCR 
experiments in terms of protocols, initial denaturation and annealing temperatures, cycle length 
and number, primers, and serial dilutions of the positive control DNA. The optimization for the 
P. bivia qPCR protocol presented the most issues, with the final quantification results being 
unreliable and requiring further work. Once the qPCR conditions were optimized for each 
bacterium; all samples, non-template control and standards were run in triplicate to quantify the 
number of bacterial copies per ng of DNA for each participant. The average of the three values 
were used as the final quantities and then used for downstream analyses. 
The bacterium L. crispatus, L. jensenii and L. gasseri, had median readings of 3.957 copies/ng, 
1.568 copies/ng, and 17.58 copies/ng, respectively, with increased L. iners (2807 copies/ng) and 
G. vaginalis (8540 copies/ng). BV negative participants had increased levels of L. crispatus 
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(p=0.0004, p=0.0002) and L. gasseri (p=0.0016, p<0.0001) in comparison to both BV 
intermediate and BV positive participants. L. jensenii (p<0.0001) and L. iners (p=0.0461) 
readings were increased in BV negative participants compared with BV positive and BV 
intermediate participants, respectively. BV positive participants had increased levels of G. 
vaginalis in comparison with both BV intermediate (p=0.0059) and BV negative (p<0.0001) 
adolescents. The 47 immunological factors, assessed via luminex, were categorized into high and 
low genital inflammation based on the unsupervised analysis by partitioning around medoids 
(PAM) using an R package ‘cluster’ with a k-value of 2. The inflammation-low group had 
increased levels of L. crispatus (p=0.0005), L. gasseri (p=0.033) and L. jensenii (p=0.0046) in 
comparison to the genital inflammation-high group.  
In participants with two viral STIs (Herpes Simplex Virus 2 and Human Papilloma Virus), there 
were increased copies/ng of G. vaginalis in comparison with participants with none (p=0.0098) 
or one viral STI (p=0.0324). Participants with high-risk HPV subtypes had significantly higher 
copy numbers of L. crispatus in comparison to the participants with low risk HPV subtypes 
(p=0.0181). Further, the only association demonstrated between the qPCR-based bacterial levels 
and the hormonal contraceptive prescribed was indicated by L. jensenii (ANOVA p=0.0222), 
possibly due to the low copy number readings.  
In conclusion, BV status, low levels of genital inflammation and the presence of two viral STIs 
indicate an association with bacterial copy numbers reported in this study, with increased median 
levels of L. iners and G. vaginalis across all adolescent participants compared to the other 
reported bacterial copy numbers. This indicates a possible alternate ‘normal’ microbiota profile 
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Chapter 1: Literature Review 
1.1 Human-Immunodeficiency Virus in South Africa 
In sub-Saharan Africa, the Human immunodeficiency virus (HIV) is an epidemic (Byrne et al. 
2016; Cohen et al. 2012; Mitchell & Marrazzo 2014; Murphy et al. 2014; Roberts et al. 2012). 
Within the high risk reproductive-age adolescent population, there are approximately 7000 
young women infected weekly in sub-Saharan Africa (Roxby et al. 2016). In South Africa in 
2015, an estimated 7 million people were living with HIV, of which 4 million were women aged 
15 years and over, with 180 000 Acquired Immune Deficiency Syndrome (AIDS) related deaths 
(UNAIDS 2015). Such high numbers have been attributed to poverty, as well as the lower status 
of women in some cultures, social instability and inequality, high levels of sexually transmitted 
infections (STIs), limited access to medical care, and sexual violence (AFSA 2011). These 
factors are further aggravated by the limited knowledge surrounding HIV infection and 
transmission in a large proportion of the population (AFSA 2011).  South Africa has one of the 
highest rates of HIV with 15% of the young women and close to 5% of young men between the 
ages of 15-24 years infected. Females aged between 18 and 24 years are at highest risk of HIV 
acquisition which can be attributed to sexual activity and associated factors such as either heavier 
or thin vaginal discharge, thought to be in conjunction with the use of hormonal contraceptives, 
older male sexual partners as well as high numbers of sexual partners and inconsistent condom 
use (Pettifor et al. 2005; Seutlwadi et al 2012). Programs such as the loveLife campaign are 
designed to incorporated education, multi-media awareness, sexual health and outreach services 
for adolescents in order to lower HIV prevalence and related risk behaviors (loveLife 1999). Due 
to multiple factors such as socio-economic variables and potentially biological factors, black 
South African women have an increased risk of HIV acquisition in comparison to other races 
(Pettifor et al. 2005).  
HIV infects and dysregulates multiple key innate and adaptive immune cell populations. 
Infection results in severe damage to mucosal barriers within the female genital tract (FGT) and 
leads to infiltration of symbiotic bacteria present within the FGT into the tissue, which could 
potentially cause opportunistic infections and activation of the systemic immune system (Reis 
Machado et al. 2014). The induction of an inflammatory response results in spreading of the 
virus to specific HIV target cells, such as activated CD4
+ 
T-cells expressing CXCR4 and CCR5 
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HIV co-receptors, which promote viral infection. In addition to activated T cells, HIV can also 




T-cells present a particular challenge as their preferential targeting by 
HIV results in their possible impairment or elimination from the immune response. Increased 
levels of inflammatory cytokines that promote CD4
+ 
T-cell activation result in increased sources 
of target cells for HIV. This results in the hyper-activation of CD8
+
 T cells and over production 
of antibodies which can lead to a poor specific antibody response, lack of cytotoxic T 
lymphocytes and an overall impairment of the immune system. High levels of these activated 
CD4
+ 
T-cells within the FGT mucosa further facilitate shedding of HI-virus and overall depletion 
of CD4
+ 
T-cells. HIV infection is further facilitated by Langerhans cells which act as 
transmission channels for the HI-virus within the FGT (Jaspan et al. 2011; Riou et al. 2012; Xu 
et al. 2013).  
 
1.2 The female genital tract (FGT) immune response 
The FGT is comprised of the upper and lower FGT, with the upper FGT including the uterus 
body, fallopian tubes, endocervix, which are lined by type I mucosa with columnar epithelial 
cells, while the lower FGT includes the ectocervix, vagina and type II mucosa with squamous 
epithelial cells (Xu et al. 2013; Reis Machado et al. 2014). The FGT immune system includes  all 
cell types associated with innate and adaptive immune functions (Xu et al. 2013). The activity 
and numbers of T cells, B cells, neutrophils, monocytes, macrophages, dendritic and other 
antigen presenting cells, along with other components of the mucosal immune system, is 
hormonally controlled with oestradiol and progesterone. These two hormones are involved in the 
regulation of cytokine levels, cell population distributions, immunoglobulin transport and antigen 
presentation and production during immune response (Beagley & Gockel 2003; Mestecky & 
Fultz 1999; Wira, Fahey, et al. 2005). FGT hormones further regulate the immune system in such 
a way as to favour optimal conditions and functions for fecundity, such as sperm migration and 
implantation (Reis Machado et al. 2014).  
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Columnar epithelial cells play an important role in innate and adaptive immunity by forming a 
physical barrier and, through the secretion of specific cytokines and chemokines which link the 
adaptive immune system, are antimicrobial and play a role in tissue physiology and 
differentiation for support of the fetus during gestation (Wira, Grant-Tschudy, et al. 2005). 
Epithelial cells further prevent pathogenic and opportunistic bacteria from entering the body 
through the secretion of mucus which lines the cervix and vagina, trapping any unwanted 
pathogenic microbes. The mucus which contains antimicrobial defensin proteins, in conjunction 
with the epithelial cells which express TLRs, myeloid differentiation factor 2 (MD-2) and major 
histocompatibility complex molecules, ensures the innate and adaptive immune systems are fully 
functional and efficient within the FGT (Wira, Fahey, et al. 2005; Mirmonsef et al. 2011).  
The FGT has a multi-layered immune defense system composed of mucus lining, antimicrobial 
peptide secretions, tight epithelial barriers, and cytokines monitored by innate and epithelial 
immune cells, which bridge the gap of cell-mediated and pathogen-specific humoral adaptive 
immunity (Hickey et al. 2011; Reis Machado et al. 2014; Ochiel et al. 2008).  Mucosal immunity 
plays a specific role in female reproductive organ functioning and embryonic development 
during pregnancy. Mucosal immunity is specifically active against the multitude of 
microorganisms that access the FGT and that can cause dysbiosis and infection while 
maintaining a balance with commensal bacteria, preventing unnecessary inflammation. The FGT 
defends against microorganisms via toll-like receptors (TLRs) such as TLRs 7-9 in the uterine 
and fallopian tubes, ectocervix and cervix as well as Nucleotide Oligomerization Domain (NOD) 
like receptors such as NOD1 and NOD2 along with Receptor-Interacting serine/threonine protein 
Kinase 2 (RICK) which are all expressed within the FGT tissues. These receptors induce pro-
inflammatory CXCL8 and aid in the removal of pathogens (Reis Machado et al. 2014; Xu et al. 
2013). Additionally the squamous epithelium forms a physical barrier of defense as a result of 
tight junctions, desmosome proteins, and adherens junctions to reduce permeability to the HI-
virus (Reis Machado et al. 2014; Mestecky & Fultz 1999; Xu et al. 2013).  
The release and concentration of pro-inflammatory and anti-inflammatory cytokines secreted by 
the cellular components of the FGT affects the functionality of the immune-competent tissues 
which comprise the mucosal immune defense system (Anjuère et al. 2012). Cytokines are 
signaling molecules that allow information exchange between the immune system and tissue 
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network. Cytokines bind to their cognate receptors, which results in a change in function or 
phenotype of the recipient cell upon acceptance of the antigen signal through antigen receptors 
(Firestein et al. 2013; Su et al. 2012). Cytokines can be anti- or pro-inflammatory, potentially 
modulating multiple pathways throughout the immune system. Common anti-inflammatory 
cytokines include interleukin-4 (IL-4), IL-6, IL-10, IL-11, IL-13, alpha-interferon (IFN-α), 
Transforming growth factor-beta (TGF-β), and IL-1 receptor antagonist (IL-1ra). Anti-
inflammatory cytokines act through various pathways in order to combat infections, such as IL-
4, IL-10 and IL-13 which activate B lymphocytes during infection (Dinarello 2000). Common 
pro-inflammatory cytokines include IL-7, tumor necrosis factor alpha (TNF-α), IFN-γ, IL-12, IL-
18, granulocyte-macrophage stimulating factor (MG-CSF), IL-23/17, and IL-1β (Arnold et al. 
2015; Cavaillon 2000; Jung et al. 1995; Su et al. 2012; Sultani et al. 2012). In addition to the role 
of cytokines, the inflammatory response may be further modulated by the nature and quantity of 
target cells and cytokine activating signals, the timing, sequence of cytokine action, as well as 
cytokine polymorphisms, which can have a further impact on the magnitude of the response 
(Cavaillon 2000). Chemokines control the differentiation and development of immune precursor 
cells in the thymus and bone marrow as they are chemotactic cytokines which influence the 
positioning and migratory patterns of the immune cells. Common cytokines include IFN-gamma 
inducible protein 10 (IP-10) involved in TH1 response and natural killer cell trafficking, 
RANTES, MIP-1α and MIP-1β which play a role in the migration of macrophage and natural 
killer cells, as well as interactions between dendritic cells and T cells (Griffith et al. 2014).  
Several pro-inflammatory cytokines have been associated with STIs in high-risk HIV uninfected 
adult women and can therefore be used as a possible indicator of infection and HIV susceptibility 






) have been associated 
with chlamydia and gonorrhea (Masson et al. 2015). Inflammatory cytokines can inhibit HIV 
replication and disease progression and as such play an important role in disease prevention 
(Breen 2002), with certain cytokines, including IFN-γ, IL-2, IL-4 and IL-5 predominantly 
associated with T-cell effector function which direct participation in the immune response to 
foreign bodies (Firestein et al. 2013). Inflammatory cytokines such as IL-10, have been 
associated with the inhibition of long terminal repeats (LTR)-directed HIV gene expression 
through cyclin T1 proteolyis induction in human macrophages (Wang & Rice 2006), while IL-16 
is associated with inhibition of HIV replication in acutely infected T cells and the suppression of 
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lymphocyte activation (Idziorek et al. 1998). Circulating T-lymphocytes, bone marrow and 
thymus T-cell precursors, macrophages and monocytes, eosinophils, dendritic and microglial 
cells have been identified as targets for HIV replication and their increased levels with STI 
infections have been associated with increased activation of target cells and susceptibility to HIV 
acquisition (Fanales-Belasio et al. 2010; Hunt et al. 2011; Masson et al. 2015). The possible 
cause of this susceptibility is the decreased production of IL-21, IL-22, IL-1β, IL-17, IL-18 and 
Macrophage inflammatory protein-3α (MIP-3α), which is associated with the promotion of tight 
junctions, barrier functions, proteases and production of mucin by the mucosal epithelial cells of 
the FGT. The interruption of the FGT epithelial cell wall functions results in mechanical errors 
leading to the entry of HIV across the cellular barrier. A possible mechanism for the entry of, 
and efficient infection by, HIV, could be the increase in the frequency of endocervical CD4
+
 T-
cells upon any mechanical damage within the FGT mucosal lining (Arnold et al. 2015).  
The FGT is equipped to remove foreign substances and microbes such as fungi, viruses, parasites 
and bacteria, but is also colonized by commensal bacteria, predominantly Lactobacillus species, 
which aid in its immune defense (Mirmonsef et al. 2011). The innate and adaptive immune 
systems interact with uterine epithelial cells and microbiota to optimize the FGT health through 
the removal of harmful infections while maintaining inflammation to prevent self- responses 
(Mirmonsef et al. 2011). Thus the FGT microbiota, in conjunction with the immune system and 
vaginal environment as a whole, plays a major role in women's health (Jespers et al. 2016a; 
Ravel et al. 2011; Anahtar et al. 2015), which also has important implications for fetal and 
neonatal health (Srinivasan et al. 2010; Srinivasan et al. 2012). 
 
1.3 FGT Microbiota 
The FGT microbiota is a combined community of commensal microbes co-existing together, 
with changes within the balance resulting in changes in health which occur due to colonization 
with pathogenic microbes (Salipante et al. 2013; Srinivasan & Fredricks 2008). A ‘healthy’ 
microbiome is dominated by Gram-positive bacteria such as the commensal Lactobacillus 
species (Selle et al. 2014), that play an important role in the FGT due to their numerical 
dominance (Lamont et al. 2011), production of lactic acid and hydrogen peroxide which reduce 
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the pH of the genital tract to maintain the optimal conditions for commensal bacteria. 
Furthermore, lactobacilli prevent the growth of pathogens, compete for adherence to the vaginal 
epithelium and for nutrients, thus making the vagina less hospitable to pathogens (Vitali et al. 
2007; Mirmonsef et al. 2011), STIs, yeast, and urinary tract infections (Balkus et al. 2012). The 
reduction of lactobacilli present within the FGT, and the increase in BV associated anaerobes has 
been associated with increased risk of HIV acquisition and seroconversion (Atashili et al. 2008; 
Myer et al. 2005). Lactobacilli influence HIV by playing a role in the control in the genital 
shedding of newly reproduced HIV to another part of the body or another person (Balkus et al. 
2012).  Lactobacilli species further maintain an inhospitable environment for pathogenic bacteria 
by acting as probiotics, producing bacteriocins and antibiotic toxic hydroxyl radicals (Lamont et 
al. 2011). The loss of lactobacilli species results in the overgrowth of anaerobic and facultative 
bacteria which can lead to dysbiosis of the FGT microbiome (Jespers et al. 2012; Lopes dos 
Santos Santiago et al. 2012; Srinivasan et al. 2012; Ravel et al. 2011). Although it is understood 
that a ‘healthy’ microbiome is lactobacilli -dominated, the microbiome diversity and structure is 
strongly influenced by geographical location, ethnicity, age and culture (Ravel et al. 2011; 
Jespers et al. 2012). 
Common lactobacilli found within the FGT include L. crispatus, L. gasseri, L. jensenii, as well 
as L. iners; however, L. iners has been shown to be present during the intermediate phase 
between dysbiosis and a healthy microbiome within the FGT and thus is not as strongly 
associated with what is considered to be a ‘healthy’ FGT microbiome (Jespers et al. 2012; Mayer 
et al. 2015; Macklaim et al. 2013; Roxby et al. 2016; Srinivasan & Fredricks 2008). In contrast, 
common facultative and anaerobic bacterial species associated with the loss of lactic acid 
producing bacteria include Gardnerella vaginalis and Prevotella bivia, whose presence within 
the FGT microbiome is concomitant with Bacterial Vaginosis (BV), which is the dysbiosis of the 
FGT microbiome and considered to be  ‘unhealthy’ (Mayer et al. 2015; Fredricks et al. 2007; 
Fredricks et al. 2015; Lopes dos Santos Santiago et al. 2012; Saito et al. 2006). Some bacteria 
present within the FGT associated with BV are further associated with the change in vaginal pH 
and influence the inflammatory status of the FGT mucosa (Roy et al. 2006). This is achieved 
through the production of microbial products such as short chain fatty acids, which can inhibit 
pro-inflammatory cytokines secretion, affect phagocytosis and migration of immune cells 
(Mirmonsef et al. 2011).  
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Although the exact protective mechanisms of lactobacilli are partially unknown, H2O2 
production creates a hostile acidic environment, which inhibits the growth of many harmful 
micro-organisms (Jespers et al. 2012).  There is much debate about what constitutes a ‘normal’ 
FGT microbiome, as different cultures and races such as Hispanic, black, white and Asian 
populations have been found to have different predominant species present depending on BV 
status as well as pH (Ravel et al. 2011).   
 
1.4 Bacterial vaginosis (BV) 
Bacterial vaginosis (BV) is an alteration within the vaginal flora, with an increase in anaerobic 
and facultative bacteria, and overall diversity, and a concomitant decrease in the relative 
abundance of Lactobacilli. The most common bacteria associated with BV include Gardnerella 
vaginalis, Prevotella bivia, Atopobium vaginae, Shuttleworthia sp., BV associated bacteria 2 
(BVAB2), BVAB3, Sneathia sp., Megasphaera sp. Phylotype 1, and Leptotrichia sp. (Jespers et 
al. 2012; Lopes dos Santos Santiago et al. 2012; Srinivasan et al. 2010; Srinivasan et al. 2012). In 
healthy, BV-negative women, lactobacilli predominate the FGT microbiome, with a distinct 
reduction in their colonization upon the initiation of BV (Fredricks et al. 2007; Srinivasan et al. 
2012).  
BV is commonly diagnosed based on Amsel’s clinical criteria, which include the presence of 
clue cells, vaginal fluid pH of greater than 4.5, a positive amine odor whiff test and a thin, 
homogenous milky discharge. A woman is classified as being BV positive if at least three of 
these four criteria are positive (Amsel et al. 1983; Eschenbach et al. 1988). BV can also be 
classified by Nugent scoring, which is based on the presence of specific morphotypes with 
different associated scores where the Lactobacillus morphotypes have a score of 4-0 (large gram-
positive rods), the G. vaginalis and Bacteroides spp. morphotypes have a score of 0-4 (small 
gram-variable and gram negative rods) and Mobiluncus spp. morphotypes are scored 0-2 (curved 
gram-variable rods) (see Table 1.1 for scoring system) (Gad et al. 2014; Nugent et al. 1991; 
Spiegel et al. 1983). The vaginal smear is graded according to the presence of each morphotype 
to calculate the final Nugent score. A Nugent score of 0-3 is considered BV negative, a score of 
4-6 is considered BV intermediate and a Nugent score between 7-10 is considered BV positive 
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(Srinivasan et al. 2010; Lopes dos Santos Santiago et al. 2012; Jespers et al. 2012; Srinivasan & 
Fredricks 2008).  









0 4+ 0 0 
1 3+ 1+ 1+ or 2+ 
2 2+ 2+ 3+ or 4+ 
3 1+ 3+  
4 0 4+  
ª0 - no morphotypes present; 1 - <1 morphotype present; 2 – 1 to 4 morphotypes present; 3 – 5 to 
30 morphotypes present; 4 – 30 or more morphotypes present.  
Risk factors for BV include new and multiple sexual partners, vaginal douching, as well as a 
slight association with wearing tight trousers more than once a week. BV incidence and recurring 
infection could be reduced by decreasing unprotected sexual encounters and increased in condom 
use (Chiaffarino et al. 2004; Fethers et al. 2008). Further factors, such as the presence of 
Prostate-specific antigen (PSA), age, sexual preference or point in the menstrual cycle have yet 
to be successfully associated with BV status (Jespers et al. 2012). BV has been associated with 
increased risk of pelvic inflammatory disease and acquisition of HIV (Fredricks et al. 2007; 
Fredricks et al. 2009). In pregnancy specifically it has been associated with the multiple 
complications such as early and late miscarriage, recurrent abortion, post-abortal sepsis, preterm 
pre-labor rupture of membranes, spontaneous preterm labor, preterm birth, postpartum 
endometriosis and histological chorioamnionitis (Lamont et al. 2011; Malaguti et al. 2015). In a 
study performed by Petricevic et al. (2014), it was shown that most Lactobacillus species were 
associated with full term gestation periods in healthy pregnant women, whereas L. iners 
specifically was shown to be present in 85% of the women who delivered preterm.  
The dysbiosis and increase in diversity of the FGT microbiome, change in pH and loss of 
defensive lactobacilli due to the onset of BV have been associated with an increased risk of 
sexually transmitted and upper genital tract infections. Further, BV has been associated with HIV 
(Lamont et al. 2011; Srinivasan et al. 2010; Srinivasan et al. 2012).  
 
11 
 A. O. Breetzke 
1.5 Sexually Transmitted Infections (STIs) 
There multiple different types of STIs with the most infamous viral STI being HIV (Hunt et al. 
2011; Patterson et al. 2002; O’Farrell 2008). Common bacterial sexually transmitted infections 
include Mycoplasma genitalium, Chlamydia caused by Chlamydia trachomatis, Gonorrhea 
caused by Neisseria gonorrhea, and Syphilis caused by Treponema pallidum. Parasitic infections 
such as Trichomoniasis are caused by Trichomonas vaginalis, while the human papilloma virus 
(HPV) and herpes simplex virus (HSV-2) are two of the most common viral infections. 
Candidiasis is a yeast overgrowth that is not sexually transmitted, yet often co-occurs with other 
STIs (Reproductive Health and Research & Who 2005; Reis Machado et al. 2014; Anahtar et al. 












Figure 1.1: Adaptation from Reproductive Health and Research (WHO) sites of infection in the 
FGT and the associated STIs and other infections with associated sequela (Reis Machado et al. 
2014; Chinsembu 2009; Reproductive Health and Research & Who 2005; Minnesota 2005; CDC 
2014a; CDC 2014b; CDC 2014c; CDC 2014d).  
CERVIX 
Gonorrhoea – vaginal discharge, 
inflammation 
Chlamydia – infertility, chronic 
pelvic pain, ectopic pregnancy, 
vaginal discharge 
M. genitalium – cervicitis, urethritis, 
pelvic inflammatory disease 
VULVAL, LABIA, VAGINA 
HSV-2 – inflammation, genital 
ulcers 
Human Papilloma Virus – genital 
warts, cervical cancer 
VAGINA 
Bacterial Vaginosis (non STI)– milky 
discharge, amine odor, increase in 
vaginal pH 
Candidiasis (non STI) – loss of normal 
vaginal flora, reduction in pH, germ 
tube formation, inflammation, vaginal 
discharge 
Trichomoniasis – premature birth and 
membrane rupture, infertility, cervical 
cancer, vaginal discharge 
UTERUS 





 producing bacteria 
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Adolescents in particular are at higher risk of STI acquisition, with a ratio of 2:1 adolescent 
females to their male counterparts (Chinsembu 2009). This increased ratio is thought to be 
partially due to increased cervical ectopy, cognitive, biological and socio-cultural factors. STIs 
can be asymptomatic or symptomatic in adolescents, and can further cause tubal pregnancy, 
infertility, and cervical cancer (Chinsembu 2009; Ohene & Akoto 2008). Further factors 
associated with the acquisition of STIs in adolescents include drug and alcohol use, 
unavailability and lack of condom use, as well as an early initiation age of sexual activity and 
multiple sexual partners (Ohene & Akoto 2008; Reproductive Health and Research & Who 
2005).  
Importantly, STIs have been shown to increase the risk of HIV acquisition by three fold or more 
(Mlisana et al. 2012; Newman et al. 2013; Ohene & Akoto 2008) with 16.3% co-infection 
between genital inflammatory diseases and HIV (Reis Machado et al. 2014). HIV positive 
individuals have reduced immune function and favor the colonization of STIs as local infections 
within the FGT. This facilitates local replication of HIV within the FGT through HIV shedding 
(Reis Machado et al. 2014). One important issue in Southern Africa is that STIs are treated by 
the syndromic approach, yet up to 50% of the women infected with an STI are asymptomatic and 
therefore remain untreated. STIs may have subclinical manifestations such as elevated cytokines 
due to genital tract inflammation. However, due to the lack of diagnosis, under- and over-
treatment of STIs is common, further increasing adolescent HIV risk (Mlisana et al. 2012).   
 
1.6 Hormonal Contraceptives 
Several different types of contraceptives are currently licensed, including Intra-Uterine Devices 
(IUD’s), barrier methods, hormonal contraception, spermicides and operative sterilization, with 
other methods including fertility cycle awareness methods, situational methods such as coitus 
interruptus, douching and abstinence  (Draper 2006; Mitchell 2008). Hormonal contraception 
and condom use are two of the most commonly used methods (Smit et al. 2002).   
The two hormones oestradiol and progesterone play a major role in the regulation and defensive 
immunity of the FGT, along with controlling the monthly menstrual cycle. Synthetic version of 
these two hormones are used in contraceptives, administered  as a daily oral pill, injection, patch, 
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or inserted in the form of a rod to adjust the monthly menses and FGT conditions in order to 
prevent pregnancy (Murphy et al. 2014; van de Wijgert et al. 2013). Hormonal contraceptives 
can contain one or a combination of hormones in various doses, and usually suppress ovulation, 
increase the viscosity of cervical mucus to impair sperm movement, or induce morphological 
changes to the endometrium lining to prevent nidation of the egg in the cervix (Family Planning 
Western Australia 2012; Murphy et al. 2014; Organon Pharmaceuticals USA 2011; Pfizer 2011; 
Pharmaceutical/Industry 2005). 
In Sub-Saharan Africa, the three hormonal contraceptives (HCs) Depo-Provera, Implanon and 
Nur-Isterate are particularly popular as they do not require daily administration, can go unnoticed 
due to the manner and frequency in which they are administered, as well as do not require coital-
dependent insertion or use (Organon Pharmaceuticals USA 2011; Pharmaceutical/Industry 2005; 
Pfizer 2011). These three HCs contain progestogens only with the active agents of Depot 
Medroxyprogesterone acetate (DMPA), Norethisterone Enantate and Progestin Etonogestrel in 
Depo-Provera, Nur-Isterate and Implanon respectively. Depo-Provera lasts for 12 weeks, Nur-
Isterate are injections for 8 weeks, while Implanon is an ethylene vinyl acetate rod that is 
inserted under the subdermal connective tissue in the arm and can remain for up to three years. 
The three HCs have similar side effects, such as irregular or prolonged bleeding as well as heavy 
bleeding or amenorrhea, weight gain, headaches and mood changes. They differ in that Depo-
Provera can cause an allergic reaction, albeit rare, as well as loss of bone density. Nur-Isterate 
can cause dizziness and loss of glucose tolerance while the Implanon can cause bruising, breast 
pain and acne (Mitchell 2008; Organon Pharmaceuticals USA 2011; Pharmaceutical/Industry 
2005; Pfizer 2011).  
Progestin-only hormonal contraceptives are favoured in Sub-Saharan Africa due to their privacy, 
convenience, low cost and efficacy. They were used by an estimated 8 million women in 2015, 
with specific popularity in South Africa (Byrne et al. 2016; Murphy et al. 2014; Smit et al. 2002; 
van de Wijgert et al. 2013).  In South Africa, male and female condoms, hormone patches, 
intrauterine devices, sterilization, hormonal pills and contraception injections are available. 
There are two combined oral contraceptive (COC) and progestin-only contraceptive pills (POP), 
as well as two progestin only contraceptive injections Nur-Isterate and Depo Provera (DMPA) 
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(Department of Health 2012; Dr Manto Tshabalala-Msimang 2013; Western Cape Government 
2015).   
Much observational and pre-clinical research has been conducted to determine the relationship 
between progestin-only hormonal contraceptives and HIV acquisition (Smit et al. 2002; van de 
Wijgert et al. 2013). Exogenous progestin’s found in hormonal contraceptive injections such as 
DMPA reportedly could accelerate CD4
+
 T cell depletion in HIV positive women through the 
physiological functions of the glucocorticoid receptor within the immune system and apoptosis 
(Govender et al. 2014; Tomasicchio et al. 2013). Increased progestin levels have been linked to 
an increased frequency of activated CCR5+ CD4 T cells within the cervix, which are HIV target 
cells, illustrating a link between the contraceptives and HIV acquisition (Byrne et al. 2016). 
Further research, originally performed on macaques, indicates that hormonal contraceptives may 
interfere with cervical cellular immune function by thinning the vaginal epithelial cell layers, 
which exposes the vaginal junctions to disruption and may therefore allow access to pathogenic 
bacteria and STIs (Murphy et al. 2014).  
Further, HIV acquisition has been linked to progestin-only contraceptives due to their proposed 
inhibition of TLR-9-induced Interferon (IFN) production by plasmacytoid dendritic cells 
(pDC’s) along with other innate and adaptive soluble factors, potentially hampering immune 
responses within the cervix against HIV infection (Murphy et al. 2014). A specific association 
has been indicated with the active agent of Depo-Provera, DMPA and the sustained decrease in 
Interleukin-8 (IL-8), Interleukin-6 (IL-6), and the Interleukin-1a receptor antagonist (IL-1a) 
within women over a prolonged period of Depo-Provera use (Borgdorff et al. 2015). Further 
studies have been conducted to determine if there is a link between the FGT microbiome, 
progestin-only contraceptives, and HIV within African women given the widespread 
contraceptive use and HIV acquisition (FSRH Clinical Effectivesness Unit 2017; Polis et al. 
2016; World Health Organization 2017). The use of injectable hormonal contraceptives have 
been implicated in the increased risk of STI acquisition, which are further associated with 
increased HIV acquisition (Grabowski et al. 2015; Noguchi et al. 2015). The prolonged use of 
DMPA resulted in a 100 fold decrease in G. vaginalis in the vaginal fluid in a study by Roxby et 
al. (2016), with the suggested explanation linking amenorrhea and the requisite for iron for G. 
vaginalis growth. The bacterial species L. crispatus and L. jensenii were below detection level 
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for most participants on DMPA with little or no change to L. iners. The total bacterial load was 
further shown to decrease over time with DMPA administration, with no correlation indicated 
with BV in vaginal health (Borgdorff et al. 2015; Roxby et al. 2016).  
 
1.7 Technical analysis of FGT bacteria 
Several techniques exist to quantify bacteria in a diverse range of samples. Although growth 
media has been used to culture many organisms within the FGT, some are more difficult to 
cultivate and therefore Polymerase chain reaction (PCR) is one of the most commonly used 
techniques for quantifying target DNA that does not depend on the culturability of the bacteria. 
The DNA is amplified through the use of primers, which can be custom designed and species-
specific or universal, for instance targeting all bacteria via genes targeting the hypervariable 
regions of the 16S rRNA gene. The DNA goes through an initial denaturation cycle most 
commonly at 95 ̊C, followed by a number of cycles of denaturation, annealing and extension 
after which the DNA product is run on an agarose gel with a DNA size marker to confirm 
expected amplicon size. PCR is a rapid, automated and when performed in a 384 well qPCR 
plate- high throughput quantitative technology used as an important tool for basic research 
(Lambert et al. 2013; Pabinger et al. 2014).  
Real-time quantitative PCR (qPCR) is an advancement of PCR where simultaneous 
amplification and quantitation of a target gene is possible. The initial amount of template DNA 
can be quantified based on the relationship between cycle number and fluorescent threshold 
signal level where the higher the initial DNA concentration, the fewer cycles required to reach 
the threshold level (Pabinger et al. 2014; Pfaffl 2004; Pfaffl & Wittwer 2015).  qPCR can be 
used for relative quantitation of bacteria through the use universal bacterial 16S rRNA primers, 
followed by sequencing in order to identify the species present. qPCR can be used for absolute 
quantification through the use of species specific primers in relation to a standard curve 
constructed through serial dilution of DNA extracted from a positive control reference 
bacterium. This technique allows absolute quantification of the bacteria of interest (copies/µL), 
which can be converted to bacterial copy numbers based on the reference bacteria’s genome size 
(see Methods Chapter 3 for details) (Grunenwald & Kramer n.d.; Hermann-bank et al. 2013; 
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Roche 2003; Smith & Osborn 2009).  With the increased use of this technique as a tool for gene 
expression, pathogen detection and biomolecular diagnostics, it is important to have stringent 
quality control measures in place. As such the Minimum Information for Publication of 
Quantitative Real-Time PCR Experiments (MIQE) has been established in order to maintain the 
standard of qPCR for all research (Bustin 2010; Pabinger et al. 2014).  
Next Generation Sequencing (NGS) is used for 16S rRNA, small subunit rRNA, hypervariable 
regions, rDNA, and metagenomics sequencing. NGS has multiple clinical applications such as 
forensic genetics, infectious disease surveillance, pathogen outbreaks and is in the early stages of 
clinical diagnostics (Jones et al. 2015; Illumina 2013; Voelkerding et al. 2010). NGS involves 
the sequencing of stretches of target DNA in order to identify the relative abundance of bacteria 
present. Sanger sequencing was the first form of sequencing and since, the advent of NGS has 
progressed to 454 pyrosequencing, Illumina MiSeq, Illumina HiSeq and Ion Torrent sequencing 
(Tan et al. 2015). NGS is a high throughput analysis technique which has a diverse set of 
applications above DNA sequencing such as re-sequencing, microsatellite analysis and Single 
nucleotide polymorphism (SNP) genotyping, multiplexing and whole-genome sequencing with 
tunable resolution, target sequencing and enrichment (Czerniecki & Wołczyński 2011; Illumina 
2013; Wienkoop & Weckwerth 2006).  
In this study, we aimed to compliment Illumina MiSeq relative abundance analysis of the vaginal 
microbiota of adolescent females by development and application of qPCR. This study aimed to 
identify the presence of a relationship between the factors such as high risk HPV subtypes, high 
genital inflammation BV positive, older adolescent age groups, DMPA hormonal contraceptives 
and the presence of an STI in relation to increased quantities of the key bacterial species which 
may influence HIV acquisition as discussed in the literature review.  
 
1.8 Aims of this Study 
1. To develop an assay for absolute quantitation of L. jensenii, L. gasseri, L. crispatus L. 
iners, G. vaginalis and P. bivia in adolescent genital tract in HIV negative South African 
adolescent females.  
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2. To analyze relationships between the copies/ng of the bacteria, and relate the absolute 
quantities to BV status, inflammation, age, hormonal contraceptive and STIs. 
 
1.9 Objectives of this Study 
1. In HIV negative adolescent females in South Africa, to asses any associations between 
the copies/ng of bacterial species of interest L. jensenii, L. gasseri, L. crispatus L. iners, 
G. vaginalis and P. bivia and; 
a. High and Low Inflammatory cytokine levels, 
b. BV Positive, Intermediate and Negative based on Nugent scores, 
c. Age (stratified as 16-18 years old vs 19-22 years old), 
d. DMPA, Nur Isterate, and Implanon hormonal contraceptives, 
e. The presence or absence of STIs (N. gonorrhea, C. trachomatis, HSV-2, T. 
vaginalis, M. genitalium, T. pallidum, H. ducreyi) 
 
1.10 Hypothesis 
We hypothesize that L. jensenii, L. gasseri, and L. crispatus will be more abundant in HIV 
negative female adolescent vaginal samples that contain low levels of inflammatory cytokines 
and/or are BV negative and/or have no STI, and/or are using the hormonal contraceptives Nur 
Isterate or Implanon between the ages of 16-18 years old.  
We further hypothesized that L. iners, G. vaginalis and P. bivia will be more abundant in HIV 
negative adolescent female vaginal samples that contain high levels of inflammatory cytokines 
and/or are BV positive and/or have one or more STIs and/or using the hormonal contraceptive 
DMPA between the ages of 19-22 years old.  
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Chapter 2: Cohort Characteristics 
2.1 Study Design 
The research group working under the Women’s Initiative in Sexual Health (WISH) cohort 
(HREC REF 267/2013) aimed to look at the relationship between inflammatory cytokines, BV, 
STI’s and genital tract microbiome in the FGT in HIV negative adolescent females in South 
Africa at high risk for HIV. The ethical approval of this MSc project (HREC REF: 678/2015) 
was granted on the 17 September 2015 as part of the WISH cohort ethical approval. Here, we 
aimed to identify the composition of the vaginal microbiome in the mucosa of the female genital 
tract, and to relate these to the composition of cervical target cells for HIV infection and levels of 
inflammation in the cervix. Next Generation Sequencing of 16S rRNA was previously performed 
by our group for this cohort to profile the FGT microbiome – mostly to genus level, with some 
species level identification (Lennard, manuscript in preparation). Participants were drawn from 
the Masiphumelele Youth Centre based in Masiphumelele, Cape Town, Western Cape. 
Participants were chosen from this area since there is a high HIV prevalence (21.9% in 2004 
(Lawn et al. 2006)) and thus an applicable population to assess adolescent HIV risk. 
2.2 Recruitment of participants 
HIV-negative, sexually active, adolescent females aged 16-22 years were recruited from the 
Masiphumelele Youth Centre. Participants provided written consent if >= 18 years old, or for 
participants < 18 years old, their guardians provided written consent while the adolescent 
provided signed assent.  
2.3 Exclusion criteria 
Participants were excluded according to the following criteria: 
1. Participants younger than 16 years or older than 22 years old. 
2. Participants who had a positive pregnancy test or had used anything that contained 
spermicide within 48 hours prior to sampling.  
3. Participants were excluded if they had inserted anything in their vagina within 24 hours 
before sampling (including but not limited to protected or unprotected vaginal 
intercourse). 
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4. Participants who had douched within 48 hours before sample collect, or were 
menstruating.  
5. Participants were excluded if they had taken antibiotics within the two weeks prior to 
sampling. 
6. HIV positive participants were excluded and referred for care. 
2.4 Participants and sample collection 
The cohort participants were sexually active female adolescents between the ages of 16 and 22 
who were enrolled in the WISH study at the Masiphumelele Youth Centre. A detailed 
questionnaire was completed by each participant in order to establish sexual practices, 
demographics, menstrual cycle, antibiotic used, STI symptoms and adherence in terms of 
condom and contraceptive use for the study. Samples were collected in the luteal phase of the 
menses cycle from participants taking no HC. A physical exam was performed and the following 
vaginal specimens were collected;  
1. A softcup to collect vaginal secretions for measurement of cytokines,  
2. A lateral wall swab for 16S microbiome profiling, 
3.  An endocervical swabs or cervical mucous plug for HPV testing,  
4. A vulvovaginal swab for STI’s and BV testing  
5. Two Digene cervical cytobrushes for cervical immune and epithelial cells.  
2.5 Human-immunodeficiency virus (HIV) testing 
HIV testing was performed using a Rapid assay on a blood sample retrieved through a prick to a 
finger, the result of which was verified using a second, Rapid test for positive samples. 
Intermediate results were sent for ELISA confirmation. 
2.6 Bacterial vaginosis (BV) testing 
BV was diagnosed based on Nugent Scoring on a vaginal swab slide where a Nugent score of 0-
3 and was considered BV-negative, a Nugent score of 4-6 BV-intermediate and a Nugent score 
of 7-10 BV-positive. The pH was noted during the sampling process, as well as symptoms such 
as the presence of heavy discharge and the colour of the patients discharge. The presence of 
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“Clue” cells were taken into account when determining Nugent Scores. All symptomatic BV 
cases were treated through the Masiphumelele Youth Centre. 
2.7 Sexually Transmitted Infections (STIs) testing 
All female participants who consented to this study provided vulvovaginal swabs, which were 
tested for N. gonorrhea, C. trachomatis, HSV-1, HSV-2, T. vaginalis, M. genitalium, T. 
pallidum, and H. ducreyi at the mucosal sampling visit. The results of the tested samples were 
made available for all participants who tested positive for one or more of the infections. These 
participants were prescribed treatment as well as counseling on site. T. pallidum was not 
included in the categorization of viral versus bacterial STI comparisons as there were no positive 
results.  
STI screening was performed by multiplex PCR on the DNA extracted from vulvovaginal swabs 
(Lewis 2000). HSV-1, HSV-2, T. pallidum, and H. ducreyi were identified through M-PCR using 
targeted gene primers. Physical exams were performed as part of the identification of T. pallidum 
and no ulcers were present. Overall there were no T. pallidum results. HSV-1 and HSV-2 were 
identified as a result of both the serology and M-PCR positive results, however, only PCR results 
were used for this analysis (i.e. only active shedding was taken into account). The serology 
results for HSV-1 and HSV-2 were not incorporated into the results such that analyses were 
performed based on the presence of absence HSV-1 and HSV-2 alone. Slides were prepared to 
identify candida hyphae and spores.  
2.8 Next Generation Sequencing (NGS) of 16S rRNA 
NGS was carried out through the extraction of microbial DNA using a MoBio Ultraclean 
microbial DNA extraction kit from cervical swabs in order to identify the bacteria present within 
the female genital tract. The following universal primers were used to amplify the SSU rRNA 
gene; 
515F 5’-GTGCCAGCMGCCGCGGTAA-3’ and 907R 5’- CCGTCAATTCCTTTRAGTTT-3’. 
These universal primers allow identification of bacteria present within the participant samples by 
Illumina Miseq (V3 chemistry 300 bp paired end).  
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The data analysis was performed by Katie Lennard (PhD) using UPARSE, Quantitative 
Inference In Microbial Ecology (QIIME) and custom R scripts.   
2.9 Cohort characteristics  
Cohort characteristics are summarized in Table 2.9.  
Table 2.9: Summarized characteristics of the WISH cohort according to the following categories.  
Category Sample 
Size 
Classification type Score Groups Participants 
(%) 
BV 143 Nugent Scoring 0-3 Positive 56 (39.16) 
 4-6 Intermediate 17 (11.89) 
 7-10 Negative 70(48.95) 





(PAM) using an R 
package ‘cluster’ 
with a k-value of 2 
Low 42 (30) 
 High 98 (70) 
Age 143 Age in years Years 16-18 75 (52.45) 
 19-22 68 (47.55) 
Hormonal 
Contraceptives 
136 Type Prescribed DMPA 25 (18.38) 
 Nur Isterate 102 (75) 
 Implanon 9 (6.62) 
STI 140 Presence/absence 
of any one STI 
N. gonorrhea, C. 
trachomatis, HSV-
2, HPV, T. 
vaginalis, M. 
genitalium 
None 62 (44.29) 
 Present  78 (55.71) 
Bacterial STI 143 Absence,  presence 
of one, presence of 





None 77 (53.85) 
 One 51 (35.66) 
 Two< 15 (10.49) 
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Mycoplasma 
genitalium 
Viral STI 143 Absence,  presence 
of one, presence of 
two 
HSV-2, HPV None 46 (32.17) 
 One 91 (63.63) 
 Two 6 (4.20) 
HPV 90 Absence, presence 
of low or high risk 
subtypes 
 None 29 (32.22) 
 6, 11, 40, 42, 54, 
55, 61, 62, 64, 67, 
69, 70, 71, 72, 81, 
83, 84, 89 
(CP6109), IS39 
Low Risk 27 (30) 
 16, 18, 26, 31, 33, 
35, 39, 45, 51, 52, 
53, 56, 58, 59, 66, 
68, 73, 82 
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Chapter 3: Laboratory Methods and Materials 
In this chapter, the protocols used in laboratory for processing and analysis of the WISH vaginal 
samples will be discussed.  
We used qPCR to quantify the presence of six microbes in the genital tract of South African 
adolescents. In addition to providing absolute quantitative data, the qPCR-based data 
complements the 16S rRNA-based microbiome data previously generated for this cohort by 
providing data on species-level taxonomic annotation for specific bacteria of interest that were 
only identified to genus level via 16S sequencing.  
3.1. Bacterial reference strains 
The ATCC reference strains Lactobacillus gasseri (ATCC 9857), Lactobacillus crispatus 
(ATCC 33197), and Lactobacillus jensenii (ATCC 25258) were kindly provided by Remy 
Froissart PhD., from the Division of Virology, University of Cape Town. The ATCC reference 
strains Lactobacillus iners Strain UPII 143-D (Product sheet HM-126), Gardnerella vaginalis 
Strain UPII 315-A (Product sheet HM-133) and Prevotella bivia Strain DNF00188 (Product 
sheet HM-1088) were obtained from BEI Resources, Manassas USA.  
The bacterial reference strains were used as positive controls and to perform absolute 
quantification by constructing standard curves with genomic DNA extracted from there strains. 
3.1.1 Bacterial Culturing 
3.1.1.1 Lactobacillus spp. growth conditions 
Lactobacillus gasseri (ATCC 9857), L. jensenii (ATCC 25258) and L. crispatus (ATCC 33197) 
were cultured in a sterile broth composed of 51 g/L of De Man, Rogosa, Sharpe broth (MRS, 
Sigma), 50 mg/l of L-Cysteine (Merck) and 1 ml of Tween 80 (Sigma) for a minimum of 48 
hours at 37°C. The ATCC Lactobacillus strains were allowed to thaw for 20 minutes on ice, after 
which a sterile tooth pick was used to culture 1.4 mL of MRS Broth in a 1.5 mL Eppendorf Tube 
and incubated at 37°C. After 48 h of growth, the 1.5 mL Eppendorf with cultured MRS Broth 
were vortexed briefly and transferred to a sterile 50 mL Falcon tube, which was topped up with 
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additional MRS Broth. The 50 mL Falcon tube was vortexed briefly and incubated at 37°C to be 
used for DNA extraction. 
A 1.5 mL Eppendorf Tube containing 1.4 mL cultured broth was centrifuged at 5500 RPM for 5 
minutes and 900 µL of supernatant was discarded. After vortexing the pellet, 250 μl of 60% 
glycerol (v/v) was added and vortexed briefly three times and subsequently stored at -80°C for 
future use.  
3.1.1.2 Lactobacillus iners, Prevotella bivia and Gardnerella vaginalis. growth conditions 
Lactobacillus iners (UPII 143-D), Prevotella bivia (DNF00188) and Gardnerella vaginalis 
(UPII 315-A) were cultured individually in reduced Schaedler Broth with 5% horse blood for a 
minimum of 48 hours at 37°C. The three strains were allowed to thaw for 20 minutes on ice, 
after which a sterile tooth pick was used to collect bacterial stock and culture 1.4 mL Schaedler 
Broth with 5% horse blood in a 1.5 mL Eppendorf tube and incubated at 37°C for 48 h, followed 
by brief vortexing and transferred to a sterile 50 mL Falcon tube which was topped up with 
additional Schaedler Broth with 5% horse blood. The 50 mL Falcon tube was vortexed briefly 
and incubated for a minimum of 48 hours at 37°C to be used for DNA extraction. 
3.1.2 DNA Extraction 
DNA was extracted from vaginal lateral wall swabs and bacterial cultures using two different 
kits, both designed to lyse the cell walls of Gram positive and Gram negative bacterium. 
The MoBio Powersoil® DNA Isolation Kit (MoBio Laboratories, Inc., USA, Biocom Biotech, 
SA) was used to extract bacterial DNA from the vaginal lateral wall swabs. Briefly, bacterial cell 
walls were lysed with buffer C1 which contains sodium dodecyl sulfate (SDS) detergent that 
breaks down fatty acids and disrupts the bacterial cell walls, and by mechanical disruption (bead 
beating). Buffers C2 and C3 contain inhibitors that remove sample contaminants including non-
DNA organic and inorganic material and proteins. Buffer C4 selectively binds DNA to the silica 
filters thus further excluding contaminants during the wash step. The final ethanol-based wash 
buffer C5 is the final step in removing any excess contaminants within the sample DNA. 
The Qiagen Blood and Tissue DNA Maxi Extraction Kit with buffers B1 and B2 (Whitehead 
Scientific (Pty) Ltd, Cape Town), was used to extract DNA from bacterial cultures.  Proteinase 
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K, which cleaves peptide bonds, was used to digest proteins, and RNase A to digest RNA (at the 
C and U residues). Lysozyme was used to lyse bacterial cell walls – more specifically 
peptidoglycan, which is found in both Gram-negative and –positive bacteria, but is most 
effective against the latter.  Buffer B1 contains Tween 20 and Triton X-100, which are 
polyethylene and polyethylene oxide surfactants respectively, which act in conjunction with 
lysozyme to lyse bacterial cell walls. Buffer B2 contains Tween 20 and guanidine hydrochloride, 
a chaotropic agent that denatures proteins.  
The quality and concentration of the DNA was confirmed with Qubit Fluorometric Quantitation 
(ThermoFisher Scientic Inc, 200 Smit Street, Fairland, 2195 Johannesburg, South Africa), using 
the Picogreen target-specific fluorescent dye, High Sensitivity dsDNA assay as per the user 
manual. 
3.1.3 Primer Design 
The species-specific primers used for the detection of each of the bacterial species of interest 
within this study were either sourced from the literature or designed de novo (Table 3.1.1). The 
specificity for all primers was confirmed using NCBI Primer BLAST website (National Center of 
Biotechnology Information, National Institute of Health, Bethesda, MD), Ribosomal Database 
Project Probe Design (http:// www.rdp.cme.msu.edu/) and PriSM Primer Designing Tool. All 
primers were obtained from Integrated DNA Technologies Inc., Coralville, IA. 
Table 3.1.3: Primers of the target genes for detection of bacteria of interest and protocol source 



















(Jespers et al. 2012; 
Tamrakar et al. 2007)  
Lactobacillus GTCTGCCTTGAA ACAGTTGATAGGC (De Backer et al. 2007; 
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(Jespers et al. 2012; Malaguti 








(Jespers et al. 2012; Malaguti 






(Premaraj et al. 1999); 
followed by Aroutcheva et 
al., 2008; followed by 
(Dumonceaux et al. 2009) 
 
3.2 Polymerase Chain Reaction 
3.2.1 Polymerase Chain Reaction (PCR) of ATCC reference strains (Primer confirmation) 
PCR was run on DNA extracted from the pure cultures of each bacterium of interest to ensure 
primer specificity and to confirm the expected amplicon size. A total of 10 μL Roche 
LightCycler® 480 SYBR Green I Master Mix was used per reaction, with 0.5 μL of each 10 µM 
primer, 3 μL template gDNA of the serially diluted positive standard controls and 6 μL nuclease-
free water for a total volume of 20 μL (Table 3.2.1). Difference cycle conditions were optimized 
and used for each bacterium (Table 3.2.2) 
Table 3.2.1: PCR mixture components. 
Reagents for PCR Volume (μL) 
Master mix 10 
Forward Primer 0.5 
Reverse Primer 0.5 
Template DNA 3 
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Table 3.2.2: PCR conditions and amplicon size of the target gene for the six bacteria of interest. 
Bacteria Initial 
Denaturation 




















15 95 15 95 60 60 20 72 45 172 
Lactobacillus 
jensenii 
15 95 15 95 55 60 60 72 40 160 
Lactobacillus 
iners 
15 95 15 95 55 60 60 65 35 158 
Lactobacillus 
gasseri 
15 95 15 95 60 57 60 65 40 322 
Gardnerella 
vaginalis 
15 95 45 95 45 55 45 72 50 330 
Prevotella 
bivia 
5 95 20 95 120 60 300 74 35 156 
 
3.2.2 Gel electrophoresis 
Gel electrophoresis was used to confirm accuracy of the primers based on the size of the PCR 
product and the presence of a single band. Amplified DNA (4 μL) was separated on 1.6% 
agarose gel (Whitehead Scientific Agarose, #D1-LE) by electrophoresis in 1X TAE buffer (40 
min, at 120 V). DNA was visualized with GelRed and viewed under a UV-Trans-illuminator. A 
ThermoFisher O’Gene Ruler® 100 bp ladder was used for sizing of the PCR amplicon bands. 
 
3.2.3 Serial dilution calculations for the known standard controls 
In order to calculate the number of copies/µL of bacteria present in the extracted DNA for each 
standard control, the method described by Dolezel et al., (2003) was used. Briefly, the 
assumptions made are that the average weights for the nucleotide pairs AT and GC are 615.3830 
and 616.3711 respectively, which can be converted to an absolute value through the 
28 
 A. O. Breetzke 





Thus, the average weight of a single nucleotide pair can be calculated at 1.023x10
-9
 pg, where a 
single picogram of DNA would be equivalent to 0.978x10
9
 base pairs.  
Genome size (bp) = (0.978x10
9 
bp) x DNA content (pg)  
DNA content (pg) = Genome size (bp) / (0.978x10
9 
bp) 
Therefore, as an example, for L. crispatus the complete genome size is 2195108.667 bp (Table 
3.2.5) DNA content (pg) = 2195108.667 bp / (0.978x10
9 
bp)  
      = 0.002244487 pg 
1 ng DNA from L. crispatus contains = 1000 pg / DNA content (pg) 
             = 1000 pg / 0.002244487 pg 
            = 445,536.0296 copies 
L. crispatus DNA concentration = 290 ng/µL 
The number of copies of DNA per µL = Number of copies DNA x DNA concentration (ng/µL) 
             = 445,536.0296 copies x 290 ng/µL 
             = 129 205 448.6 copies/µL 
C1V1 = C2V2 
(129 205 448.6 copies/µL) x V1 = (10
6
 copies/µL)x(1000 µL) 
V1 = ((10
6
 copies/µL) x (1000 µL)) / (129 205 448.6 copies/µL) 
V1 = 7.739 µL  
Therefore 7.739 µL of L. crispatus DNA was added to 992.261 µL distilled water to dilute it to 
10
6
 copies/µL. From there the DNA was serially diluted from 10
6
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The calculations for the six bacterial reference strains can be seen below in Table 3.2.3. See table 
3.5.2 for data transformation software. 
Table 3.2.3: Serial dilution calculation summary table. 









Volume of DNA into 1 
mL for 10^6 copies/µL 
L. crispatus 33820 290 0.00224449 445536.030 129205449 7.739611688 
L. jensenii 25258 870.6 0.00169902 588576.408 512414620 1.951544629 








4.28 0.00163010 613458.066 2625600.5 380.8652505 
      
Volume of DNA into 40 
µL for 10^6 copies/µL 
P. bivia DNF00188 2.773 0.00254910 392295.603 1087966.47 36.7658 
*
For all calculations, 1 pg of DNA was considered to have 0.97x10
9 
bp as per the explanation 
above in 3.2.3. See table 3.5.2 for data transformation software. 
Table 3.2.4: Calculation and source for the whole genome size for each bacterium. 









ATCC PRJNA30641, PRJNA37951, PRJNA38361, 
PRJNA38513, PRJNA36325, PRJNA42533, 
PRJNA52107, PRJNA52105, PRJNA222257, 
PRJNA200566,PRJNA267549, PRJNA213996, 
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PRJNA231005, PRJNA222257,PRJNA34097, 




ATCC PRJNA42535, PRJNA42543, PRJNA203137, 
PRJNA36379, PRJNA163367,PRJNA208361, 
PRJDB635, PRJNA267549, PRJNA267549, 
PRJNA31203, PRJNA40683, PRJNA84, 
PRJNA53061, PRJNA52039, PRJNA52037, 
14 1969914.29 
L. iners BEI PRJNA52035, PRJNA52033, PRJNA52031, 
PRJNA43549, PRJNA52041, PRJNA52043, 











PRJNA181312, PRJNA53359, PRJNA53893, 
PRJNA40893, PRJNA40895, PRJNA52049, 
PRJNA42431, PRJNA42443, PRJNA42445, 
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3.3 qPCR Optimization 
Optimization was undertaking by adjusting the following parameters of the previously published 
qPCR protocols (Table 3.1.3): 
1. Protocol 
Protocols- for each bacterial species of interest were found in the literature and run as 
published for the first trial run. Thereafter, parameters were manipulated; including 
primer concentration, annealing temperature, cycle number and sequence as a last step in 
order to achieve acceptable standard curves with low levels of primer dimers, error values 
and high efficiency values, as outlined below. If the protocol could not be improved upon 
by manipulating these parameters, a new protocol from another published article was 
used and the same steps followed as mentioned below to optimize.  
 
2. Primer optimization 
Prior to use in the wet lab, primers were first tested in silico using NCBI Primer BLAST 
to ensure primer specificity and a low level of self-complementarity. Thereafter, a PCR 
trial run was performed. If the primers amplified the correct product size in a PCR trial 
run they were kept for further qPCR optimization. If the primers were found to be 
consistent and sensitive, they were used to construct a standard curve. 
The primer concentration was further optimized by applying different starting 
concentrations. The optimum primer concentration was determined based on lower error 
and higher efficiency values in the standard curves.  
 
 
3. Annealing temperature optimization 
The annealing temperature used in the literature was used for the first qPCR trial run. If 
the DNA started amplifying at a later cycle number than anticipated, the temperature was 
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4. Cycle number optimization 
The first trial run qPCR was run with the number of cycles specified in the literature. If 
the DNA amplified at a later cycle number than anticipated, of which a possible cause is 
low DNA concentration, the cycle number was increased to by no more than 20 cycles to 
ensure complete amplification of the sample and standard DNA. 
 
5. Initial denaturation 
The initial denaturing temperature was found to be 95 ̊C in all protocols used. The 
temperature was kept the same when optimizing, however, the time the denaturation 
cycle ran was adjusted when it was found the DNA did not amplify sufficiently after the 
initial and cycle denaturation.  
 
6. Serially diluted standards 
Positive controls (DNA extracted from each reference strain) were diluted to 10
6 
copies/µL from the stock DNA and then serially diluted down to 10
0 
copies/µL. If there 
were issues with the precision or accuracy of the standard replicates, the DNA was re-
serially diluted in order to improve the standard curve error and efficiency. The goal error 
and efficiency values were <0.05 and 2, respectively.  
After optimization for each bacterium, the final qPCR cycle conditions were determined (Table 
3.2.7).  
 
3.3.1 qPCR Optimization Outcomes 
Multiple plates were run with different conditions until the error and efficiency values were as 
close to 0.05 and 2 respectively, as could be optimized. A summary of the plate errors and 
efficiencies for each step in the optimization process can be found in Table 3.3.1. All 
optimization plates are named as V1 with the point number indicating the number of plate 
replicate for each bacterium.  
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Table 3.3.1: Summary table for the optimization statistics for the following bacteria. 
Bacteria qPCR Plate Error Efficiency 
L. crispatus V1.1 0.565 1.705 
 V1.2 2.322 0.00 
 V1.3 1.141 1.717 
 V1.4 (750 nM) 1.301 1.358 
       (500 nM) 0.221 1.628 
       (250 nM) 0.223 1.985 
 V1.5 0.219 1.783 
 V1.6 0.731 1.699 
 V1.7 0.177 1.890 
L. gasseri V1.1 0.0223 1.828 
 V1.2 0.0436 1.851 
 V1.3 0.0442 1.839 
L. jensenii V1.1 0.312 1.864 
 V1.2 0.0210 1.921 
L. iners V1.1 0.0335 2.022 
 V1.2 0.0805 1.953 
G. vaginalis V1.1 0.370 1.835 
 V1.2 0.248 1.733 
 V1.3 0.351 1.671 
 V1.4 0.242 1.719 
 V1.5 0.157 1.875 
 V1.6 0.204 1.766 
P. bivia V1.1 1.191 0.997 
 V1.2 0.306 2.393 
 V1.3 0.823 1.714 
 V1.4 0.589 1.765 
 V1.5 0.283 1.983 
 V1.6 0.0376 1.904 
 V1.7 0.210 2.089 
 V1.8 0.419 2.294 
 V1.9 0.393 2.049 
 V1.10 0.628 1.550 
 V1.11 0.618 2.922 
 V1.12 0.0830 2.039 
 V1.13 0.0608 1.993 
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The qPCR optimization process outcomes for the three bacterium L. crispatus, G. vaginalis and 
P. bivia have been included as an example. The optimization process outcomes for the other 
bacterium have been recorded in Appendix C, qPCR Optimization.  
 
3.3.2 Lactobacillus crispatus 
A total of seven qPCR plates were run in order to optimize the cycle conditions for L. crispatus 
to get the error close to 0.05, the efficiency to 2.00, single melt curve peaks and clear 
amplification curves for the standard control. The first trial plate run for L. crispatus (V1.1) 
contained 10 µL SYBR Green I master mix, 1.5 µL of both the forward and reverse 10 µM 
primers to give a final concentration of 750 nM, 5 µL for each positive controls and 
corresponding amounts of Nuclease Free Water (NFW) to make up the total volume to 20 µL. 
The positive control was diluted from 10
6
 copies/µL to 10
-2
 copies/µL. Each sample was run in 
triplicate, with the NTC containing all the reagents minus the template gDNA or the known 
standard DNA. The participant sample W132 V1 A was run in triplicate of initial concentrations 
of 10 ng/µL, 7 ng/µL, 5 ng/µL, 2.5 ng/µL and 1 ng/µL. The following qPCR conditions were 
followed, 95 ̊C for 15 min initial denaturation, followed by 40 cycles of 95 ̊C for 15 s, 60 C̊ for 1 
min and 72 for 20 s (Figure 3.3.2.1 A, Figure 3.3.2.2 A). However, the error and efficiency 
values for the standard curve were not specific enough and the triplicates of the positive control 
DNA did not amplify neatly where the replicates started amplifying at different cycles.  
Therefore a few changes were made to the second trial plate for L. crispatus (V1.2) which was 
run with the same volumes and concentrations of reagents, standard control dilutions and 
participant sample W132 V1 A as mentioned in V1.1 except for the standard positive controls 
which were run in triplicate, but two of the triplicates had gDNA that had gone through PCR 
amplification using the same primers prior to qPCR and one replicate had gDNA that had not 
gone through qPCR prior to amplification in order to ensure the starting concentrations were 
sufficient. Furthermore, two different primer concentrations were run, 3 µM and 0.5 µM which 
resulted in final primer concentrations of 225 nM and 37.5 nM respectively to determine the 
ideal concentration of primer for amplification. The following qPCR conditions were followed, 
95 ̊C for 5 min initial denaturation, followed by 40 cycles of 95 ̊C for 20 s, 60 ̊C for 45 s and 72  
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for 15 s (Figure 3.3.2.1 B, Figure 3.3.2.2 B). This resulted in the positive control DNA forming 
odd amplification curves with only the two highest dilutions amplifying sufficiently, as well as a 
standard curve with poor error and efficiency values. 
 The third trial plate for L. crispatus (V1.3) contained the same reagent conditions as V1.1, 
except for the use of 1 µL of each primer, 3 µL of the standard control and sampled DNA was 
used. The participant sample W132 V1 A DNA concentrations were also varied; 1 ng/µL and 0.5 
ng/µL to determine the minimum concentration for amplification. The ATCC positive bacterial 
control standards included dilutions from 10
6
 copies/µL to 10
1
 copies/µL. The following qPCR 
conditions were followed, 95 ̊C for 5 min initial denaturation, followed by 40 cycles of 95 ̊C for 
15 s, 60 ̊C for 20 s and 72 ̊C for 10 s (Figure 3.3.2.1 C, Figure 3.3.2.2 C). This led to a high error 
rate and differences in the replicates for the positive control dilutions. The fourth trial plate for L. 
crispatus (V1.4) had the same cycle conditions and reagent volumes as V1.3 with some changes. 
Varying volumes of both the forward and reverse 10 µM primers, 0.5 µL, 1 µL and 1.5 µL were 
used to give a final concentration of 250 nM, 500 nM and 750 nM, in order to determine the 
most ideal primer concentration as well as the inclusion of sample W037 V1 which had high 
levels of lactobacilli bacteria present with 16S sequencing (Figure 3.3.2.1 D, Figure 3.3.2.2 D).  
The dilution of the primers to 250 nM resulted in the best error and efficiency readings for the 
standard curve.  
For the fifth trial plate for L. crispatus (V1.5), the same cycle conditions were used as in V1.4 
with 0.5 µL of both the forward and reverse 10 µM primers, positive controls diluted from 10
6
 
copies/ L to 10
-2
 copies/µL and the annealing temperature was reduced from 60 ̊C to 58 ̊C to try 
reduce the formation of primer dimers with the remaining conditions the same as V1.4 (Figure 
3.3.2.1 E, Figure 3.3.2.2 E). The error value was higher than ideal with the replicates of the 
standards failing to amplify at concurrent cycles. The sixth trial plate for L. crispatus (V1.6) was 
run with the same reagent concentration and volumes, as well as the conditions with the adjusted 
annealing temperature as were used for V1.5. The positive control DNA was re-diluted to try 





copies/µL (Figure 3.3.2.1 F, Figure 3.3.2.2 F). The second dilution did not improve replicate 
accuracy, and resulted in an increase in the standard curve error value. The seventh and final trial 
plate for L. crispatus (V1.7) used the same reagents and DNA in the same concentrations as used 
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in V1.6 with the standard control dilutions from 10
6
 copies/µL to 10
0 
copies/µL. New species 
specific primers for L. crispatus were designed targeting the transcription start site, tested with a 
PCR by running the product on a gel and confirming the product size and presence of a single 
band (Figure 3.3.2.1 G, Figure 3.3.2.2 G). This resulted in error and efficiency values of 
sufficient readings with the replicates of the positive control dilutions amplifying more 
accurately.  
 
B – Plate V1.2 
Error: 2.322 
Efficiency: 0.00 
C – Plate V1.3 
Error: 1.141 
Efficiency: 1.717 











A – Plate V1.1 
Error: 0.565 
Efficiency: 1.705 
E – Plate V1.5 
Error: 0.219 
Efficiency: 1.783 
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Figure 3.3.2.1:  Roche LightCycler® 480 absolute quantitative derivative max amplification 
curve for each of the seven L. crispatus optimization plates (V1.1-V1.7). The fluorescence (465-
510 nm) is indicated on the y-axis and the number of cycles is indicated on the x-axis. Red and 
brown indicate positive amplification in the unknown sample and the positive control standards 
respectively, and green indicates negative amplification in the wells.  
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Figure 3.3.2.2:  Roche LightCycler® 480 melt curve for each of the seven L. crispatus 
optimization plates (V1.1-V1.7). The –d/dT fluorescence (465-510 nm) is indicated on the y-axis 
and the temperature ( ̊C) is indicated on the x-axis. Red indicates a single peak (product), green 
indicates two peaks and blue indicates no peak for each well. 
A similar process was followed for L. gasseri, L. jensenii and L. iners. The first optimization 
plate for L. gasseri, L. jensenii and L. iners was run using the final reagent concentration and 
A – Plate V1.1 
 
B – Plate V1.2 
D – Plate V1.4 
 
C – Plate V1.3 
G – Plate V1.7 
F – Plate V1.6 
 
E – Plate V1.5 
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volumes as those in the seventh plate of L. crispatus V1.7 as the lactobacilli species have very 
similar optimal qPCR conditions. Optimization for the other lactobacilli species required far less 
trouble-shooting. (See appendix C, qPCR Optimization).  
 
3.3.3 Gardnerella vaginalis 
In order for the qPCR conditions of G. vaginalis to be optimized, six different trial plates were 
run to get the best error and efficiency values. The first trial plate for G. vaginalis (V1.1) was run 
using the same reagent and DNA volumes and concentrations as used in the L. crispatus final 
trial plate (V1.7) with the following qPCR conditions; 95 ̊C for 15 min for the initial 
denaturation of the DNA followed by 50 cycles if 95 ̊C for 45 s, 55 ̊C for 45 s, and 65 ̊C for 45 s 
(Figure 3.3.3.1 A, Figure 3.3.3.2 A). The first six serial dilutions of the positive control amplified 
well, however the lower dilutions did not reach the same amplification and the replicates did not 
at consistent cycles. The second trial plate (V1.2) was run with a final extension temperature of 
72 ̊C for 45 s in order to try improve primer specificity (Figure 3.3.3.1 B, Figure 3.3.3.2 B) with 
little improvement and high levels of primer dimerization, while the third trial plate (V1.3) was 
run using the same conditions as the previous trial plate (V1.2), but for 40 cycles in an attempt to 
accurately amplify the lower dilutions of the positive control DNA (Figure 3.3.3.1 C, Figure 
3.3.3.2 C). Since tis did not seem sufficient, the fourth trial plate (V1.4) was run using the same 
conditions for 60 cycles (Figure 3.3.3.1 D, Figure 3.3.3.2 D). The increase in cycle number did 
not amplify the low dilutions of the positive control DNA to the same degree as the higher 
dilutions with an increase in primer dimers and thus the fifth trial plate (V1.5) was run using the 
same conditions as used in the first trial plate (V1.1), with a change in cycle conditions. The 
following qPCR conditions were followed, 95 ̊C for 15 min for the initial denaturation of the 
DNA followed by 50 cycles if 95 ̊C for 30 s, 60 ̊C for 1 min, and 72 ̊C for 45 s (Figure 3.3.3.1 E, 
Figure 3.3.3.2 E). This change improved the height of the amplification curves for the lower 
dilutions, but not the accuracy of replicate starting cycle number. The sixth trial plate (V1.6) 
served as a repeat for the fifth trial plate (V1.5) to confirm the error and efficiency values (Figure 
3.3.3.1 F, Figure 3.3.3.2 F). The error and efficiency values were the most consistent and as close 
to the ideal conditions as possible with a decent standard curve.  
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Figure 3.3.3.1:  Roche LightCycler® 480 absolute quantitative derivative max amplification 
curve for each of the six G. vaginalis optimization plates (V1.1-V1.6). The fluorescence (465-
510 nm) is indicated on the y-axis and the number of cycles is indicated on the x-axis. Red and 
brown indicate positive amplification in the unknown sample and the positive control standards 
respectively, and green indicates negative amplification in the wells. 
 
 
A – Plate V1.1 
Error: 0.370 
Efficiency: 1.835 
B – Plate V1.2 
Error: 0.248 
Efficiency: 1.733 
F – Plate V1.6 
Error: 0.204 
Efficiency: 1.766 
E – Plate V1.5 
Error: 0.157 
Efficiency: 1.875 
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Figure 3.3.3.2:  Roche LightCycler® 480 melt curve for each of the six G. vaginalis optimization 
plates (V1.1-V1.6). The –d/dT fluorescence (465-510 nm) is indicated on the y-axis and the 
temperature ( ̊C) is indicated on the x-axis. Red indicates a single peak (product), green indicates 
two peaks and blue indicates no peak for each well. 
 
3.3.4 Prevotella bivia 
A total of thirteen trial plates were necessary to optimize the cycle conditions for P. bivia. The 
first trial plate for P. bivia (V1.1) was consistent with the other five bacterium in that it was run 
using the same reagent volumes and concentrations as the final trial plate for L. crispatus (V1.7) 
with the adjusted qPCR cycles conditions of 95 ̊C for 15 min as the initial denaturation of the 
DNA followed by 35 cycles of 95 ̊C for 20 s, 60 ̊C for 2 min and 74 ̊C for 5 min using the first 
set of primers F 5’ GAACGATTTAGAGATAATGAGGTCC 3’ and R 5’ 
A – Plate V1.1 
 
B – Plate V1.2 
D – Plate V1.4 
 
C – Plate V1.3 
F – Plate V1.6 E – Plate V1.5 
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CCCCAGTCCGAACTGAGAAT 3’ (Figure 3.3.4.1 A, 3.3.4.2 A). The second trial plate (V1.2) 
was run using the different conditions of 95 C̊ for 15 min as the initial denaturation of the DNA 
followed by 50 cycles of 95 ̊C for 5 s, 60 ̊C for 20 s and 72 ̊C for 20 s in order to try improve the 
standard curve values (Figure 3.3.4.1 B, 3.3.4.2 B). This resulted in a lower error but unreliable 
efficiency as well as insufficient amplification of the positive control DNA. Since the 
improvement was minimal, the third trial plate (V1.3) was run the same as the second except the 
denaturation step was changed to 15 s, and we used a new set of primers 
(F5’GAACGATTTAGAGATAATGAGGTCC3’ and R5’CCCCAGTCCGAACTGAGAAT3’) 
to try improve amplification accuracy and a single melt curve product (Figure 3.3.4.1 C, 3.3.4.2 
C). The same reagent volumes and concentrations were used in the fourth trial plate (V1.4) with 
new qPCR cycle conditions; 95 ̊C for 5 min, followed by 40 cycles of 95 ̊C for 30 s, 42 ̊C for 30 
s and 72 ̊C for 30 s (Figure 3.3.4.1 D, 3.3.4.2 D). These conditions produced a high error reading 
and did not amplify the positive control DNA with a late starting cycle number. The fifth trial 





 copies/µL to try improve the standard curve values and improve the starting 
cycle number (Figure 3.3.41 E, 3.3.4.2 E). A set of cycle conditions was used for the sixth trial 
plate (V1.6) where the initial denaturation was 95 ̊C for 5 min, followed by 50 cycles of 95 ̊C for 
30 s, 60 ̊C for 30 s and 72 ̊C for 30 s (Figure 3.3.4.1 F, 3.3.4.2 F). Although the efficiency and 
error readings were good the positive control DNA was not amplifying concurrently below 10
5
 
copies/µL and had a high start cycle. 
The seventh trial plate for P. bivia (V1.7) was run using the same conditions as V1.6; except for 
a change in the annealing temperature to 50 ̊C to try amplify the standard control DNA more 
consistently (Figure 3.3.4.1 G, 3.3.4.2 G). This shifted the standard curve readings and produced 
come primer dimers and separate peaks. The eight trial plate (V1.8) was a repeat of V1.7 with re-
serially diluted standard controls from 10
9
 copies/µL down to 10
0
 copies/µL to try amplify the 
DNA at a lower CP value than 25 cycles (Figure 3.3.4.1 H, 3.3.4.2 H). This positive control DNA 
did amplify more successfully, however the error reading showed a big increase. In the ninth trial 
plate (V1.9) the same qPCR conditions were followed as mentioned in V1.8, except the 
annealing temperature was 48 ̊C and the cycle number was changed to 60 (Figure 3.3.4.1 I, 
3.3.4.2 I). The replicates of the positive control DNA serial dilutions did not amplify 
concurrently and the melt curve illustrated more than a single peak with primer dimers present. 
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The tenth trial plate (V1.10) was a repeat of V1.9 with the alteration of the annealing temperature 
to 46 ̊C (Figure 3.3.4.1 J, 3.3.4.2 J) which resulted in a slight improvement in replicate accuracy 
but not in the primer dimers and separate peaks within the melt curve. The eleventh trial plate 
(V1.11) is a further repeat of V1.9 with newly designed primers F 5’ 
TGGGGATAAAGTGGGGAACG 3’ and R 5’ ACAACACGCTTACCAA 3’ (Figure 3.3.4.1 K, 
3.3.4.2 K). This lead to the positive control DNA serial dilutions amplifying closer to each other 
and the production of two distinct peaks in the melt curve. For the twelfth trial plate (V1.12) 
same qPCR conditions as V1.9 were used, with the change of the annealing temperature to 48 ̊C, 
and two sets of serially diluted standard DNA were run. P. bivia was re-cultured, DNA extracted 
and serially diluted as well as the standards from 10
9
 copies/µL were diluted down to 10
0 
copies/ 
µL (Figure 3.3.4.1 L, 3.3.4.2 L), resulting in acceptable error and efficiency values and a single 
main melt curve peak with a lower abundance peak slightly shift. The thirteenth trial plate 
(V1.13) was a repeat of V1.12 with the serially diluted standard DNA run from 10
6
 copies/µL to 
10
0 
copies/ µL (Figure 3.3.4.1 M, 3.3.4.2 M). This final plate had sufficient error and efficiency 
readings with neat positive control replicates.  
A – Plate V1.1 
Error: 1.191 
Efficiency: 0.997 
B – Plate V1.2 
Error: 0.306 
Efficiency: 2.393 
D – Plate V1.4 
Error: 0.589 
Efficiency: 1.765 
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F – Plate V1.6 
Error: 0.0376 
Efficiency: 1.904 
E – Plate V1.5 
Error: 0.283 
Efficiency: 1.983 
G – Plate V1.7 
Error: 0.210 
Efficiency: 2.089 
H – Plate V1.8 
Error: 0.419 
Efficiency: 2.294 
I – Plate V1.9 
Error: 0.393 
Efficiency: 2.049 
J – Plate V1.10 
Error: 0.628 
Efficiency: 1.550 
L – Plate V1.12 
Error: 0.0830 
Efficiency: 2.039 
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Figure 3.3.4.1:  Roche LightCycler® 480 absolute quantitative derivative max amplification 
curve for each of the thirteen P. bivia optimization plates (V1.1-V1.13). The fluorescence (465-
510 nm) is indicated on the y-axis and the number of cycles is indicated on the x-axis. Red and 
brown indicate positive amplification in the unknown sample and the positive control standards 
respectively, and green indicates negative amplification in the wells. 
M – Plate V1.13 
Error: 0.0608 
Efficiency: 1.993 
A – Plate V1.1 B – Plate V1.2 
F – Plate V1.6 E – Plate V1.5 
D – Plate V1.4 C – Plate V1.3 
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Figure 3.3.4.2: Roche LightCycler® 480 melt curve for each of the thirteen P. bivia optimization 
plates (V1.1-V1.13). The –d/dT fluorescence (465-510 nm) is indicated on the y-axis and the 
temperature ( ̊C) is indicated on the x-axis. Red indicates a single peak (product), green indicates 
two peaks and blue indicates no peak for each well. 
M – Plate V1.13 
 
G – Plate V1.7 H – Plate V1.8 
I – Plate V1.9 J – Plate V1.10 
L – Plate V1.12 K – Plate V1.11 
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It should be noted that there were major limitations with the accurate amplification of P. bivia 
DNA due to the qPCR conditions coupled with inaccurate primers. The results were included in 
this thesis, however, they cannot be relied upon and further work and experiments will need to be 
run and optimized in future.  
 
3.4 Real-Time PCR (qPCR) Protocol 
Prior to PCR the laminar flow hood and pipettes were exposed to UV light to crosslink any 
contaminant DNA, and the master mix was kept away from any light and DNA. The qPCR 
master mix was prepared on ice in a 2 mL reaction tube by pipetting 10 μl of the LightCycler® 
480 SYBR Green I Master Mix into each well of the LightCycler® 480 Multiwell Plate, along 
with the relative amounts of PCR-grade water, forward primer and reverse primer (Table 3.4.1). 
Reactions were mixed by aspiration.   
Refer to Tables 3.1.3, 3.4.1 and 3.4.2 for qPCR conditions and primer sequences.  
A 1 in 10 serial dilution of the gDNA isolated from each of the positive control reference ATCC 
strains was prepared, ranging from 1x10
6
 copies/µL to 1x10
0
 copies/µL. A volume of 9 μl 
nuclease free water for the negative control, 3 µL gDNA template standard for the positive 
control was added to the appropriate wells. The participant sample DNA was diluted to 0.5 
ng/µL with TE Buffer, unless the DNA concentration was lower than 1 ng/µL, in which case 
samples were used as is. Once the master mix, positive standard control and sample DNA, and 
PCR-grade water had been added to the white multiwell plate, it was sealed with LightCycler® 
480 Multiwell Sealing Foil. All non-template controls, positive controls and samples were run in 
triplicate. The Multiwell Plate was placed in the centrifuge and centrifuged at 2500 x g for 2 
minutes.  
After the Multiwell Plate has been spun down, the qPCR cycle is run using the Roche 
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Table 3.4.1: qPCR mixture components. 
Component Final Concentration 1 reaction (μl) 
Nuclease Free Water - 6 
2X Master Mix 1x 10 
10 μM Forward Primer 0.25 μM 0.5 
10 μM Reverse Primer 0.25 μM 0.5 
Template DNA 0.075 ng/µL 3 
Total - 20 
 
Table 3.4.2: qPCR Cycle Conditions after optimization. 
Step Cycles Temperature (̊C) Time (sec) 









































































































Cooling 1 40 30 sec 
 
3.5 Analysis 
Triplicate values of the quantified unknown bacterial quantities (copies/µL) from the Roche 
LightCycler® 480 output were averaged to get a single value. Vaginal DNA samples that had 
one or two negative amplification readings in a triplicate, had primer dimers or showed separate 
peaks on the melt curve analysis (indicating more than a single product), were re-run in a qPCR 
through the Roche LightCycler II 480 ® to confirm the results (Table 3.5.1 and Table 3.5.2). All 
of the triplicate samples that were re-run were averaged again and incorporated into the results as 
replacement values. After the second set of qPCR, there were no further ambiguous results.  
The below figure (Figure 3.5.1) illustrates an example of how the Non-Template Control, 
Positive reference dilutions and WISH vaginal DNA samples were set up on a 96 Multiwell 
plate.  
 1 2 3 4 5 6 7 8 9 10 11 12 
A NTC NTC NTC 10^6 10^6 10^6 10^5 10^5 10^5 10^4 10^4 10^4 



















































































































































 Figure 3.5.1: Example of a multi-well qPCR plate set out. Each non-template control (NTC), 
Standards diluted from 10
6 
copies/µL down to 10
0 
copies/µL and the WISH participant vaginal 
DNA are run in triplicate and the resulting value is the mean value of the three replicates.  
The Roche LightCycler® quantified readings per bacteria were measured in copies/µL. The 
average for each triplicate was calculated, followed by the conversion to copies/ng. The WISH 
samples of a concentration higher than 0.5 ng/µL were standardized and diluted to 0.5 ng/µL, 
while any samples of a lower concentration than 1 ng/µL were used as is.  
 
For all statistical analyses, the raw values were used. For the bacterium that had zero quantified 
values, half the lowest value was taken for each to replace the zero values for figure 
representation (Table 3.4.1), after which the data was log10 transformed for analysis for 
comparison between bacterial species with contrasting median values (copies/ng). The lowest 
values for L. iners (copies/ng), G. vaginalis (copies/ng), and P. bivia (copies/ng) were above 
zero and thus were not altered.  
Table 3.5.1 Illustration of the replacement of the zero values with the replacement of half the 
lowest positive quantified value (copies/ng) for each bacterium.  
Quantified values (copies/ng) L. gasseri L. jensenii L. crispatus 
Positive lowest value 0.052 0.00116 0.000297334 
Copies/ng = copies/µL (Roche LightCycler reading) ÷ ng/µL (WISH participant reading) 
      = copies/µL x µL/ng 
     = copies/ng 
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Half positive lowest value 0.026 0.00058 0.000148667 
*
See table 3.6.2 for data transformation software. 
The following comparisons were made in terms of the bacterial quantities (copies/ng) measured 
in each WISH participant sample and the following cohort characteristics: BV (positive, 
intermediate, negative); Inflammation (high, low); Age (16-18 years old, 19-22 years old); 
Hormonal contraceptive (DMPA, Implanon, Nur Isterate), and STI (none, any one), Bacterial 
(none, one two or more), Viral STI (none, one, two), HPV (none, low risk, high risk) (Table 
3.6.2). 
 
3.6 Statistical considerations 
Three different statistical software programs were used to perform the data the data analyses as 
mentioned above in 3.5 Analysis. 
3.6.1 Statistical software used for data analysis 
Table 3.6.1: Statistical software used in this study. 
Software Objective 
Roche LightCycler II 480 ® Data acquisition 
Microsoft Excel 2010 Data cleaning 
STATA® Version 12 (for Windows StataCorp 
LP, College Station, TX77845, USA)  
Inferential statistical analyses between the 
bacteria quantities, cytokines and level of 
inflammation 
GraphPad Prism V5 (for Windows, GraphPad 
Software, San Diego California USA) 
Comparison of bacterial quantities between BV 
groups, age groups and hormonal 
contraceptives 
 
3.6.2 Statistical tests used for data analysis in this study 
The software Microsoft Excel was used to calculate the triplicate average of the raw quantified 
data readings (copies/ng ) for all participant samples as measured for each of the bacterium. 
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These average values were then used in all downstream analyses and the log-transformed data 
used to form figures. 
The software STATA® V12 was used to perform a Shapiro-Wilk test to test if averaged 
triplicate data was normally distributed or not. The data was log transformed when not normally 
distributed (this was done to all the data as none of the data sets were normally distributed). 
STATA® V12 was used to perform Two-sample Wilcoxon rank-sum (Mann-Whitney) tests in 
order to compare the difference in bacterial quantities between the two group readings for each 
inflammation (low and high), and age (16-18 and 19-22 years). STATA® V12 was used to 
calculate the Spearman Rank correlation coefficient (rho) to determine if there was a correlation 
between bacterial quantities and the 47 immunological factors, as well as to calculate the Beta-
coefficient Regression in order to determine if there was regression between bacterial quantity 
and cytokines.  
The software GraphPad Prism V5 was used to calculate the paired, non-parametric Friedman’s 
ANOVA statistical test to compare the distribution of bacterial quantities across each category 
group measured for the BV, hormonal contraceptive, bacterial and viral STI categories. 
GraphPad Prism V5 was used to calculate the unpaired, non-parametric Kruskal-Wallis ANOVA 
statistical test to compare the distribution of each bacterium across the three groups in the BV 
(positive, intermediate, negative), hormonal contraceptive (Implanon, DMPA, Nur Isterate), 
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3.6.3 Conceptual Framework: 
 
This framework has been established as a visual representation of the hypothesis studied in this 
thesis.  As part of the first hypothesis, the green category groups on the left have been associated 
with a healthy/normal FGT microbiome, while the red/orange category groups have been 
associated with dysbiosis and an unhealthy FGT microbiome in the second hypothesis. The 
orange intermediate and L. iners groups have been associated with dysbiosis and an unhealthy 
FGT microbiome to a lesser degree than the other groups. These associations have been 
hypothesize through the knowledge provided by published literature articles.  
 
3.7 Sequencing and Analysis 
Full Service sequencing was performed by Inqaba Biotechnical Industries (Pty) Ltd. PO Box 
14356, Hatfield 0028, Pretoria, South Africa (http://www.inqababiotec.co.za/).  
The sequences were visualized and the reverse compliment sequences formed using SnapGene 
V3.2, GSL Biotech LLC (http://www.snapgene.com/).  
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The National Centre for Biotechnology Information (NCBI), U.S. National Library of Medicine, 
8600 Rockville Pike, Bethesda MD, 20894 USA was used for two functions: 
1. To Nucleotide BLAST (BLASTN) the sequences samples to determine what species 
they are most related to (percentage identity)  
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=
MicrobialGenomes). 
2. To retrieve the reference strains used for alignment using the Nucleotide search 
function through ( http://www.ncbi.nlm.nih.gov/nucleotide).  
The samples sequenced were aligned using the EMBOSS Needle Nucleotide program and the 
Primer BLAST program, run through European Molecular Biology Laboratory Bioinformatics 
Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/nucleotide.html).  
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Chapter 4: Results 
This chapter serves as a summary of the optimization of the qPCR absolute quantification of the 
key species of interest namely; L. crispatus, L. gasseri, L. jensenii, L. iners, G. vaginalis and P. 
bivia and the subsequent results in relation to the BV status, inflammation levels, age, hormonal 
contraceptive and STI status, bacterial versus viral STIs and HPV. Due to the fact that not all 
samples had complete data, these results are based on varying samples sizes: n= 90 participants 
for HPV, n=140 participants for inflammation levels and STI status, n=136 participants for 
hormonal contraceptive, n=143 participants for BV, age, bacterial vs viral STIs and HPV 
adolescent female participants from the Masiphumelele Desmond Tutu Youth Centre, 
Masiphumelele.  
The bacterium P. bivia could not accurately be identified at species level in this study. As such, 
the following section indicates the steps taken in order to analyze the results. The log 
transformed copies/ng readings for P. bivia have been included as a possible reference to the 
other bacterium; however, they should not be relied upon.  
 
4.1 P. bivia Sequencing 
The qPCR products that were formed run across the five qPCR multiwall plates using the final 
pair of P. bivia optimized primers showed increased levels of primer dimers and different 
products present within the melt curves. As such, a set of 7 samples in total were sent for 
sequencing with Inqaba Biotech in order to determine the cause of such high levels of variability.  
Three NTC controls, a standard positive control sample and three random samples were taken in 
a random selection of plates, rows, and replicate wells indicated by the number and letter 
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4.1.1 NCBI Blast Analysis 
The first step was to perform a nucleotide NCBI BLASTN 2.5.0 using a representative genome 
reference sequence database for the forward and reverse compliment sequence for each sample 
to identify what species the primer products are most closely related to (Table 4.1.1). 
Table 4.1.1: NCBI BLASTN results for the seven samples sequenced. 












Forward 499 NSSF - - - 
Reverse 
Compliment 
496 NSSF - - - 
NTC A3 
V2.2 
Forward 54 NSSF - - - 
Reverse 
Compliment 
36 NSSF - - - 
NTC A2 
V2.4 
Forward 156 NSSF - - - 
Reverse 
Compliment 
130 NSSF - - - 
10^5 A5 
V2.1 
Forward 147 188 P. bivia DSM 20514 
Scfld 1 










116 178 P. bivia DSM 20514 
Scfld 1 










Forward 114 5 P. bivia DSM 20514 
Scfld 3 










427 4 P. bivia DSM 20514 
Scfld 1 










Forward 428 12 P. stercorea 
DSM18206 Scfld41 













426 NSSF - - - 
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W174 F11 
V2.4 
Forward 116 5 P. bivia DSM 20514 
Scfld 3 










412 4 P. bivia DSM 20514 
Scfld 1 








*Scfld – Scaffold, NSSF – No significant similarities found.   
The presence of amplification peaks within the NTC of the qPCR multiwall plates indicated 
contamination. The contamination peaks amplified later between 40-50 cycles whereas the 
sample DNA amplified between 10-35 cycles on average. It can be tentatively said that there was 
no specific contaminating bacterial DNA amplifying within the NTC wells due to the peaks 
having no identity with any bacterial species with the NCBI BLASTN. Further, there are large 
differences in size (base pairs) between the three sets of forward and reverse compliment 
sequences amplified by the primers, illustrating a strong lack of specificity. This could indicate 
that the primer set designed was not accurate enough with non-specific products. 
There was a common top hit of P. bivia strain DSM 20514 Scaffolds 1 and 3 as seen with the 
forward and reverse compliment sequence of the standard control sample 10^5 A5 V2.1 with 
99% and 100% percent respectively. However, only three of the hits for the forward sequence 
had an alignment score above 200 with + 120 base pairs (bp) while the rest of the hits were a 
combination of + 100 bp and + 120 bp with alignment scores between 80-200. The reverse 
compliment sequence differed in that the top two hits had a + 120 bp alignment with a score 
above 200 while the rest were a combination of + 120 and + 90 bp with scores between 80 and 
200. These alignments are unlikely since both the forward and reverse sequences are smaller 
than the primer product of 156 bp. 
 The forward sequence for ample W125 E4 V2.3 had 100% identity with two different Prevotella 
species, P. stercorea commonly associated with the human fecal microbiome (Hayashi et al. 
2007), and P. bivia DSM 20514 Scaffold 1, similar to the standard control sample. However, 
only one alignment had a score above 200 with an alignment of + 410 bp, far above the primer 
product size, with the rest of the alignments ranging from + 40 bp to + 230 bp with scores 
between 50-80 and 80-200. The forward and reverse compliment sequences were far larger than 
the expected primer product size. Both samples W012 C8 V2.0 and W174 F11 V2.4 had the 
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same top two hits of P. bivia DSM 20514 Scaffold 3 with a higher percentage identity for the 
forward sequences, 100% and 94% respectively, and P. bivia DSM 20514 Scaffold 1 for the 
reverse compliment sequences with 92% and 90% respectively. The two samples had smaller 
forward sequences with much larger reverse compliment sequences, with alignments between + 
40-55 bp long and scores of 50-80 and a single 80-200. The high percentage identity could be 
due to the small-aligned sequences.  
These percentage identity differences between the different samples and the forward and reverse 
compliment sequences, as well the diverse set of alignment scores and sequence sizes (bp) 
further indicates the non-specificity of the P. bivia primers that were designed and further 
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Figure 4.1.1.1: NCBI BLASTN hit results for the 147 bp forward (top) and 116 bp reverse 
compliment (bottom) sequences of the positive control sample 10^5 A5 V2.1 
Figure 4.1.1.2: NCBI BLASTN hit results for the 114 bp forward (top) and 427 bp reverse 
compliment (bottom) sequences for sample W012 C8 V2.0.  
 
Figure 4.1.1.3: NCBI BLASTN hit results for the 428 bp forward sequences for sample W125 E4 
V2.3.  
 
Figure 4.1.1.4: NCBI BLASTN hit results for the 116 bp forward (top) and 412 bp reverse 
compliment (bottom) sequences for sample W174 F11 V2.4. 
Since the NTC samples did not identify with any species, no figures have been illustrated for the 
negative BLASTN hit results. The positive control sample 10^5 A5 V2.1 had the most diverse 
set of results due to such a high number of BLASTN hits, with the forward and reverse 
compliment sequences indicating identity with P. bivia as well as P. stercorea, P. oulorum, P. 
buccalis, P. saccharolytica, P. marshi, P. pallens, P. dentalis, P. copro, P. oralis, P. scopos, P. 
melaninogenica, P. multiformis, P. denticola, and P. ruminicola to name a few, with the majority 
being associated with the oral, gut and faecal human microbiomes (Faust et al. 2012; Filippo et 
al. 2010; Gupta et al. 2015; Hayashi et al. 2007; Kolenbrander et al. 2002; Scher et al. 2013; Wu 
et al. 2011). A single BLASTN hit was associated with the vaginal microbiome; Prevotella sp. 
S7 MS 2 contig097, since it has not been identified to species level no specificity is possible 
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(Figure 4.1.1.1).  Both the forward and reverse compliment sequences for sample W012 C9 V2.0 
showed high percentage identification with P. bivia DSM 20514 Scaffold 3 and P. bivia DSM 
20514 Scaffold 1, with the forward sequence showing 100% identification with P. stercorea 
DSM 18206 Scaffold41(Figure 4.1.1.2) indicating possible higher levels of specificity for the 
sequences with P. bivia. Sample W125 E4 V2.3 has an increased number of BLASTN hits for 
the forward sequence versus the reverse compliment sequence, which had no significant 
similarities with any species. The forward sequence showed 100% identity with P. stercorea 
Scaffold41, P. bivia DSM 20514 Scaffold 1 and 3, as well as a combination of 
Rhodospeudomonas sp. B29, Alcanivorax hongdengensis A-11-13 contigs 94 and 71, 
Stenotrophomonas panacihumi, and Nocardia brevicatena identifying from 99% to 83% (Figure 
4.1.1.3). The last sample that was sequenced showed similar results with similar percentage 
identities for the forward and reverse compliment sequences with the forward sequence showing 
94% identity with P. bivia DSM 20514 Scaffold 1 and 3 and P. stercorea Scaffold41, while the 
reverse compliment sequence showed 90% for P. bivia DSM 20514 Scaffold 1 and 3 (Figure 
4.1.1.4).  
 
4.1.2 Sequence Alignment 
The forward and reverse compliment sequences for each sample were then aligned to the ATCC 
P. bivia reference strain DNF00188 contig005 sequence (NCBI NZ_JRNF01000005.1) (Table 
4.1.2.1) and the NCBI Primer BLAST Hit P. bivia strain DSM 20514 genomic scaffold 
Prebiscaffold_1, whole genome shotgun sequence (NCBI NZ_JH660658.1) (Table 4.1.2.2) for 
comparison using the EMBOSS Needle nucleotide alignment search tool with a gap penalty of 
10.0 and an extension penalty of 0.5.  
Table 4.1.2.1: Emboss Needle nucleotide alignment results using the ATCC P. bivia reference 

















 (0.2) 352 (0.3) 138188 577.5 6401-7316 
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Values that are the concurrent as the alignment in Table 4.1.2.2. 
Table 4.1.2.2: Emboss Needle nucleotide alignment results using the NCBI Primer BLAST Hit 






Gaps (%) Score Alignment (bp) 
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NTC A2 
V2.4 






























































Values that are the concurrent as the alignment in Table 4.1.2.1. 
From the above tables 4.1.2.1 and 4.1.2.2 it can be seen that the two reference strains are similar 
in size (bp) which correlates to the same identity, similarity and gap percentages for the forward 
and reverse compliment sequences for the seven samples. This occurrence is mostly due to the 
fact that the alignment sequences are far larger than the sample sequences and if a portion of the 
alignment sequences could be use the percentages may identify some differences. Since the 
sample sequences aligned to different portions of the alignment sequences, it was not possible to 
focus on a specific section and whole sequences were used. The identity and similarity 
percentages are so low due to such a large difference in size between the sequenced samples and 
the reference strains. The reverse compliment sequences for the samples NTC A1 V2.0 and NTC 
A3 V2.2 have the same identity across the reference strains with the NTC A3 V2.2 showing the 
same similarity as well. The forward sequence for sample NTC A2 V2.4 has the same score in 
both sequence alignments. The position of the aligned sequences appears to be different for each 
sample, as well as between the forward and reverse compliment sequences. Further discrepancies 
include the different sizes of the overlapping sequences with none being the expected 256 bp.  
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The alignment score for each sequence indicates the quality of the samples sequences against the 
alignment strains, with a higher score indicating a stronger alignment. The forward and reverse 
compliment sequences for samples NTC A1 V2.0, NTC A3 V2.2 and NTC A2 V2.4 show 
similar score results, which is to be expected as they do not correlate with any species 
specifically. The largest difference can be seen with the positive control sample 10^5 A5 V2.1 
which has scores of 165.5 and 171.5 aligned with P. bivia reference strain NDF00188 versus 
554.0 and 552.0 with NCBI Primer Blast Hit P. bivia strain DSM 20514 for the forward and 
reverse compliment sequences respectively (Figure 4.1.2.1). The scores for the sample sequences 
could be skewed based on the distinct difference in size (bp) between the alignment strains and 
the sample sequences.  
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Figure 4.1.2.1: Comparison of the forward (top __ and …) and reverse compliment (bottom _ _  
and __) sequence alignments for sample NTC A1 V2.0 against the ATCC P. bivia reference 




Figure 4.1.2.2: Comparison of the forward (top __ and …) and reverse compliment (bottom _ _  
and __) sequence alignments for sample NTC A3 V2.2 against the ATCC P. bivia reference 
strain DNF00188 (left) and the NCBI Primer BLAST Hit P. bivia strain DSM 20514 (right).  
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Figure 4.1.2.3: Comparison of the forward (top __ and …) and reverse compliment (bottom _ _  
and __) sequence alignments for sample NTC A2 V2.4 against the ATCC P. bivia reference 
strain DNF00188 (left) and the NCBI Primer BLAST Hit P. bivia strain DSM 20514 (right). 
The NTC samples sequences aligned against P. bivia reference strain NDF00188 and NCBI 
Primer Blast Hit P. bivia strain DSM 20514 show poor alignment for both the forward and 
reverse compliment sequences as seen for NTC A1 V2.0 (Figure 4.2.2.1), NTC A3 V2.2 (Figure 
4.2.2.2) and NTC A2 V2.4 (Figure 4.2.2.3) where there are very little solid alignment stretches 
against the alignment sequences regardless of the length and direction.  
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Figure 4.1.2.4: Comparison of the forward (top __ and …) and reverse compliment (bottom _ _  
and __) sequence alignments for the positive standard control 10
5
 copies/ng A5 V2.1 against the 
ATCC P. bivia reference strain DNF00188 (left) and the NCBI Primer BLAST Hit P. bivia 
strain DSM 20514 (right).  
When the forward and reverse compliment positive standard control 10
5
 copies/ng sequences 
were aligned against the P. bivia reference strain NDF00188 and NCBI Primer Blast Hit P. bivia 
strain DSM 20514, the forward and reverse compliment sequences had the same identity, 
similarity and gap percentages, based on different sequence lengths and alignments. The 
differences came through in the number of gaps in relation to the two alignment strains lengths 
(bp) and the position that the forward and reverse compliment sequences aligned. The forward 
sequence aligned between base pairs 34 301 and 34 574 of the P. bivia reference strain 
NDF00188 and aligned between base pairs 44 351 and 44 579 of the NCBI Primer Blast Hit P. 
bivia strain DSM 20514, while the reverse compliment aligned between 77 501 - 77 738 base 
pairs and 44 351 – 44 500 base pairs, respectively. From Figure 4.1.2.4 it can be quite clearly 
seen that both the forward and reverse compliment sequences of the positive standard control 10
5
 
copies/ng aligned better to the NCBI Primer Blast Hit P. bivia strain DSM 20514, which is 
further emphasized by alignment scores of 554.0 and 552.0 respectively, as well as a product size 
of 149 bp, similar to the expected size of 156 bp. In contrast, the forward and reverse 
compliment sequences had reasonably smaller alignment scores of 165.5 and 171.5 respectively, 
as illustrated by the poor alignment in Figure 4.1.2.4.  
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Figure 4.1.2.5: Comparison of the forward (top __ and …) and reverse compliment (bottom _ _ 
and __) sequence alignments for W012 C8 V2.0 against the ATCC P. bivia reference strain 
DNF00188 (left) and the NCBI Primer BLAST Hit P. bivia strain DSM 20514 (right).  
The forward and the reverse compliment sequence of W012 C8 V2.0 when aligned against NCBI 
Primer BLAST Hit P. bivia strain DSM 20514 show improved alignment in comparison to when 
the sequences are aligned against ATCC P. bivia reference strain DNF00188 (Figure 4.1.2.5) 
with larger stretches of concurrent base pair alignments. Despite the increased length of the 
reverse compliment sequence, the alignment quality does not improve in comparison to the 
shorter forward sequence.  
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Figure 4.1.2.6: Comparison of the forward (top __ and …) and reverse compliment (bottom _ _  
and __) sequence alignments for W125 E4 V2.3 against the ATCC P. bivia reference strain 
DNF00188 (left) and the NCBI Primer BLAST Hit P. bivia strain DSM 20514 (right).  
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A similar alignment pattern can be seen for sample W125 E4 V2 as W012 C8 V2.0 where the 
quality of alignment of both the forward and reverse compliment sequences to the NCBI Primer 
BLAST Hit P. bivia strain DSM 20514 show slightly improved alignment in comparison to 
when the sequences are aligned against ATCC P. bivia reference strain DNF00188 with little 
difference between the direction of the sequences.  
 
Figure 4.1.2.7: Comparison of the forward (top __ and …) and reverse compliment (bottom _ _  
and __) sequence alignments for W174 F11 V2.4 against the ATCC P. bivia reference strain 
DNF00188 (left) and the NCBI Primer BLAST Hit P. bivia strain DSM 20514 (right).  
The last sample analyzed showed improved alignment to both alignment sequences with 
improved alignment to NCBI Primer BLAST Hit P. bivia strain DSM 20514 in comparison to 
when the sequences are aligned against ATCC P. bivia reference strain DNF00188 for both the 
forward and reverse compliment sequences. This indicates the primers have a higher specificity 
for the P. bivia strain DSM 20514, to which the samples should be compared to.  
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From the above data, it can be seen that there are multiple products and sizes that are amplified 
by the set of primers that were eventually used to assess the WISH samples, which indicates their 
non-specificity, as indicated by the poor alignments. This means that the primers are not reliable 
and should not be used for future research, with further effort going into designing species 
specific primers. This variability of the primers can be seen in the high readings of quantified P. 
bivia (copies/ng) indicated by the lack of significant difference in any of the above associations. 
As such, the P. bivia results have not been included in the category figures for comparison 
between the bacterium. The individual figures for the P. bivia results for each category have 
been included for referral, but should be interpreted with strong criticism and not compared to 
the other bacterium figures, with any future progress involving optimized primers.  
 
4.2 Real-Time PCR (qPCR) Results 
For all amplification, standard and melt curves for qPCR results see appendix D qPCR Results. 
 
Figure 4.2: Example of an amplification and standard curve run with the WISH samples. 
Amplification and standard curves of L. iners qPCR Plate V2.5 generated based on all wells and 





 copies/µL. Red and brown indicate positive amplification in the 
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unknown samples and the positive control standards respectively, blue indicates uncertainty and 
green indicates negative amplification in the wells. 
4.2.1 Descriptive statistics  
All six bacterial species DNA quantities in the WISH samples had a p<0.0001 for the Shapiro-
Wilk normality test, indicating none of the bacterial species were normally distributed across the 
participant samples, which can be seen by the large discrepancies between the mean and median 
values across the bacteria (Table 4.2.1). The box plots in the figure below illustrate the log10-
transformed values for copies/ng DNA of each of the bacteria. As illustrated below, the medians 
of L. iners, G. vaginalis copies/ng are consistently higher and more evenly distributed than L. 
crispatus, L. jensenii and L. gasseri, which are skewed left towards the lower range of copies/ng, 
except for L. gasseri. This shows a distinct separation of the bacteria into two different groups of 

























































Figure 4.2.1: Box plot comparison of the copies of each bacterial species of interest quantified in 
the DNA extracted from WISH participants’ lateral wall swabs; showing the entire cohort 
reported as log transformed copies/ng total DNA for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple). The ‘box’ component of each plot 
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indicates the interquartile range (IQR) of the data set and the ‘whiskers’ which are the two lines 
(bottom and top) extending from the box component of each block that end with a horizontal 
stroke, indicate the range from the smallest and largest non-outliers to the 25% and 75% 
percentile components, respectively. The middle line indicates the median value for each data 
set.  
Table 4.2.1: Descriptive statistics for each bacterial species, quantified from DNA extracted from 
the WISH lateral wall swab for each participant. 
 Bacteria 
L. crispatus L. gasseri L. jensenii L. iners G. vaginalis P. bivia 
Min 0.0 0.0 0.0 1.034 1.738 1.738 
25% Percentile 0.0 1.976 1.570e-016 266.7 1015 3667 
Median 3.957 17.58 1.568 2807 8540 11073 
75% Percentile 4980 64.67 59.00 18727 49867 75533 
Max 7.113e+007 320000 5.440e+006 4.167e+007 3.033e+006 2.553e+007 
Mean 858412 3327 48743 337988 151382 750128 
Std. Deviation 7.157e+006 27908 462042 3.485e+006 414156 3.405e+006 
Std. Error 598472 2334 38638 291468 34633 284714 
 
Although we only measured the most common vagina-associated bacteria, using these as 
markers for total lactobacillus bacterial load we can assume this cohort of adolescent females had 
predominantly non-lactobacillus species dominating their vaginal microbiome, indicating a shift 
in what is considered the ‘normal’ vaginal microbiome in terms of the standard ‘healthy’ 
Lactobacillus dominated microbiome.  
Due to the data set being non-parametric, all figures below represent the log10 transformed values 
for each area of comparison. The comparisons were considered statistically significantly 
different if the p-values were lower than 0.05; medians and 95% confidence intervals are 
reported. 
For all of the following analyses, the same shapes have been used for each bacterium; L 
crispatus (equilateral triangle), L. gasseri (square), L. jensenii (circle), L. iners (square balanced 
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4.3 Comparison of absolute bacterial quantities to BV status, inflammation levels, age, 
hormonal contraceptive and STI status, bacterial versus viral STIs and HPV 
4.3.1 Association between the quantities of the bacteria of interest and BV status 
Participants were categorized as being BV positive, intermediate or negative based on Nugent 
scoring. A Nugent score of 0-3 is BV negative, a score of 4-6 is BV intermediate and a score of 
7-10 is BV positive. 
The median copies/ng for each bacterium were compared using a Friedman’s ANOVA with a 
Dunn’s Multiple Comparison test for BV positive (n=56, 39.16%), BV intermediate (n=17, 
11.89%) and BV negative (n=70, 48.95%) groups. All ANOVA tests were statistically 
significant (p<0.0001) indicating an overall significant difference between the copies/ng of the 
bacteria in each BV group. For the p-values of the Friedman’s ANOVA test with a Dunn’s 
Multiple Comparison test run across all BV groups, see Appendix D qPCR results, Section 2.1. 
Asterisk stars were used in the following figures where one start (*) indicates a p-value lower 
than 0.05, two stars (**) indicate a p-value lower than 0.01 and three stars (***) indicate a p-
value lower than 0.001.  
Within the BV positive group (Figure 4.3.1A), L. iners and G. vaginalis both showed 
significantly higher copies/ng in comparison to L. gasseri (p<0.0001), L. jensenii (p<0.0001) and 
L. crispatus (p<0.0001). G. vaginalis was significantly more abundant than L. iners (p=0.007) 
and L. gasseri was more abundant than L. jensenii (p=0.0157). G. vaginalis had significantly 
higher copies/ng within the BV intermediate group (Figure 4.3.1B), with higher copies/ng in 
comparison to L. gasseri (p=0.0123), and L. jensenii (p=0.0074), with both G. vaginalis and L. 
iners being significantly greater than L. crispatus (p=0.0001, p=0.0044). The BV negative group 
(Figure 4.3.1C) had greater copies/ng of L. crispatus, L. iners and G. vaginalis in comparison to 
L. gasseri (p=0.0009, p<0.0001, p=0.0002 respectively).  L. crispatus, L. iners and G. vaginalis 
had higher median copies/ng with a significant difference of p<0.0001 in comparison to L. 
jensenii. Overall, the greatest differences occurred between the high median copies/ng of G. 
vaginalis in comparison to L. gasseri, L. jensenii, and L. crispatus, with L. iners to varying 
degrees across the BV positive, intermediate and negative groups. The increased copies/ng of L. 
crispatus within the BV negative group follows the literature of a ‘healthy’ FGT microbiome. 
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Interestingly, L. crispatus and L. iners were the most prevalent of the lactobacilli species we 
quantified in the BV negative group, however this trend is further followed by L. iners and G. 
vaginalis across all three BV groups which differs strongly from the general lactobacilli 
dominated FGT within a ‘healthy’ FGT microbiome. This could indicate a difference in what is 



































































Figure 4.3.1A: Box-plot of L. gasseri (red), L. jensenii (orange), L. crispatus (green), L. iners 
(blue), and G. vaginalis (purple) quantities for BV positive participants reported as log 
transformed copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile 
range (IQR) of the data set and the ‘whiskers’ which are the two lines (bottom and top) 
extending from the box component of each block that end with a horizontal stroke, indicate the 
range from the smallest and largest non-outliers to the 25% and 75% percentile components, 
respectively. The middle line indicates the median value for each data set.  
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Figure 4.3.1B: Box-plot of L. gasseri (red), L. jensenii (orange), L. crispatus (green), L. iners 
(blue), and G. vaginalis (purple) quantities for BV intermediate participants reported as log 
transformed copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile 
range (IQR) of the data set and the ‘whiskers’ which are the two lines (bottom and top) 
extending from the box component of each block that end with a horizontal stroke, indicate the 
range from the smallest and largest non-outliers to the 25% and 75% percentile components, 
respectively. The middle line indicates the median value for each data set.  
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Figure 4.3.1C: Box-plot of L. gasseri (red), L. jensenii (orange), L. crispatus (green), L. iners 
(blue), and G. vaginalis (purple) quantities for BV negative participants reported as log 
transformed copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile 
range (IQR) of the data set and the ‘whiskers’ which are the two lines (bottom and top) 
extending from the box component of each block that end with a horizontal stroke, indicate the 
range from the smallest and largest non-outliers to the 25% and 75% percentile components, 
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4.3.1.1 Lactobacillus crispatus 
We compared the quantified log copies/ng of L. crispatus between the BV groups. BV negative 
participants had a significantly higher median value of L. crispatus (copies/ng) compared to 
those in the BV intermediate (p=0.0004) and BV positive (p=0.0002) participant groups. There 
was an overall significant difference in L. crispatus between the BV groups (Kruskal-Wallis 




































Figure 4.3.1.1: Comparison of the quantities of L. crispatus (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between BV positive, intermediate and negative groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.1.2 Lactobacillus gasseri 
We compared the quantified log copies/ng of L. gasseri between the BV groups. The BV 
negative participants had a significantly higher median value of L. gasseri (copies/ng) compared 
to those in the BV intermediate (p=0.0016) and BV positive (p<0.0001) participant groups. 
There was an overall significant difference between the BV groups (Kruskal-Wallis ANOVA 

































Figure 4.3.1.2: Comparison of the quantities of L. gasseri (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between BV positive, intermediate and negative groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.1.3 Lactobacillus jensenii 
We compared the quantified log copies/ng of L. jensenii between the BV groups. BV negative 
participants had a significantly higher median value of L. jensenii (copies/ng) compared to those 
in the BV positive (p<0.0001) participant group. There was an overall significant difference in L. 



































Figure 4.3.1.3: Comparison of the quantities of L. jensenii (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between BV positive, intermediate and negative groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.1.4 Lactobacillus iners 
We compared the quantified log copies/ng of L. iners between the BV groups. BV negative 
participants had a significantly higher median value of L. iners (copies/ng) compared to those in 
the BV intermediate (p=0.0461) participant group. There was an overall significant difference in 
































Figure 4.3.1.4: Comparison of the quantities of L. iners (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between BV positive, intermediate and negative groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.1.5 Gardnerella vaginalis 
We compared the quantified log copies/ng of G. vaginalis between the BV groups. BV positive 
participants had significantly higher copies/ng of G. vaginalis compared to those in the BV 
intermediate (p=0.0059) and BV negative (p<0.0001) participant groups. There was an overall 
significant difference in G. vaginalis between the BV groups (Kruskal-Wallis ANOVA 

































Figure 4.3.1.5: Comparison of the quantities of G. vaginalis (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between BV positive, intermediate and negative groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
Therefore, we can conclude than women without BV had higher median levels of L. crispatus 
(copies/ng) and L. gasseri (copies/ng) compared to those in the BV intermediate and BV positive 
groups. Further, the BV negative group had higher median levels of L. jensenii (copies/ng) and 
L. iners (copies/ng) compared to the BV positive and intermediate groups, respectively. Overall, 
L. crispatus, L. iners and G. vaginalis, which are associated with both dysbiosis and a ‘healthy’ 
vaginal microbiome, dominated the BV negative group. The BV positive group had higher 
median levels of G. vaginalis (copies/ng) compared to those in the BV intermediate and BV 
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positive groups, with none of the BV groups having any difference in the median levels of P. 
bivia (copies/ng) present. This follows the expected trend of association between the presence of 
increased G. vaginalis copies/ng with BV positive literature and increased L. crispatus, L. 
gasseri and L. jensenii and BV negative literature.  
Due to the unreliability of the qPCR amplification results, the P. bivia data regarding BV has not 
been included and can be found in Appendix E: Results, page 186. 
 
4.3.2 Association between bacteria of interest and inflammatory immunological factor levels 
The two inflammatory groups were defined based on the unsupervised analysis of the 47 
immunological factors of interest in the cervicovaginal fluid of women in the WISH cohort. 
These immunological factors were categorized into high and low inflammation by partitioning 
around medoids (PAM) using an R package ‘cluster’ with a k-value of 2. The samples were 
originally separated into high and low inflammation based on the levels of only the pro-
inflammatory and chemokine factors measured. However, the inflammation separation of the 
participant samples showed little difference between the two pro-inflammatory and chemokine 
groups of immunological factor analysis in comparison to using all of the factors to determine 
high and low inflammation. Thus the final inflammation categorization was done using all 47 
immunological factors.  
The immunological factors measured in this study can be generally grouped into five different 
categories. The immunological factors considered as pro-inflammatory were IL-1a, IL-1b, IL-6, 
IL-12p40, IL-12(p70), IL-18, MIF, TNF-a, TNF-b and TRAIL. The immunological factors 
considered chemokines were CTACK, Eotaxin, GROa, IL-8, IL-16, IP-10, MCP-1, MCP-3, 
MIG, MIP-1a, MIP-1b, IFN-a2, and RANTES. The immunological factors considered growth 
factors were b-NGF, FGF basic, G-CSF, GM-CSF, HGF, IL-3, IL-7, IL-9, LIF, M-CSF, PDGF-
bb, SCF, SCGF-b, SDF-1a and VEGF. The immunological factors considered adaptive were 
IFN-g, IL-4, IL-13, IL-17, IL-2Ra, IL-2, and IL-5. The immunological factors considered 
regulatory were IL-10 and IL-1ra.  
The median log transformed copies/ng for each bacterium were compared using a Friedman’s 
ANOVA with a Dunn’s Multiple Comparison test for high (n=98, 70%) and low (n=42, 30%) 
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inflammation groups. Both ANOVA tests were significant (p<0.0001) indicating statistically 
different median values for the bacterial copies/ng in the low and high genital inflammation 
groups. For the p-values of the Friedman’s ANOVA test with a Dunn’s Multiple Comparison test 
run across the inflammation groups, see Appendix D qPCR results, Section 2.2. Asterisk stars 
were used in the following figures where one start (*) indicates a p-value lower than 0.05, two 
stars (**) indicate a p-value lower than 0.01 and three stars (***) indicate a p-value lower than 
0.001.  
In the women with low levels of inflammation, both G. vaginalis and L. iners were significantly 
higher compared to L. gasseri and L. jensenii (p<0.0001) (Figure 4.3.2A), L. crispatus copies/ng 
were also significantly higher than L. gasseri and L. jensenii (p=0.0097 and p=0.0005, 
respectively). There were no differences between L. iners, L. crispatus and G. vaginalis in the 
low inflammation group. The high inflammation group (Figure 4.3.2B) also had the significantly 
higher copies/ng of G. vaginalis and L. iners compared to L. gasseri (p<0.0001), L. jensenii 
(p<0.0001), and L. crispatus (p<0.0001). L. gasseri had higher copies/ng compared to L. jensenii 
(p=0.0463). Regardless of inflammatory factor level, copies/ng of G. vaginalis and L. iners were 
high. However, the low inflammation group had equivalent copies/ng of L. crispatus and the 
high inflammation group had increased copies/ng of L. gasseri.  
84 































































Figure 4.3.2A: Box-plot of the low inflammation for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log transformed copies/ng 
total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data 
set and the ‘whiskers’ which are the two lines (bottom and top) extending from the box 
component of each block that end with a horizontal stroke, indicate the range from the smallest 
and largest non-outliers to the 25% and 75% percentile components, respectively. The middle 
line indicates the median value for each data set.  
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Figure 4.3.2B: Box-plot of the high inflammation for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log transformed copies/ng 
total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data 
set and the ‘whiskers’ which are the two lines (bottom and top) extending from the box 
component of each block that end with a horizontal stroke, indicate the range from the smallest 
and largest non-outliers to the 25% and 75% percentile components, respectively. The middle 
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4.3.2.1 Lactobacillus crispatus 
We compared the quantified log copies/ng of L. crispatus between the inflammation groups. The 
low inflammation group had significantly higher copies/ng compared to those in the high 

































Figure 4.3.2.1: Comparison of the quantities of L. crispatus (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between women with high and low genital inflammation. All p-value comparisons were 
based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.2.2 Lactobacillus gasseri 
We compared the quantified log copies/ng of L. gasseri between the inflammation groups. The 
low inflammation group had significantly higher copies/ng of L. gasseri compared to those in the 































Figure 4.3.2.2: Comparison of the quantities of L. gasseri (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between women with high and low genital inflammation. All p-value comparisons were 
based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.2.3 Lactobacillus jensenii 
We compared the quantified log copies/ng of L. jensenii between the inflammation groups. The 
low inflammation group had significantly higher copies/ng compared to those in the high 
































Figure 4.3.2.3: Comparison of the quantities of L. jensenii (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between women with high and low genital inflammation. All p-value comparisons were 
based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.2.4 Lactobacillus iners 
We compared the quantified log copies/ng of L. iners between the inflammation groups. There 
was no significant difference in L. iners between the high inflammation group and the low 































Figure 4.3.2.4: Comparison of the quantities of L. iners (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, women with high and low genital inflammation. All p-value comparisons were based on 
an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the figure represents an 
individual participant. The three horizontal bars represent the median value (middle bar), upper 
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4.3.2.5 Gardnerella vaginalis 
We compared the quantified log copies/ng of G. vaginalis between the inflammation groups. The 
high inflammation group and the low inflammation group had no significant difference 






























Figure 4.3.2.5: Comparison of the quantities of G. vaginalis (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between women with high and low genital inflammation. All p-value comparisons were 
based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
In summary, consistent with our hypothesis, participants with low inflammation in their genital 
tract fluid had significantly higher copies/ng of L. crispatus, L. gasseri, and L. jensenii compared 
to those present in the high inflammation group. Conversely, there were no significant 
differences in the copies/ng for L. iners or G. vaginalis between women with high or low 
inflammation. Thus there is an association with the presence of lactobacilli and low 
inflammation. This begs the question of whether the presence of bacteria such as G. vaginalis, 
versus the absence of lactobacilli bacterium playing any role in high genital inflammation 
91 
 A. O. Breetzke 
Due to the unreliability of the qPCR amplification results, the P. bivia data regarding 
Inflammation has not been included and can be found in Appendix E: Results, page 189. 
4.3.3 Association between the quantities (copies/ng) of bacteria of interest and age  
The age of all participants was recorded upon screening for participation within the study. For 
this analysis, age was binarised into 16-18 years of age versus 19-22 years of age.  
The median copies/ng for each bacterium were compared using a Friedman’s ANOVA with a 
Dunn’s Multiple Comparison test for the two age groups 16-18 years (n=75, 52.45%) and 19-22 
years (n=68, 47.55%). Both ANOVA tests were significant (p<0.0001), indicating the bacterial 
copies/ng in each age group were statistically different from each other. For the p-values of the 
Friedman’s ANOVA test with a Dunn’s Multiple Comparison test run across the inflammation 
groups, see Appendix D qPCR results, Section 2.2.3. Asterisk stars were used in the following 
figures where one start (*) indicates a p-value lower than 0.05, two stars (**) indicate a p-value 
lower than 0.01 and three stars (***) indicate a p-value lower than 0.001.  
In both the 16-18 years (Figure 4.3.3A) and 19-22 years (Figure 4.3.3B) age groups, G. vaginalis 
and L. iners were significantly higher compared to L. gasseri (p<0.0001), L. jensenii (p<0.0001) 
and L. crispatus (p<0.0001). L. crispatus was significantly higher to L. jensenii (p=0.0419) in the 
16-18 years’ group. This data set is similar to the study cohort as a whole.  
92 

































































Figure 4.3.3A: Box-plot of the 16-18 years for L. gasseri (red), L. jensenii (orange), L. crispatus 
(green), L. iners (blue), and G. vaginalis (purple) reported as log transformed copies/ng total 
DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data set 
and the ‘whiskers’ which are the two lines (bottom and top) extending from the box component 
of each block that end with a horizontal stroke, indicate the range from the smallest and largest 
non-outliers to the 25% and 75% percentile components, respectively. The middle line indicates 
the median value for each data set.  
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Figure 4.3.3B: Box-plot of the 19-22 years for L. gasseri (red), L. jensenii (orange), L. crispatus 
(green), L. iners (blue), and G. vaginalis (purple) reported as log transformed copies/ng total 
DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data set 
and the ‘whiskers’ which are the two lines (bottom and top) extending from the box component 
of each block that end with a horizontal stroke, indicate the range from the smallest and largest 
non-outliers to the 25% and 75% percentile components, respectively. The middle line indicates 
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4.3.3.1 Lactobacillus crispatus 
The 16-18 years old age group and the 19-22 years old age group had no significant difference in 

































Figure 4.3.3.1: Comparison of the quantities of L. crispatus (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the two 16-18 years old and 19-22 years old age groups. All p-value comparisons 
were based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the 
figure represents an individual participant. The three horizontal bars represent the median value 
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4.3.3.2 Lactobacillus gasseri 
We compared the quantified copies/ng of L. gasseri between the age groups. The 16-18 years old 
age group and the 19-22 years old age group had no significant difference in log copies/ng 

































Figure 4.3.3.2: Comparison of the quantities of L. gasseri (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the two 16-18 years old and 19-22 years old age groups. All p-value comparisons 
were based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the 
figure represents an individual participant. The three horizontal bars represent the median value 
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4.3.3.3 Lactobacillus jensenii 
The 16-18 years old age group and the 19-22 years old age group had no significant difference in 

































Figure 4.3.3.3: Comparison of the quantities of L. jensenii (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the two 16-18 years old and 19-22 years old age groups. All p-value comparisons 
were based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the 
figure represents an individual participant. The three horizontal bars represent the median value 
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4.3.3.4 Lactobacillus iners 
We compared the quantified copies/ng of L. iners between the age groups. The 16-18 years old 
age group and the 19-22 years old age group had no significant difference in log copies/ng 
































Figure 4.3.3.4: Comparison of the quantities of L. iners (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the two 16-18 years old and 19-22 years old age groups. All p-value comparisons 
were based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the 
figure represents an individual participant. The three horizontal bars represent the median value 
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4.3.3.5 Gardnerella vaginalis 
We compared the quantified copies/ng of G. vaginalis between the age groups. The 16-18 years 
old age group and the 19-22 years old age group had no significant difference in log copies/ng 































Figure 4.3.3.5: Comparison of the quantities of G. vaginalis (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the two 16-18 years old and 19-22 years old age groups. All p-value comparisons 
were based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the 
figure represents an individual participant. The three horizontal bars represent the median value 
(middle bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
Therefore, age did not influence the bacterial quantities (copies/ng) regardless of the species 
associated with health or dysbiosis, as the comparisons between the median quantified values of 
the two different age groups 16-18 years old and 19-22 years old, did not significantly differ in 
any way towards a particular age set. Analyzing age as continuous variable, yielded similar 
results.  
Due to the unreliability of the qPCR amplification results, the P. bivia data regarding age has not 
been included and can be found in Appendix E: Results, page 190. 
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4.3.4 Association between the quantities (copies/ng) of vaginal bacteria and hormonal 
contraceptives 
The hormonal contraceptive that each participant was using was recorded at the first visit of the 
WISH Cohort study process. The three hormonal contraceptives of particular interest within this 
study include DMPA, the Implanon and Nur Isterate.  
The median copies/ng for each bacterium were compared using a Friedman’s ANOVA with a 
Dunn’s Multiple Comparison test for hormonal contraceptive use of DMPA (n=25, 18.38%), 
Implanon (n=9, 6.62%) and Nur Isterate (n=102, 75%). The copies/ng between the bacteria in 
each hormonal contraceptive usage group were significantly different to each other (ANOVA 
p<0.0001). For the p-values of the Friedman’s ANOVA test with a Dunn’s Multiple Comparison 
test run across all hormonal contraceptive usage groups, see Appendix D qPCR results, Section 
2.4. Asterisk stars were used in the following figures where one start (*) indicates a p-value 
lower than 0.05, two stars (**) indicate a p-value lower than 0.01 and three stars (***) indicate a 
p-value lower than 0.001.  
The copies/ng of G. vaginalis and L. iners in the DMPA (Figure 4.3.4A) and Nur Isterate (Figure 
4.3.4C) hormonal contraceptive groups were significantly higher compared to L. gasseri 
(p=0.0057, p<0.0001), L. jensenii (p<0.0001, p<0.0001) and L. crispatus (p=0.0132, p<0.0001). 
The Implanon hormonal contraceptive (Figure 4.3.4B) had significantly higher copies/ng of G. 
vaginalis in comparison to L. gasseri (p=0.0375) L. jensenii (p<0.0001) and L. crispatus 
(p=0.003) with L. iners having significantly higher copies/ng in comparison to L. jensenii 
(p=0.0375). The Implanon hormonal contraceptive had the least association with the bacterial 
copes/ng with DMPA and Nur Isterate having similar patterns between G. vaginalis and L. iners.  
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Figure 4.3.4A: Box-plot of hormonal contraceptive use of DMPA for L. gasseri (red), L. jensenii 
(orange), L. crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log 
transformed copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile 
range (IQR) of the data set and the ‘whiskers’ which are the two lines (bottom and top) 
extending from the box component of each block that end with a horizontal stroke, indicate the 
range from the smallest and largest non-outliers to the 25% and 75% percentile components, 
respectively. The middle line indicates the median value for each data set.  
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Figure 4.3.4B: Box-plot of hormonal contraceptive use of the Implanon for L. gasseri (red), L. 
jensenii (orange), L. crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log 
transformed copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile 
range (IQR) of the data set and the ‘whiskers’ which are the two lines (bottom and top) 
extending from the box component of each block that end with a horizontal stroke, indicate the 
range from the smallest and largest non-outliers to the 25% and 75% percentile components, 
respectively. The middle line indicates the median value for each data set.  
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Figure 4.3.4C: Box-plot of hormonal contraceptive use of Nur Isterate for L. gasseri (red), L. 
jensenii (orange), L. crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log 
transformed copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile 
range (IQR) of the data set and the ‘whiskers’ which are the two lines (bottom and top) 
extending from the box component of each block that end with a horizontal stroke, indicate the 
range from the smallest and largest non-outliers to the 25% and 75% percentile components, 









 A. O. Breetzke 
4.3.4.1 Lactobacillus crispatus 
We compared the quantified log copies/ng of L. crispatus, and found no significant differences 











































Figure 4.3.4.1: Comparison of the quantities of L. crispatus (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value 
comparisons were based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each 
point in the figure represents an individual participant. The three horizontal bars represent the 
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4.3.4.2 Lactobacillus gasseri 
We compared the quantified log copies/ng of L. gasseri between the contraceptive groups, and 
we noted that levels of L. gasseri were much lower in the Implanon group that the DMPA group, 
but the difference did not achieve statistical significance (Kruskal-Wallis ANOVA p=0.0918) 









































Figure 4.3.4.2: Comparison of the quantities of L. gasseri (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value 
comparisons were based on an unpaired, non-parametric Dunn’s Multiple Comparison test.  Each 
point in the figure represents an individual participant. The three horizontal bars represent the 
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4.3.4.3 Lactobacillus jensenii 
We compared the quantified log copies/ng of L. jensenii between the hormonal contraceptive 












































Figure 4.3.4.3: Comparison of the quantities of L. jensenii (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value 
comparisons were based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each 
point in the figure represents an individual participant. The three horizontal bars represent the 
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4.3.4.4 Lactobacillus iners 
We compared the quantified log copies/ng of L. iners and found no significant differences 










































Figure 4.3.4.4: Comparison of the quantities of L. iners (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value 
comparisons were based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each 
point in the figure represents an individual participant. The three horizontal bars represent the 
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4.3.4.5 Gardnerella vaginalis 
We compared the quantified log copies/ng of G. vaginalis, and found no difference between the 









































Figure 4.3.4.5: Comparison of the quantities of G. vaginalis (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value 
comparisons were based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each 
point in the figure represents an individual participant. The three horizontal bars represent the 
median value (middle bar), upper interquartile range (top bar) and lower interquartile range 
(bottom bar). 
 
Therefore, the hormonal contraceptives DMPA, Implanon and Nur Isterate showed no patterns of 
significantly different copies/ng of bacteria, except for an overall significant Kruskal-Wallis 
statistic for L. jensenii (p=0.00222). There is no specific association between the hormonal 
contraceptive usage and bacterial log copes/ng. However, the sample size for Implanon was 
small and as such the computing power of the Kruskal-Wallis statistic could be less accurate than 
with a larger sample size due to weakened statistical power. Thus it can be postulated that the 
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type of hormonal contraceptive used by female adolescents does not have a direct impact on the 
FGT microbiota. 
Due to the unreliability of the qPCR amplification results, the P. bivia data regarding hormonal 
contraceptives has not been included and can be found in Appendix E: Results, page 192. 
 
4.3.5 Association between the quantities (copies/ng) of the bacteria of interest and the absence or 
presence of any one STI in the WISH cohort 
The STI status was determined based on the absence or presence of any one bacterial 
(Chlamydia trachomatis, Neisseria gonorrhea, and Mycoplasma genitalium), viral (Herpes 
Simplex Virus 2, and Human Papilloma Virus) or parasitic (Trichomonas vaginalis) STI for each 
participant. 
The median copies/ng for each bacterium were compared using a Friedman’s ANOVA with a 
Dunn’s Multiple Comparison test for the absence or presence of any one STI. The bacterial 
copies/ng in the women with (n=78, 55.71%) and without (n=62, 44.29%) any one STI were 
significantly different to each other (ANOVA p<0.0001). For the p-values of the Friedman’s 
ANOVA test with a Dunn’s Multiple Comparison test run across both STI groups, see Appendix 
D qPCR results, Section 2.5. Asterisk stars were used in the following figures where one start (*) 
indicates a p-value lower than 0.05, two stars (**) indicate a p-value lower than 0.01 and three 
stars (***) indicate a p-value lower than 0.001.  
In the absence of any one STI (Figure 4.3.5A), G. vaginalis and L. iners had a significant higher 
in copies/ng with a p-value of >0.0001 in comparison to L. gasseri, L. jensenii and L. crispatus. 
The same pattern was followed by G. vaginalis and L. iners in the presence of any one STI 
(Figure 4.3.5B), except L. iners had significantly higher p-value of 0.0002 compared to L. 
crispatus, which in turn was significantly higher to L. jensenii (p=0.0079). The absence of or 
presence of any one STI is similar to the overall cohort.  
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Figure 4.3.5A: Box-plot of the absence of any one STI for L. gasseri (red), L. jensenii (orange), 
L. crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log transformed 
copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) 
of the data set and the ‘whiskers’ which are the two lines (bottom and top) extending from the 
box component of each block that end with a horizontal stroke, indicate the range from the 
smallest and largest non-outliers to the 25% and 75% percentile components, respectively. The 
middle line indicates the median value for each data set. 
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Figure 4.3.5B: Box-plot of the presence of any one STI for L. gasseri (red), L. jensenii (orange), 
L. crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log transformed 
copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) 
of the data set and the ‘whiskers’ which are the two lines (bottom and top) extending from the 
box component of each block that end with a horizontal stroke, indicate the range from the 
smallest and largest non-outliers to the 25% and 75% percentile components, respectively. The 
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4.3.5.1 Lactobacillus crispatus 
We compared the quantified log copies/ng of L. crispatus, and found no difference between the 




































Figure 4.3.5.1: Comparison of the quantities of L. crispatus (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on absence or presence of any one of the 
WISH cohort STIs present. All p-value comparisons were based on an unpaired, non-parametric 
Mann-Whitney t-test statistic. Each point in the figure represents an individual participant. The 
three horizontal bars represent the median value (middle bar), upper interquartile range (top bar) 
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4.3.5.2 Lactobacillus gasseri 
We compared the quantified log copies/ng of L. gasseri and found no significant differences 


































Figure 4.3.5.2: Comparison of the quantities of L. gasseri (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on absence or presence of any one of the 
WISH cohort STIs present. All p-value comparisons were based on an unpaired, non-parametric 
Mann-Whitney t-test statistic. Each point in the figure represents an individual participant. The 
three horizontal bars represent the median value (middle bar), upper interquartile range (top bar) 
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4.3.5.3 Lactobacillus jensenii 
We compared the quantified log copies/ng of L. jensenii and found no difference between the 




































Figure 4.3.5.3: Comparison of the quantities of L. jensenii (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on absence or presence of any one of the 
WISH cohort STIs present. All p-value comparisons were based on an unpaired, non-parametric 
Mann-Whitney t-test statistic. Each point in the figure represents an individual participant. The 
three horizontal bars represent the median value (middle bar), upper interquartile range (top bar) 
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4.3.5.4 Lactobacillus iners 
We compared the quantified log copies/ng of L. iners and found no difference between the 


































Figure 4.3.5.4: Comparison of the quantities of L. iners (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on absence or presence of any one of the 
WISH cohort STIs present. All p-value comparisons were based on an unpaired, non-parametric 
Mann-Whitney t-test statistic. Each point in the figure represents an individual participant. The 
three horizontal bars represent the median value (middle bar), upper interquartile range (top bar) 
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4.3.5.5 Gardnerella vaginalis 
We compared the quantified log copies/ng of G. vaginalis and found no significant differences 



































Figure 4.3.5.5: Comparison of the quantities of G. vaginalis (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on absence or presence of any one of the 
WISH cohort STIs present. All p-value comparisons were based on an unpaired, non-parametric 
Mann-Whitney t-test statistic. Each point in the figure represents an individual participant. The 
three horizontal bars represent the median value (middle bar), upper interquartile range (top bar) 
and lower interquartile range (bottom bar). 
 
Therefore, the absence of, or presence of any one of the STIs i.e. bacterial (Chlamydia 
trachomatis, Neisseria gonorrhea, and Mycoplasma genitalium), viral (Herpes Simplex Virus 2, 
and Human Papilloma Virus) or parasitic (Trichomonas vaginalis), showed no association with 
the copies/ng of L. crispatus, L. gasseri, L. jensenii, L. iners, G. vaginalis, and P. bivia. This 
could correlate with a lack of interaction between the STIs and the bacterium studied in this 
cohort within the FGT.  
Due to the unreliability of the qPCR amplification results, the P. bivia data regarding STIs has 
not been included and can be found in Appendix E: Results, page 193. 
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4.3.6 Association between the quantities (copies/ng) of the bacteria of interest and the presence 
of bacterial or viral STIs in the WISH cohort 
The STI status was determined based on the sum value of the presence or absence of all bacterial 
(Chlamydia trachomatis, Neisseria gonorrhea, and Mycoplasma genitalium), or viral (Herpes 
Simplex Virus 2, and Human Papilloma Virus) for each participant within the WISH cohort.  
The median copies/ng for each bacterium were compared using a Friedman’s ANOVA with a 
Dunn’s Multiple Comparison test for the absence (n=77, 53.85%), presence of one (n=51, 
35.66%) or presence of two or more (n=15, 10.49%) bacterial STIs. Further, the median 
copies/ng for each bacterium were compared using a Friedman’s ANOVA with a Dunn’s 
Multiple Comparison test for the absence (n=46, 32.17%), presence of one (n=91, 63.63%) or 
presence of two (n=6, 4.20%) viral STIs. There was an overall significant difference between the 
copies/ng of the bacteria in the bacterial STI groups (ANOVA p<0.0001). The ANOVA tests 
were significantly different for copies/ng of the bacteria in both the absence of and presence of 
one viral STI (p<0.0001) and the presence of two viral STIs (p=0.0162). The figures comparing 
the bacterium copies/ng per bacterial and viral STI group followed the same trends as the 
absence or presence of any one STI as well as the overall cohort and as such have not been 
included within this chapter. For the representative figures and p-values of the Friedman’s 
ANOVA test with a Dunn’s Multiple Comparisons run across the bacterial and viral STI groups, 
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4.3.6.1 Lactobacillus crispatus 
We compared log copies/ng of L. crispatus between those with none, one or two (or more) 
bacterial or viral STI groups. There was no significant difference in L. crispatus between the 
bacterial STI groups (Kruskal-Wallis ANOVA p=0.8469). There was no significant difference in 






















































Figure 4.3.6.1: Comparison of the quantities of L. crispatus (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on none, one, two (or more <) of the WISH 
cohort Bacterial (B) versus Viral (V) STIs being present. All p-value comparisons were based on 
an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.6.2 Lactobacillus gasseri 
We compared the quantified log copies/ng of L. gasseri between those with none, one or two (or 
more) bacterial or viral STI groups. There was no significant difference in L. gasseri between the 
bacterial STI groups (Kruskal-Wallis ANOVA p=0.8184) and the viral STI groups (Kruskal-




















































Figure 4.3.6.2: Comparison of the quantities of L. gasseri (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on none, one, two (or more <) of the WISH 
cohort Bacterial (B) versus Viral (V) STIs being present. All p-value comparisons were based on 
an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.6.3 Lactobacillus jensenii 
We compared the quantified log copies/ng of L. jensenii between those with none, one or two (or 
more) bacterial or viral STI groups. The bacterial STI groups had no significant difference in L. 
jensenii between the bacterial STI groups (Kruskal-Wallis ANOVA p=0.4743) and the viral STI 






















































Figure 4.3.6.3: Comparison of the quantities of L. jensenii (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on none, one, two (or more <) of the WISH 
cohort Bacterial (B) versus Viral (V) STIs being present. All p-value comparisons were based on 
an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.6.4 Lactobacillus iners 
We compared the quantified log copies/ng of L. iners between those with none, one or two (or 
more) bacterial or viral STI groups. Both the bacterial and viral STI groups had no significant 





















































Figure 4.3.6.4: Comparison of the quantities of L. iners (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on none, one, two (or more <) of the WISH 
cohort Bacterial (B) versus Viral (V) STIs being present. All p-value comparisons were based on 
an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.6.5 Gardnerella vaginalis 
We compared the quantified log copies/ng of G. vaginalis between those with none, one or two 
(or more) bacterial or viral STI groups. In the bacterial STI groups there was no significant 
difference in G. vaginalis (Kruskal-Wallis ANOVA p=0.2239). The group with two viral STIs 
had significantly different copies/ng of G. vaginalis compared to no viral STI (p=0.0098) and 
one viral STI (p=0.0324). There was an overall significant difference in G. vaginalis between the 
viral STI groups (Kruskal-Wallis ANOVA p=0.0126) (Figure 4.3.6.5). This significance could 























































Figure 4.3.6.5: Comparison of the quantities of G. vaginalis (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on none, one, two (or more <) of the WISH 
cohort Bacterial (B) versus Viral (V) STIs being present. All p-value comparisons were based on 
an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
The above figures thus indicate that the presence of none, one or two or more bacterial STIs 
(Chlamydia trachomatis, Neisseria gonorrhea, and Mycoplasma genitalium), have no association 
122 
 A. O. Breetzke 
with the copies/ng of L. crispatus, L. gasseri, L. jensenii, L. iners, G. vaginalis and P. bivia. The 
absence or presence of one or two viral STIs (Herpes Simplex Virus 2, and Human Papilloma 
Virus) showed no association with the copies/ng of L. crispatus, L. gasseri, L. jensenii, and L. 
iners. There was an association between the presence of two viral STIs and the copies/ng of G. 
vaginalis and P. bivia, which was not seen in the comparison of the copies/ng of the bacteria 
within the group. However, this could be due to the low participant number within the group and 
the statistical significance may decrease with an increase in number of participants. The bacterial 
and viral STI groups had increased copies/ng of G. vaginalis and L. iners in comparison to the 
other four bacteria. From this data it can be estimated that neither the absence, nor the increasing 
presence of bacterial or viral STIs have any association with the copies/ng of the bacterium 
quantified in this cohort.  
Due to the unreliability of the qPCR amplification results, the P. bivia data regarding bacterial 
and viral STIs has not been included and can be found in Appendix E: Results, page 201. 
 
4.3.7 Association between the quantities (copies/ng) of bacteria of interest and the absence or 
presence of low and high risk HPV subtypes in the WISH cohort 
The HPV status was considered negative in the absence of all HPV subtypes amplified by the 
Roche linear array, low risk if 6, 11, 40, 42, 54, 55, 61, 62, 64, 67, 69, 70, 71, 72, 81, 83, 84, 
89(CP6109) and IS39 HPV subtypes were present, and high risk if 16, 18, 26, 31, 33, 35, 39, 45, 
51, 52, 53, 56, 58, 59, 66, 68, 73 and 82 HPV subtypes were present.  
The median copies/ng for each bacterium were compared using a Friedman’s ANOVA with a 
Dunn’s Multiple Comparison test for the negative (n=29, 32.22%), low risk (n=27, 30%) and 
high risk (n=34, 37.78%) HPV groups. The comparison of the copies/ng between the bacteria in 
each category, were significantly different to each other overall (ANOVA p<0.0001). For the p-
values of the Friedman’s ANOVA test with a Dunn’s Multiple Comparison test run across the 
HPV groups, see Appendix D qPCR results, Section 2.7. Asterisk stars were used in the 
following figures where one start (*) indicates a p-value lower than 0.05, two stars (**) indicate 
a p-value lower than 0.01 and three stars (***) indicate a p-value lower than 0.001. 
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Within the negative HPV group (Figure 4.3.7A), G. vaginalis and L. iners had significantly 
higher copies/ng in comparison to L. gasseri (p=0.0023) and L. jensenii (p<0.0001), with L. 
crispatus having a significantly higher copies/ng with p=0.0023 in comparison to L. jensenii. 
Within the low risk HPV group (Figure 4.3.7B), G. vaginalis and L. iners were significantly 
higher than L. jensenii (p<0.0001), L. crispatus (p<0.0001) and L. gasseri (p=0.0001, p=0.0017 
respectively). G. vaginalis and L. iners were significantly higher than L. jensenii (p<0.0001) and 
L. gasseri (p<0.0001) in the high risk HPV group (Figure 4.3.7C) with G. vaginalis and L. 
crispatus showing significantly higher copies/ng in comparison to L. crispatus (p=0.00112) and 
L. jensenii (p=0.0089) respectively. The low and high risk HPV groups showed similar trends in 
the copies/ng of the bacteria with only a slight difference with L. crispatus in relation to the 































































Figure 4.3.7A: Box-plot of the negative HPV group for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log transformed copies/ng 
total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data 
set and the ‘whiskers’ which are the two lines (bottom and top) extending from the box 
component of each block that end with a horizontal stroke, indicate the range from the smallest 
and largest non-outliers to the 25% and 75% percentile components, respectively. The middle 
line indicates the median value for each data set. 
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Figure 4.3.7B: Box-plot of the low risk HPV group for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log transformed copies/ng 
total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data 
set and the ‘whiskers’ which are the two lines (bottom and top) extending from the box 
component of each block that end with a horizontal stroke, indicate the range from the smallest 
and largest non-outliers to the 25% and 75% percentile components, respectively. The middle 
line indicates the median value for each data set. 
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Figure 4.3.7C: Box-plot of the high risk HPV group for L. gasseri (red), L. jensenii (orange), L. 
crispatus (green), L. iners (blue), and G. vaginalis (purple) reported as log transformed copies/ng 
total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data 
set and the ‘whiskers’ which are the two lines (bottom and top) extending from the box 
component of each block that end with a horizontal stroke, indicate the range from the smallest 
and largest non-outliers to the 25% and 75% percentile components, respectively. The middle 
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4.3.7.1 Lactobacillus crispatus 
The log copies/ng of L. crispatus within the high risk HPV group were significantly higher than 
the copies/ng in the low risk HPV group. There was an overall significant difference in L. 













































Figure 4.3.7.1: Comparison of the quantities of L. crispatus (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the negative, low risk and high risk HPV groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.7.2 Lactobacillus gasseri 
The quantified log copies/ng of L. gasseri had no significant difference between the HPV groups 












































Figure 4.3.7.2: Comparison of the quantities of L. gasseri (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the negative, low risk and high risk HPV groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.7.3 Lactobacillus jensenii 
The compared quantified log copies/ng of L. jensenii between the HPV groups had no significant 













































Figure 4.3.7.3: Comparison of the quantities of L. jensenii (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the negative, low risk and high risk HPV groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.7.4 Lactobacillus iners 
There was no significant difference in L. iners between the HPV groups (Kruskal-Wallis 











































Figure 4.3.7.4: Comparison of the quantities of L. iners (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the negative, low risk and high risk HPV groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
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4.3.7.5 Gardnerella vaginalis 
The compared quantified log copies/ng of G. vaginalis between the HPV groups had no 















































Figure 4.3.7.5: Comparison of the quantities of G. vaginalis (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the negative, low risk and high risk HPV groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
Therefore, the absence of HPV, as well as the presence of low risk or high risk HPV sub-types 
showed no association with the bacterial copies/ng of L. gasseri, L. jensenii, L. iners, G. 
vaginalis, and P. bivia. There were significantly higher copies/ng of L. crispatus in the high risk 
HPV in comparison to the low risk HPV group, with an overall significant difference between 
the negative, low risk and high risk HPV groups (ANOVA p=0.0145). Thus high-risk HPV 
subtypes indicate an association with increased L. crispatus copies/ng, with no further 
associations with the other bacterium within this cohort.  
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Due to the unreliability of the qPCR amplification results, the P. bivia data regarding HPV has 
not been included and can be found in Appendix E: Results, page 203. 
 
4.4 Overview 
Overall, within the cohort, G. vaginalis and L. iners had high copies/ng in vaginal samples in 
comparison to the other bacteria. There was a diverse effect of the BV status on the quantities 
(copies/ng) of bacteria measured on the adolescent female lateral wall swab DNA. As expected, 
participants who were BV negative had increased levels of L. crispatus (copies/ng) and L. 
gasseri (copies/ng) in comparison to both the BV intermediate and BV positive participants 
while L. jensenii (copies/ng) and L. iners (copies/ng) showed increased levels in comparison to 
the BV positive and BV intermediate participants, respectively. The participants in the BV 
positive group showed the opposite traits with increased levels of G. vaginalis (copies/ng) in 
comparison to both the BV intermediate and BV negative groups. L. iners, although significantly 
higher in BV negative versus BV intermediate, did not differ between BV positive and BV 
negative, and was ubiquitously present. The low inflammation group showed increased copies/ng 
of L. crispatus, L. gasseri, and L. jensenii in comparison to the high inflammation group. The 
two inflammatory groups indicated no association with the copies/ng of L. iners, and G. 
vaginalis, within the FGT of these adolescent participants. 
There was a slight association between L. jensenii and hormonal contraceptive usage, G. 
vaginalis and the presence of two viral STIs in comparison to none and one, P. bivia and the 
presence of two viral STIs in comparison to none present, and L. iners with the low risk and high 
risk HPV groups. Furthermore, no category of interest within this study showed any impact on 
with the copies/ng of P. bivia with non-significant p-values in all group comparisons, except for 
the presence of the two viral STIs. From the above data, we can conclude that within this cohort, 
the quantities (copies/ng DNA) of the bacteria we measured within the FGT microbiome are do 
not have a distinct association with age, the absence or present of any one STI, absence or 
presence of any one, two or more bacterial STIs (Chlamydia trachomatis, Neisseria gonorrhea, 
and Mycoplasma genitalium) in the adolescent females based in Masiphumelele who were part 
of the WISH cohort. 
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Finally, research should be undertaken to design and optimize primers for P. bivia that are 
species specific, have low levels of self-complementarity and are reliable in order to validate the 
results and allow for accurate and direct analyses.  
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Chapter 5: Discussion 
Adolescent and young adult women are at extreme risk for HIV infection (Jaspan et al. 2011; 
Seutlwadi et al. 2012), the cause of which has yet to be determined (Jaspan 2011; Pettifor et al. 
2005). Within our South African cohort different factors such as BV status, genital inflammation, 
age, hormonal contraceptive (HC) usage, and the absence or presence of bacterial or viral STIs 
were investigated. The absolute quantified log copies/ng of L. crispatus, L. gasseri, L. jensenii, 
L. iners, G. vaginalis and P. bivia were compared between the subset groups of these factors in 
order to determine any associations with HIV acquisition risk. We hypothesized that individuals 
with vaginal microbiota dominated by L. crispatus, L. jensenii and L. gasseri were more likely 
BV negative, had low genital low inflammation, had no STIs, were using either the hormonal 
contraceptive Nur Isterate or Implanon, and were between the ages of 16-18 years old. We 
further hypothesized that L. iners, G. vaginalis and P. bivia would be relatively more abundant in 
females with high levels of genital inflammatory cytokines, in individuals who were BV 
positive, had one or more STIs, and/or were using the hormonal contraceptive DMPA and/or 
were between the ages of 19-22 years old.  
The most fundamental step in the development of the qPCR protocols for the six bacteria 
involved was to ensure pure colonies and the correct growth conditions in order to guarantee 
accurate and reliable standard curves. If the serially diluted pure positive control DNA was 
incorrectly extracted from contaminated bacterial colonies, the entire standard curve which was 
the basis for the bacterial quantification would have been unreliable, rendering all the results null 
and void. The accuracy of the DNA extraction and quantification process further have a large 
influence on the data. Errors and contamination during this stage of the assay development 
would have resulted in inaccurate readings, preventing any reliable analyses of the data. The 
optimization of the qPCR protocols for the first Lactobacillus spp. required the most time. Seven 
optimization runs were performed in order to ensure the most accurate quantification readings of 
L. crispatus, after which three were generally required for L. jensenii, L. iners and L. gasseri as 
the protocol conditions were very similar. The qPCR protocols for the L. crispatus, followed by 
G. vaginalis and P. bivia were optimized through single step-by-step changes. The guidance for 
optimization was based on the error (< 0.05) and efficiency (2) values being as close to target as 
possible. The first step take with the optimization process would be to either increase and/or 
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decrease the annealing temperatures by up to 5 ̊C to improve the amplification peaks. If the 
change in annealing temperature did not yield sufficient improvements, the length of the initial 
denaturation step was adjusted in order to determine if the DNA was not denaturing sufficiently. 
The next step would be to increase the number of cycles in the amplification step of the protocol 
in order to improve the amplification curves as well as the error and efficiency value readings. 
The next step would be to be to either re-dilute the serially diluted standard curves in order to 
determine of the standard curve DNA was inaccurate, or to change the protocol entirely based 
from published literature research. The last step in the optimization process would be to change 
the primers, this was only necessary for L. crispatus, and P. bivia, after which the above steps 
would need to be repeated in order to finalize the qPCR protocol. Most differences occurred 
between primers, and the cycling conditions in terms of temperatures, length of and number of 
cycles per step in the qPCR protocol. 
In this cohort, it was established that in general, L. iners and G. vaginalis were present at 
significantly higher copy numbers in comparison to the other Lactobacillus species in the 
adolescent FGT. L. gasseri and L. jensenii were present at particularly low levels in the majority 
of the adolescents, compared to other Lactobacilli. There were significantly higher copies/ng of 
L. crispatus in participants who were BV negative, had low genital inflammation levels, were 
16-18 years of age, and were using the hormonal contraceptive Nur Isterate in comparison to the 
copies/ng of L. jensenii. Further, participants with no STI present, any one bacterial STI present 
(N. gonorrhea, C. trachomatis, HSV-2, T. vaginalis, M. genitalium, T. pallidum, H. ducreyi), and 
who were either negative or had high risk HPV subtypes present within their vaginal secretions, 
had significantly higher copies/ng of L. crispatus in comparison to L. jensenii. These increased 
copy numbers could be due to the dominance of L. crispatus within the FGT and its relation to 
maintaining health and preventing any infections. Nevertheless, L. iners remained the dominant 
lactobacilli species even in these “healthy” women. It is possible that since we only assessed four 
of the main lactobacilli species from the genital tract, the ratio of increased copies/ng of L. 
crispatus and the decreased copies/ng of L. gasseri and L. jensenii could change in relation to 
other lactobacilli when quantified. Most publications associate lactobacilli dominance with a 
healthy FGT microbiome (Jespers et al. 2015; Ravel et al. 2011; Lopes dos Santos Santiago et al. 
2012).  
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The increased copy numbers of L. iners in comparison to the other measured lactobacilli in this 
cohort, is consistent with other studies conducted in South African women (Anahtar et al. 2015), 
with another study indicating that African and Asian women who had low Nugent scores, had 
increased levels of G. vaginalis, and decreased Lactobacillus species, except for L. iners (Jespers 
et al. 2012).  It has been established that women of African descent have a different FGT 
microbiota profile compared with Caucasian women, which is in agreement with the L. iners 
dominance seen in our cohort. Moreover, Caucasian and Asian women are reportedly more 
likely to have FGT dominated by lactobacilli than Hispanic or black women who are more likely 
to have FGT microbiota dominated by L. iners and increased vaginal pH (R. F. Lamont et al. 
2011; Ma et al. 2013; Ravel et al. 2011; Srinivasan et al. 2012). A study based on black South 
African women between the ages of 18-23 reported four cervicotypes; including one-dominated 
by non-iners lactobacilli species, another L. iners-dominated, a predominantly G. vaginalis 
group and a Prevotella-mixed group was present in all communities (Anahtar et al. 2015). This 
indicates that ethnicity and the increased risk status of adolescents influences the FGT 
microbiota profile (Jespers et al. 2012). Research should compare the vaginal microbiota of 
African women across different age groups beyond 16-22 years of age in order to determine any 
trends across different African races in combination with different dietary factors and vaginal 
hygiene practices, and whether any of these factors influence differences in FGT microbiota.  
As expected from previous studies, the FGT microbiota of BV-negative participants were 
dominated by L. crispatus, L. gasseri, and L. jensenii, while BV-positive participants were 
dominated by G. vaginalis (Datcu 2014; Fredricks et al. 2015; Fredricks et al. 2007; Marrazzo et 
al. 2012; Mayer et al. 2015; Srinivasan et al. 2010). Interestingly, L. iners had the highest 
quantified log copies/ng across the cohort as well as in the BV negative and BV intermediate 
participants. Although both L. crispatus and L. iners are associated with a healthy FGT 
microbiota and there may be some overlap, they do not share the same niche. Studies have 
shown that L. iners is the first lactobacilli species to establish after BV within the mucosa of the 
vagina, restoring pH through the production of lactate, allowing for the growth of the normal 
dominant lactobacilli species such as L. crispatus, L. gasseri and L. jensenii (France et al. 2016; 
Jakobsson & Forsum 2008; Mayer et al. 2015; Petrova et al. 2015). This has been demonstrated 
by the differential production of L- and D- lactic acid by L. crispatus, and only L- lactic acid by 
L. iners; and the genetic inability of L. iners to oxidize pyruvate to produce hydrogen peroxide 
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(France et al. 2016). In addition, L. crispatus contains genes for an iron transport system within 
its genome while L. iners does not, while L. crispatus is able to break down putrescine, an amino 
acid associated with BV. This indicates differential competition for the dominance of the shared 
FGT microbiota possibly through nutrient sources, ability to respond to invading pathogens and 
menses (France et al. 2016).  
As hypothesized, increased log transformed copies/ng readings of L. crispatus, L. gasseri and L. 
jensenii were observed in participants with low levels of genital inflammation, indicating an 
inferred negative association with participants with high levels of genital inflammation. 
However, there was no direct association between any log transformed copies/ng readings for the 
bacteria and participants with high levels of genital inflammation, contradicting our second 
hypothesis that adolescents with high levels of genital inflammation have FGT microbiota 
profiles dominated by L. iners, G. vaginalis and P. bivia. This could indicate that high levels of 
genital inflammation are not due to the presence of pathogenic bacteria such as BV-associated G. 
vaginalis, but rather due to the absence of health-associated lactobacilli species. Further research 
would be required as this does not agree with current literature.  
It was hypothesized that young adolescents between the ages of 16-18years would have 
increased L. jensenii, L. gasseri and L. crispatus while adolescents between the ages of 19-22 
would have increased L. iners, G. vaginalis and P. bivia. However, there were no differences in 
bacterial quantities when stratifying participants by age (16-18 versus 19-22 years), or when 
considering age as a continuous variable (data not included). This lack of age-specific FGT 
microbiota could also however, be due to the tight age range that we studied. Indeed, women 30 
years and older (who are many years past menarche, are experiencing menses or have been 
pregnant), reportedly have different FGT microbiota profiles compared with adolescents 
(Chaban et al. 2014; Ma et al. 2013; MacIntyre et al. 2015). Studies have shown that the 
presence and relative abundance of lactobacilli within the FGT microbiota profile changes with 
age (Cauci et al. 2002; Madan et al. 2012; Thoma et al. 2011). A cohort involving older women 
should be studied in order to determine whether the trend of fewer lactobacilli species and the 
increased copies/ ng of G. vaginalis are possibly culture-dependent, due to personal hygiene and 
bathing habits, or age. The point at which sexual debut occurs could further influence the FGT 
microbiota through the increase in BV-associated bacteria such as G. vaginalis (Mitchell et al. 
137 
 A. O. Breetzke 
2012), however, other studies indicate that bacteria such as G. vaginalis  could colonize the FGT 
prior to the onset of menarche (Hickey et al. 2015). The data suggest that the driving factor for 
increased HIV acquisition risk may be something age.  
Progestin-only hormonal contraceptives are the most commonly prescribed hormonal 
contraceptive in South Africa (Byrne et al. 2016; Murphy et al. 2014; van de Wijgert et al. 2013). 
These are particularly popular among adolescents due to their long-lasting effects.  However, 
observational data suggest that injectable progestin-only hormonal contraceptives may increase 
risk for HIV (Byrne et al. 2016; Murphy et al. 2014; Roxby et al. 2016). There are contradicting 
data regarding the difference in HIV acquisition risk between DMPA and Nur Isterate, with 
suggestions that the active agent of Nur Isterate is the safer alternative (Govender et al. 2014; 
Tomasicchio et al. 2013). It was hypothesized that adolescents prescribed the contraceptives Nur 
Isterate or Implanon would have increased levels of L. jensenii, L. gasseri, and L. crispatus, 
while those prescribed DMPA would have increased levels of L. iners, G. vaginalis and P. bivia. 
However, there were no significant differences in abundance for any of the bacteria studied here 
between adolescents on DMPA versus those on Nur Isterate.  Although the active agents are very 
similar, the difference in initial dosage due to the 8 week, versus 12week activity could possibly 
influence the level of association with the bacteria, as well as reduced numbers of participants 
prescribed DMPA (n=25) in comparison to those prescribed Nur Isterate (n=102). There were no 
differences in copy number for any of the bacteria for participants prescribed Implanon. 
However, there were fewer participants within this group (n=9) than those using DMPA and Nur 
Isterate which may have resulted in inaccurate differences. The only association identified was 
an overall significant difference in L. jensenii copies/ng across the three hormonal contraceptive 
groups; based on higher copies/ng in participants prescribed DMPA and Nur Isterate compared 
to those prescribed Implanon.  
A better comparison would be to compare the copies/ng of the participants using the different 
hormonal contraceptives in comparison the participants who were using non-hormonal 
contraceptive methods.  In order to increase the reliability of the results, repeats would need to be 
run, with equal numbers of participants in each three hormonal group. Further, as part of the 
WISH cohort through Masiphumelele, there were no girls who were not on a form of 
contraceptive. The larger study collected samples from Johannesburg where participants were 
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not taking any form of oral/injectable contraceptive. Further analysis could compare overall 
participants taking a form of contraceptive versus those participants not taking a hormonal 
contraceptive. However, this would require crossing location samples which was not a part of 
this master’s thesis study and thus only inter-hormonal contraceptive comparisons could be 
performed. 
The copies/ng of the bacteria were compared between women with and without any one 
laboratory-diagnosed STI. We hypothesized that the FGT microbiota of participants who had no 
STI would be more abundant in L. jensenii, L. gasseri, and L. crispatus, while participants who 
had one or more STIs would have a FGT microbiota dominated by L. iners, G. vaginalis and P. 
bivia. No such association was found in relation to the absence or presence of any one STI; the 
absence, presence of one, or presence of two or more bacterial STIs, or the absence or presence 
of one viral STI. There was an association between increased copies/ng of G. vaginalis and the 
presence of two viral STIs; however, the number of participants within this group was small. 
This trend was further observed for P. bivia; however, because the primers were not reliable the 
data should be interpreted with caution. The serological data for HSV-2 was not included within 
the results, nor incorporated within the statistical analyses, thus further associations cannot be 
conducted with the abundance of the bacteria and  HSV-2. The serological status of HSV-2 is 
important as studies have shown a link with BV as well as multiple immunological changes 
within the immune system with further associations with HIV acquisition (Kaul et al. 2007; 
Keller et al. 2012).  The presence of HPV was not associated with any of the bacteria studied 
here. However, participants who had high risk HPV subtypes had increased levels of L. crispatus 
compared with their HPV low risk counterparts. Research has established that HPV is essentially 
a marker for sexual debut, and it is unlikely to see any major difference between the bacteria for 
this STI (Aujo et al. 2014; Bednarczyk et al. 2012; Houlihan et al. 2014). Validation of the STI 
results would be recommended as the  small sample size could possibly have influenced the 
results.  
Multiple factors likely drive increased risk of HIV acquisition in South African adolescent 
females. Within the U.S.A, male adolescents within the same age group with the same number of 
reported sexual partners have a lower risk of HIV acquisition in comparison to their South 
African counterparts (Cohen et al. 2012; Jaspan 2011; Pettifor et al. 2011). The increased 
139 
 A. O. Breetzke 
copies/ng of G. vaginalis within these adolescents could indicate a shift in the FGT microbiota 
profile in comparison to what is generally seen in adults as an indicator for BV (Datcu 2014; 
Hickey et al. 2015). Different FGT microbiota trends can be influenced by the use of agents to 
dry, tighten or warm the vagina having a possible link to vaginal health and HIV risk. The 
misuse of such agents through misunderstanding, could lead to decreased vaginal health in 
adolescents. Studies have shown than adolescents as well as older women, insert agents such as 
ice, newspaper, snuff, menthol-based ointments, washing with sunlight soap, cleansing with 
Disprin and tissues, and using traditional herbs as ointments, ingestion or smoking and douching 
in order to remove any ‘excess’ vaginal wetness and increase friction and the ‘dryness’ of sexual 
intercourse (Scorgie et al. 2009; Hilber et al. 2010; Jespers et al. 2016b; Mitchell et al. 2011; 
Smit et al. 2002). Further factors that should be taken into consideration include the living 
conditions and cultural practices within Masiphumelele (Cauci et al. 2002; Madan et al. 2012; 
Thoma et al. 2011). 
Limitations of this study include uneven numbers of participants for each of the factors 
compared, as well large differences between group participant numbers, especially the viral 
STIs. Future statistical analyses should be performed using category groups with more even 
numbers of participants for comparison and validation of these results. Further, a larger age 
range as well as more lactobacilli species would have benefitted the understanding of dominant 
abundance. The comparison for association between bacterial copy number and HC would have 
benefitted with a non-HC base group of adolescents. Finally, the P. bivia primers were not 
reliable and thus the data cannot be used for comparison or association with the factors of 
interest within this study. Multiple changes were implemented in order to try and optimize the 
qPCR protocol for P. bivia, however, none of the changes performed resulted in sufficient 
identification of the bacterium in order to produce reliable results. Any further work with P. 
bivia will involve more in-depth research into more reliable primers, possibly TaqMan probes, in 
order to improve specificity and reliability. Further limitations of this study include the simple 
statistical analyses performed. More multivariate comparisons could have been performed in 
order to better understand the relationships between the classification types and their groups, 
rather than simply in direct relation to the copies/ng of the bacterium. Potential associations 
could have been missed due to statistical analyses that did not take into account interrelatedness 
and confounding variables.  
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Chapter 6: Conclusion 
In conclusion, the FGT microbiota of the adolescent population of females in Masiphumelele is 
dominated by L. iners relative to the other bacteria within this cohort, similar to previous studies 
with black women, and G. vaginalis, which does not follow the normal ‘healthy’ microbiome. 
This trend is shifted by L. crispatus, which had increased copy numbers across the different 
factors such as BV status, low levels of genital inflammation and the presence of two viral STIs, 
with a slight association with high risk HPV subtypes. The age of the participants, high levels of 
genital inflammation, absence or presence of any one STI, the absence or presence of one, or two 
or more bacterial STIs, and the absence of or presence of one viral STI do not have any 
association with the copies/ng of L. crispatus, L. gasseri, L. jensenii, L. iners, and G. vaginalis.  
The FGT microbiota profile is different within the Masiphumelele female adolescents in 
comparison to many publications based on different ethnicities and geographical locations based 
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Appendix A – DNA Concentrations 
The DNA from the majority of the lateral wall swab participant samples from the adolescent 
females who took part of the WISH cohort had been extracted by Enock Bugaye Havyarimana 
and Anna Blakney. The DNA was extracted from the remaining samples during this study. The 
DNA was extracted using the MoBio Powersoil® DNA Isolation Kit.  
Table 1: List of DNA concentrations (ng/µL) extracted from WISH participant lateral wall swab 
vaginal samples collected at Visit 1. 
Count Participant sample: DNA concentration (ng/µL) 
1 W001 V1 0.053 
2 W002 V1 0.17 
3 W004 V1 2.62 
4 W005 V1 0.13 
5 W006 V1 0.47 
6 W007 V1 8.24 
7 W008V1 0.6 
8 W009 V1 9.40 
9 W010 V1 8.84 
10 W011 V1 2.88 
11 W012 V1 Rep B 7.82 
12 W013  V1 0.452 
13 W015 V1 2.31 
14 W016 V1 3.3 
15 W017 V1 2.42 
16 W019 V1 0.188 
17 W021 V1 3.02 
18 W022 V1 2.6 
19 W023 V1 0.93 
20 W024 V1 1.28 
21 W025 V1 0.79 
22 W026 V1 7.54 
23 W027 V1 6.48 
24 W028 V1 4.40 
25 W030  V1 0.288 
26 W031 V1 0.86 
27 W032 V1 2.26 
28 W033 V1 2.64 
29 W034 V1 0.005 
30 W035 V1 0.15 
31 W036 V1 16.3 
32 W037 V1 1.40 
33 W038 V1 3.6 
34 W039 V1 4.0 
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35 W040 V1 1.7 
36 W041 V1 6.06 
37 W043 V1 4.20 
38 W044 V1 6.32 
39 W045 V1 0.22 
40 W046 V1 0.005 
41 W047 V1 37.2 
42 W048 V1 3.76 
43 W050 V1 0.17 
44 W051 V1 0.68 
45 W052 V1 4.08 
46 W053 V1 0.80 
47 W054 V1 0.25 
48 W055 V1 0.53 
49 W056 V1 0.80 
50 W057 V1 3.48 
51 W059 V1 0.64 
52 W060 V1 1.79 
53 W061V1 0.48 
54 W062 V1 0.46 
55 W063V1 0.20 
56 W064 V1 0.52 
57 W065 V1 0.52 
58 W066 V1 2.20 
59 W067 V1 2.20 
60 W068 V1 2.66 
61 W070 V1 10.40 
62 W071 V1 1.02 
63 W072 V1 1.64 
64 W073 V1 10.2 
65 W074 V1 0.96 
66 W076 V1 8.76 
67 W077 V1 5.20 
68 W079 V1 1.46 
69 W080 V1 0.005 
70 W081 V1 1.80 
71 W082 V1 6.32 
72 W083 V1 Rep A 19.38 
73 W084 V1 1.07 
74 W085 V1 4.52 
75 W086 V1 2.05 
76 W087 V1 5.72 
77 W088 V1 2.71 
78 W089 V1 5.12 
79 W091 V1 1.23 
80 W092 V1 7.84 
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81 W094 V1 3.82 
82 W095 V1 3.04 
83 W096 V1 3.24 
84 W097 V1 0.76 
85 W098 V1 1.11 
86 W099 V1 0.005 
87 W100 V1 0.30 
88 W101 V1 1.61 
89 W102 V1 1.01 
90 W104 V1 7.0 
91 W105 V1 1.40 
92 W106 V1 6.28 
93 W107 V1 4.36 
94 W108 V1 7.28 
95 W110 V1 3.4 
96 W112 V1 1.06 
97 W113 V1 5.12 
98 W114 V1 6.96 
99 W115 V1 3.83 
100 W116 V1 4.44 
101 W117 V1 6.48 
102 W118 V1 4.84 
103 W119 V1 Rep A 25 
104 W120 V1 8.24 
105 W121 V1 1.44 
106 W122 V1 1.14 
107 W123 V1 0.038 
108 W124 V1 1.36 
109 W125 V1 0.60 
110 W126 V1 9.76 
111 W127 V1 5 
112 W128 V1 1.38 
113 W129 V1 4.68 
114 W130 V1 7.24 
115 W131 V1 4.68 
116 W132 V1 Rep B 25.2 
117 W135 V1Rep A 10.42 
118 W136 V1 11.7 
119 W137 V1 3.3 
120 W138 V1 Rep A 88.7 
121 W139 V1 7.40 
122 W141 V1 1.62 
123 W147 V1 9.68 
124 W148 V1 Rep A 17.44 
125 W149 V1 2.92 
126 W150 V1 Rep B 20.8 
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127 W152 V1 13.2 
128 W154 V1 8.4 
129 W156 V1 Rep A 4.5 
130 W157 V1 Rep B 30.4 
131 W158 V1 Rep B 2.28 
132 W159 V1 Rep A 15.56 
133 W160 V1 Rep B 15.06 
134 W161 V1 Rep B 5.94 
135 W163 V1 Rep B 45 
136 W164 V1 Rep A 9.44 
137 W165 V1 Rep A 5.14 
138 W166 V1 Rep A 0.1 
139 W167 V1 Rep A 32.8 
140 W168 V1 Rep A 3.84 
141 W170 V1 Rep A 15.74 
142 W171 V1 Rep B 0.78 
143 W172 V1 Rep A 4.4 
144 W173 V1 Rep B 7.88 
145 W174 V1 Rep A 1.6 
146 W176 V1  Rep A 7.06 
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Appendix B – Primer Confirmation 
A PCR was run using the DNA extracted from the growth of each bacterial positive control in 
duplicate with a Non-Template Control (NTC) (Qiagen Blood and Tissue DNA Maxi Extraction 
Kit with Buffers B1 and B2). The PCR products were then run on a 1.6% agarose gel at 130V for 
1 h with a 100 bp ladder to visualize the size of the bands to confirm the species specific primer 
product sizes for each species. 
          
 
 
Figure 1: Gel electrophoresis of the standard positive control species specific PCR to confirm 
primer specificity and product size. 1 and 14 indicate a ThermoFisher O’Gene 100 bp ruler, lanes 
2, 4, 6, 8, 10, and 12 indicates the PCR products for L. crispatus, L. gasseri, L. jensenii, L. iners, 
G. vaginalis and P. bivia, and lanes 3, 5, 7, 9, and 11 indicate their respective NTC’s.  
   1       2       3        4     5        6        7        8      9       10      11     12      13      14 
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Appendix C: qPCR Optimization  
For the optimization of each bacterial specific absolute qPCR, multiple plates were run with 
different conditions until the error and efficiency values were as close to 0.05 and 2 respectively, 
as could be optimized. The following figures illustrate each trial plate that was run for each 
bacterial species, as well as the changes that were made for each plate.  
The optimization figures for L. crispatus, G. vaginalis and P. bivia can be found in Chapter 4, 
Results, 4.1 Real-Time PCR (qPCR) Optimization.  
Real-Time PCR (qPCR) Optimization: 
1 Lactobacillus gasseri 
A total of three trial plates were run to finalize the optimization of L. gasseri qPCR conditions. 
The first trial plate (V1.1) was run using the same reagent volumes as the finalized conditions for 
L. crispatus (V1.7). The following qPCR conditions were followed,  95 ̊C for 15 min initial 
denaturation, followed by 40 cycles of 95 ̊C for 15 s, 57 ̊C for 1 min and 65 ̊C for 1 min (Figure 
1.1 A, Figure 1.2 A). The replicates for the positive controls showed some inaccuracies and thus 
required a second run. The second trial plate for L. gasseri (1.2) was run under the same 
conditions as qPCR trial plate V1.1 in order to improve efficiency and pipetting accuracy with 
the exception of the initial denaturation being for 5 min (Figure 1.1 B, Figure 1.2 B). The error 
and efficiency values showed good readings and the positive controls amplified well. The third 
and final optimization plate for L. gasseri was run using the same conditions as V1.2 in order to 
determine whether the lack of amplification in the positive controls at 10
-2
 copies/µL was due to 
a pipetting error or the concentration threshold for amplification of the standard control DNA 
(Figure 1.1 C, Figure 1.2 C). The final standard curve error and efficiency readings were good 
with single peaks in the melt curves and thus accepted to run samples.  
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Figure 1.1: Roche LightCycler® 480 absolute quantitative derivative max amplification curve 
for the three L. gasseri optimization plates (V1.1-V1.3). The fluorescence (465-510 nm) is 
indicated on the y-axis and the number of cycles is indicated on the x-axis. Red and brown 
indicate positive amplification in the unknown sample and the positive control standards 
respectively, and green indicates negative amplification in the wells. 
 
Figure 1.2: Roche LightCycler® 480 melt curve for the three L. gasseri optimization plates 
(V1.1-V1.3). The –d/dT fluorescence (465-510 nm) is indicated on the y-axis and the 
A – Plate V1.1 
Error: 0.0223 
Efficiency: 1.828 
B – Plate V1.2 
Error: 0.0436 
Efficiency: 1.851 
C – Plate V1.3 
Error: 0.0442 
Efficiency: 1.839 
A – Plate V1.1 B – Plate V1.2 
C – Plate V1.3 
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temperature (̊C) is indicated on the x-axis. Red indicates a single peak (product), green indicates 
two peaks and blue indicates no peak for each well. 
 
2 Lactobacillus jensenii 
Two qPCR trial plates were run for L. jensenii where the first (V1.1) was run using the same 
reagent volumes as the finalized conditions for L. crispatus (V1.7). The following qPCR 
conditions were followed,  95 ̊C for 5 min for initial denaturation, followed by 40 cycles of 95 ̊C 
for 15 s, 60 ̊C for 55 s, and 72 ̊C for 1 min (Figure 2.1 A, Figure 2.2 A). The error value was 
higher than optimum despite the clean amplification curves of the positive controls. The second 
L. jensenii qPCR trial plate (V1.2) was run under the same conditions as qPCR trial V1.1 to try 
and improve efficiency and pipetting accuracy (Figure 2.1 B, Figure 2.2 B). The error and 
efficiency values were close to optimum with a good standard curve and single melt curve peaks.  
 
Figure 2.1: Roche LightCycler® 480 absolute quantitative derivative max amplification curve 
for the two L. jensenii optimization plates (V1.1-V1.2). The fluorescence (465-510 nm) is 
indicated on the y-axis and the number of cycles is indicated on the x-axis. Red and brown 
indicate positive amplification in the unknown sample and the positive control standards 




A – Plate V1.1 
Error: 0.312 
Efficiency: 1.864 
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Figure 2.2: Roche LightCycler® 480 melt curve for the two L. jensenii optimization plates 
(V1.1-V1.2). The –d/dT fluorescence (465-510 nm) is indicated on the y-axis and the 
temperature (̊C) is indicated on the x-axis. Red indicates a single peak (product), green indicates 
two peaks and blue indicates no peak for each well. 
 
3 Lactobacillus iners 
As seen above for L. jensenii, L. iners was optimized with two trial plates with the first trial plate 
(V1.1) being run using the same reagent volumes and concentrations as set up in the final trial 
run for L. crispatus (V1.7) with the following qPCR conditions 95 ̊C for 15 min for the initial 
denaturation, followed by 40 cycles of 95 ̊C for 15 s, 60 ̊C for 55s and 69 C̊ for 1 min (Figure 3.1 
A, Figure 3.2 A). The efficiency was slightly higher than expected with some dimerization 
present within the melt curve. The second trial plate for L. iners (V1.2) was run using the same 
conditions as in V1.1 in order to confirm the error and efficiency values before running  samples 
(Figure 3.1 B, Figure 3.2 B). The error and efficiency were of sufficient readings with a single 
melt curve peak.  
 
A – Plate V1.1 
 
B – Plate V1.2 
 
A – Plate V1.1 
Error: 0.0335 
Efficiency: 2.022 
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Figure 3.1: Roche LightCycler® 480 absolute quantitative derivative max amplification curve 
for the two L. iners optimization plates (V1.1-V1.2). The fluorescence (465-510 nm) is indicated 
on the y-axis and the number of cycles is indicated on the x-axis. Red and brown indicate 
positive amplification in the unknown sample and the positive control standards respectively, 
and green indicates negative amplification in the wells. 
 
Figure 3.2: Roche LightCycler® 480 melt curve for the two L. iners optimization plates (V1.1-
V1.2). The –d/dT fluorescence (465-510 nm) is indicated on the y-axis and the temperature (̊C) 
is indicated on the x-axis. Red indicates a single peak (product), green indicates two peaks and 
blue indicates no peak for each well. 
For all result amplification and melt curves, see Appendix D, qPCR Results.  
 
A – Plate V1.1 
 
B – Plate V1.2 
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Appendix D: qPCR Results  
Thhis appendix serves as a refrence for the raw qPCR results for the absolute quantitifcation od 
each bacterial species of interest i.e. L. crispatus (copies/ng), L. gasseri (copies/ng), L. jensenii 
(copies/ng), L. iners (copies/ng), G. vaginalis (copies/ng), and P. bivia (copies/ng) in the DNA 
extracted from the lateral wall swabs from adolescent females who partook in the WISH Cohort 
at the Masiphumelele Youth Centre.  
1. Real-Time PCR (qPCR) Results: 
Table 1.1: Summary table for the WISH sample run qPCR standard curve statistics for the 
following bacteria of interest: 
Bacteria qPCR Plate Error Efficiency 
L. crispatus V2.1 0.244 1.704 
 V2.2 0.259 1.807 
 V2.3 0.0130 1.896 
 V2.4 0.0264 1.903 
 V2.5 0.488 1.521 
 V2.6 0.0215 1.867 
 V2.7 0.0393 1.819 
 V2.8 0.0290 1.865 
L. gasseri V2.1 0.0557 1.803 
 V2.2 0.0672 1.741 
 V2.3 0.0565 1.743 
 V2.4 0.0592 1.691 
 V2.5 0.0609 1.695 
 V2.6 0.0511 1.701 
 V2.7 0.122 1.801 
 V2.8 0.0328 1.858 
 V2.9 0.0261 1.846 
L. jensenii V2.1 0.0256 1.897 
 V2.2 0.0521 1.962 
 V2.3 0.0498 1.912 
 V2.4 0.0458 1.901 
 V2.5 0.0521 1.930 
 V2.6 0.0508 1.686 
 V2.7 0.0466 1.961 
 V2.8 0.0401 1.941 
L. iners V2.1 0.0139 1.810 
 V2.2 0.0237 1.764 
 V2.3 0.0203 1.698 
 V2.4 0.0143 1.825 
 V2.5 0.0832 1.867 
173 
 A. O. Breetzke 
 V2.6 0.0132 1.935 
G. vaginalis V2.1 0.0252 1.895 
 V2.2 0.0151 1.856 
 V2.3 0.0375 1.902 
 V2.4 0.0601 1.892 
 V2.5 0.0255 1.901 
 V2.6 0.0751 1.821 
 V2.7 0.0805 1.835 
P. bivia V2.1-V2.6 0.0608 1.993 
 
1.1 Lactobacillus crispatus 
Eight plates were run in total for the 143 samples in triplicate with the positive controls for L. 
crispatus. For instances where either one or two replicates showed primer dimers, no 
amplification or different values in comparison to the other replicates for the sample, the sample 
was re-run on another plate to confirm the readings (Figure 1.1.1, Figure 1.1.2).  
B – Plate V2.2 
Error: 0.259 
Efficiency: 1.807 
A – Plate V2.1 
Error: 0.244 
Efficiency: 1.704 
C – Plate V2.3 
Error: 0.0130 
Efficiency: 1.896 
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Figure 1.1.1: Absolute quantitative derivative max amplification curve of L. crispatus qPCR 
(V2.1-V2.8) reported as log transformed copies/ng total DNA, generated based on all wells and 





 copies/µL. The fluorescence (465-510 nm) is indicated on the y-axis and 
the number of cycles is indicated on the x-axis. Red and brown indicate positive amplification in 
the unknown samples and the positive control standards respectively; blue indicates uncertainty 
and green indicates negative amplification in the wells. 
H – Plate V2.8 
Error: 0.0290 
Efficiency: 1.865 
G – Plate V2.7 
Error: 0.0393 
Efficiency: 1.891 
E – Plate V2.5 
Error: 0.488 
Efficiency: 1.521 
F – Plate V2.6 
Error: 0.0215 
Efficiency: 1.867 
B – Plate V2.2 A – Plate V2.1 
C – Plate V2.3 D – Plate V2.4 
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Figure 1.1.2: Melt curve of L. crispatus, qPCR (V2.1-V2.8) generated based on the amplification 
curve of all wells where red indicates a single product (peak) and blue indicates no product. The 
–d/dT fluorescence (465-510 nm) is indicated on the y-axis and the temperature (̊C) is indicated 
on the x-axis. 
 
1.2 Lactobacillus gasseri 
Nine plates were run in total for the 143 samples in triplicate with the positive controls for L. 
gasseri due to more samples requiring confirmation of their replicate consistency. For instances 
where either one or two replicates showed primer dimers, no amplification or different values in 
comparison to the other replicates for the sample, the sample was re-run on another plate to 
confirm the readings (Figure 1.2.1, Figure 1.2.2). 
H – Plate V2.8 G – Plate V2.7 
E – Plate V2.5 F – Plate V2.6 
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B – Plate V2.2 
Error: 0.0672 
Efficiency: 1.741 
A – Plate V2.1 
Error: 0.0557 
Efficiency: 1.803 
C – Plate V2.3 
Error: 0.0565 
Efficiency: 1.743 
D – Plate V2.4 
Error: 0.0592 
Efficiency: 1.691 
E – Plate V2.5 
Error: 0.0609 
Efficiency: 1.695 
F – Plate V2.6 
Error: 0.0511 
Efficiency: 1.701 
H – Plate V2.8 
Error: 0.0328 
Efficiency: 1.858 
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Figure 1.2.1: Absolute quantitative derivative max amplification curve of L. gasseri qPCR 
(V2.1-V2.9) reported as log transformed copies/ng total DNA, generated based on all wells and 





 copies/µL. The fluorescence (465-510 nm) is indicated on the y-axis and 
the number of cycles is indicated on the x-axis. Red and brown indicate positive amplification in 
the unknown samples and the positive control standards respectively; blue indicates uncertainty 
and green indicates negative amplification in the wells.  
I – Plate V2.9 
Error: 0.0261 
Efficiency: 1.846 
B – Plate V2.2 
C – Plate V2.3 
A – Plate V2.1 
D – Plate V2.4 
F – Plate V2.6 E – Plate V2.5 
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Figure 1.2.2: Melt curve of L. gasseri qPCR (V2.1-V2.9) generated based on the amplification 
curve of all wells where red indicates a single product (peak) and blue indicates no product. The 
–d/dT fluorescence (465-510 nm) is indicated on the y-axis and the temperature (̊C) is indicated 
on the x-axis. 
 
1.3 Lactobacillus jensenii 
Eight plates were run in total for the 143 samples in triplicate with the positive controls for L. 
jensenii due to more samples requiring confirmation of their replicate consistency. For instances 
where either one or two replicates showed primer dimers, no amplification or different values in 
comparison to the other replicates for the sample, the sample was re-run on another plate to 
confirm the readings (Figure 1.3.1, Figure 1.3.2). 
H – Plate V2.8 G – Plate V2.7 
I – Plate V2.9 
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Figure 1.3.1: Absolute quantitative derivative max amplification curve of L. jensenii qPCR 
(V2.1-V2.8) reported as log transformed copies/ng total DNA, generated based on all wells and 





 copies/µL. The fluorescence (465-510 nm) is indicated on the y-axis and 
the number of cycles is indicated on the x-axis. Red and brown indicate positive amplification in 
the unknown samples and the positive control standards respectively; blue indicates uncertainty 
and green indicates negative amplification in the wells.  
E – Plate V2.5 
Error: 0.0521 
Efficiency: 1.930 
B – Plate V2.2 
Error: 0.0521 
Efficiency: 1.962 
F – Plate V2.6 
Error: 0.0508 
Efficiency: 1.686 
C – Plate V2.3 
Error: 0.0498 
Efficiency: 1.912 
D – Plate V2.4 
Error: 0.0458 
Efficiency: 1.901 
A – Plate V2.1 
Error: 0.0256 
Efficiency: 1.897 
G – Plate V2.7 
Error: 0.0466 
Efficiency: 1.961 
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Figure 1.3.2: Melt curve of L. jensenii qPCR (V2.1-V2.8) generated based on the amplification 
curve of all wells where red indicates a single product (peak) and blue indicates no product. The 
–d/dT fluorescence (465-510 nm) is indicated on the y-axis and the temperature (̊C) is indicated 
on the x-axis. 
 
G – Plate V2.7 
E – Plate V2.5 
B – Plate V2.2 
F – Plate V2.6 
C – Plate V2.3 D – Plate V2.4 
A – Plate V2.1 
H – Plate V2.8 
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1.4 Lactobacillus iners 
Six plates were run in total for the 143 samples in triplicate with the positive controls for L. 
iners. Repeats were not run for L. iners as it was established with the previous three bacteria that 
the majority of the negatives were due to lower readings for the bacteria in comparison to L. 
iners (Figure 1.4.1, Figure 1.4.2). 
 
Figure 1.4.1: Absolute quantitative derivative max amplification curve of L. iners qPCR (V2.1-
V2.6) reported as log transformed copies/ng total DNA, generated based on all wells and the 





 copies/µL. The fluorescence (465-510 nm) is indicated on the y-axis and 
the number of cycles is indicated on the x-axis.  Red and brown indicate positive amplification in 
the unknown samples and the positive control standards respectively; blue indicates uncertainty 
and green indicates negative amplification in the wells.  
E – Plate V2.5 
Error: 0.0832 
Efficiency: 1.867 
B – Plate V2.2 
Error: 0.0237 
Efficiency: 1.764 
F – Plate V2.6 
Error: 0.0132 
Efficiency: 1.935 
C – Plate V2.3 
Error: 0.0203 
Efficiency: 1.698 
D – Plate V2.4 
Error: 0.0143 
Efficiency: 1.825 
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Figure 1.4.2: Melt curve of L. iners qPCR (V2.1-V2.6) generated based on the amplification 
curve of all wells where red indicates a single product (peak) and blue indicates no product. The 
–d/dT fluorescence (465-510 nm) is indicated on the y-axis and the temperature (̊C) is indicated 
on the x-axis. 
 
1.5 Gardnerella vaginalis 
A total of seven plates were run for G. vaginalis in order to quantify the number of copies/ng 
present within the samples. For instances where either one or two replicates showed primer 
dimers, no amplification or different values in comparison to the other replicates for the sample, 
the sample was re-run on another plate to confirm the readings (Figure 1.5.1, Figure 1.5.2). 
E – Plate V2.5 
B – Plate V2.2 
F – Plate V2.6 
C – Plate V2.3 D – Plate V2.4 
A – Plate V2.1 
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Figure 1.5.1: Absolute quantitative derivative max amplification curve of G. vaginalis qPCR 
(V2.1-V2.7) reported as log transformed copies/ng total DNA generated based on all wells and 





 copies/µL. The fluorescence (465-510 nm) is indicated on the y-axis and 
the number of cycles is indicated on the x-axis. Red and brown indicate positive amplification in 
the unknown samples and the positive control standards respectively; blue indicates uncertainty 
and green indicates negative amplification in the wells.  
E – Plate V2.5 
Error: 0.0255 
Efficiency: 1.901 
B – Plate V2.2 
Error: 0.0151 
Efficiency: 1.856 
C – Plate V2.3 
Error: 0.0375 
Efficiency: 1.902 
A – Plate V2.1 
Error: 0.0252 
Efficiency: 1.895 
D – Plate V2.4 
Error: 0.0601 
Efficiency: 1.892 
F – Plate V2.6 
Error: 0.0751 
Efficiency: 1.821 
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Figure 1.5.2: Melt curve of G. vaginalis qPCR (V2.1-V2.7) generated based on the amplification 
curve of all wells where red indicates a single product (peak) and blue indicates no product. The 
–d/dT fluorescence (465-510 nm) is indicated on the y-axis and the temperature (̊C) is indicated 
on the x-axis. 
 
 
G – Plate V2.7 
E – Plate V2.5 
B – Plate V2.2 
F – Plate V2.6 
C – Plate V2.3 D – Plate V2.4 
A – Plate V2.1 
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1.6 Prevotella bivia 
Five plates were run in total for the 143 samples in triplicate with the positive controls for P. 
bivia. There were no instances where either one or two replicates showed primer dimers, no 
amplification or different values in comparison to the other replicates for the samples, thus no 
samples were repeated. There was not enough standard control DNA to run repeats of all the 
dilutions each time, thus a reference standard curve was used to quantify the samples (Figure 
1.6.1, Figure 1.6.2). 
 
Figure 1.6.1: Absolute quantitative derivative max amplification curve of P. bivia qPCR (V2.1-
V2.5) reported as log transformed copies/ng total DNA, generated based on all wells and the 





 copies/µL. The fluorescence (465-510 nm) is indicated on the y-axis and 
the number of cycles is indicated on the x-axis. Red and brown indicate positive amplification in 
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the unknown samples and the positive control standards respectively; blue indicates uncertainty 
and green indicates negative amplification in the wells.  
 
Figure 1.6.2: Melt curve of P. bivia qPCR (V2.1-V2.5) generated based on the amplification 
curve of all wells where red indicates a single product (peak) and blue indicates no product. The 
–d/dT fluorescence (465-510 nm) is indicated on the y-axis and the temperature (̊C) is indicated 





E – Plate V2.5 
B – Plate V2.2 
C – Plate V2.3 D – Plate V2.4 
A – Plate V2.1 
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Appendix E: Results 
This appendix contains all of the data not included within Chapter 4: Results, as well as all of the 
P. bivia data.  
1 Descriptive statistics  
Table 1.1: Descriptive statistics for each bacterial species, quantified from DNA extracted from 
the WISH lateral wall swab for each participant. 
 Bacteria 
L. crispatus L. gasseri L. jensenii L. iners G. vaginalis P. bivia 
Min 0.0 0.0 0.0 1.034 1.738 1.738 
25% Percentile 0.0 1.976 1.570e-016 266.7 1015 3667 
Median 3.957 17.58 1.568 2807 8540 11073 
75% Percentile 4980 64.67 59.00 18727 49867 75533 
Max 7.113e+007 320000 5.440e+006 4.167e+007 3.033e+006 2.553e+007 
Mean 858412 3327 48743 337988 151382 750128 
Std. Deviation 7.157e+006 27908 462042 3.485e+006 414156 3.405e+006 
Std. Error 598472 2334 38638 291468 34633 284714 
 
2. Comparison of absolute bacterial quantities to BV status, inflammation levels, age, 
hormonal contraceptive and STI status, bacterial versus viral STI’s and HPV 
2.1 Association levels between the quantities of the bacteria of interest and BV status 
Participants were categorized as being BV positive, intermediate or negative based on Nugent 
scoring. A Nugent score of 0-3 is BV negative, a score of 4-6 is BV intermediate and a score of 
7-10 is BV positive. 
Table 2.1: Comparison of the non-parametric paired Friedman’s ANOVA test across all bacterial 
groups with a Dunn’s Multiple Comparison test for BV positive, BV intermediate and BV 
negative groups: 
Bacterial comparisons BV Group p-values 
Positive Intermediate Negative 
L. gasseri vs L. jensenii 0.0158
*
 >0.9999 >0.9999 
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L. jensenii vs L. crispatus 0.741 >0.9999 <0.0001
*
 




































L. iners vs G. vaginalis 0.007 >0.9999 >0.9999 
L. iners vs P. bivia 0.0274 0.8133 0.3939 










*The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval.   
2.1.1 Prevotella bivia 
We compared the quantified log copies/ng of P. bivia between the BV groups. There was no 
significant difference in P. bivia between the BV groups (Kruskal-Wallis ANOVA p=0.8031) 
(Figure 2.1.1). This is one of the reasons that P. bivia was not included in the comparison 
between the bacteria per category. The results are not reliable and indicate and oversensitivity of 
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Figure 2.1.1: Comparison of the quantities of P. bivia (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between BV positive, intermediate and negative groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
2.2 Association levels between bacteria of interest and inflammatory immunological factor 
levels 
The two inflammatory groups were defined based on the unsupervised analysis of the 47 
immunological factors of interest in the cervicovaginal fluid of women in the WISH cohort. 
These immunological factors were categorized into high and low inflammation by partitioning 
around medoids (PAM) using an R package ‘cluster’ with a k-value of 2. The samples were 
originally separated into high and low inflammation based on the levels of only the pro-
inflammatory and chemokine factors measured. However, the inflammation separation of the 
participant samples showed little difference between the two pro-inflammatory and chemokine 
groups of immunological factor analysis in comparison to using all of the factors to determine 
high and low inflammation. Thus the final inflammation categorization was done using all 47 
immunological factors.  
The immunological factors measured in this study can be generally grouped into five different 
categories. The immunological factors considered as pro-inflammatory were IL-1a, IL-1b, IL-6, 
IL-12p40, IL-12(p70), IL-18, MIF, TNF-a, TNF-b and TRAIL. The immunological factors 
considered chemokines were CTACK, Eotaxin, GROa, IL-8, IL-16, IP-10, MCP-1, MCP-3, 
MIG, MIP-1a, MIP-1b, IFN-a2, and RANTES. The immunological factors considered growth 
factors were b-NGF, FGF basic, G-CSF, GM-CSF, HGF, IL-3, IL-7, IL-9, LIF, M-CSF, PDGF-
bb, SCF, SCGF-b, SDF-1a and VEGF. The immunological factors considered adaptive were 
IFN-g, IL-4, IL-13, IL-17, IL-2Ra, IL-2, and IL-5. The immunological factors considered 
regulatory were IL-10 and IL-1ra.  
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Table 2.2: Comparison of the non-parametric, paired Friedman’s ANOVA test across all 
bacterial groups with a Dunn’s Multiple Comparison test for the Inflammation high and low 
groups: 
Bacterial comparisons Inflammation Level p-values 
Low High 
L. gasseri vs L. jensenii >0.9999 0.0463 
L. gasseri vs L. crispatus 0.0097
*
 >0.9999 















L. jensenii vs L. crispatus 0.0005
*
 0.23 















L. crispatus vs L. iners >0.9999 <0.0001
*
 
L. crispatus vs G. vaginalis 0.9929 <0.0001
*
 





L. iners vs G. vaginalis >0.9999 0.8439 
L. iners vs P. bivia 0.1302 0.0117
*
 







 The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval.  
2.2.1 Prevotella bivia 
We compared the quantified log copies/ng of P. bivia between the inflammation groups. The 
high inflammation group and the low inflammation group had no significant difference 
(p=0.8438) (Figure 2.2.1). The copies/ng within this inflammatory group should not be 
compared against the other five bacteria due to unreliable primers.  
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Figure 2.2.1: Comparison of the quantities of P. bivia (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between women with high and low genital inflammation. All p-value comparisons were 
based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
 
2.3 Association levels between the quantities (copies/ng) of bacteria of interest and age 
The age of all participants was recorded upon screening for participation within the study. For 
this analysis, age was binarised into 16-18 years of age versus 19-22 years of age. 
Table 2.3: Comparison of the non-parametric paired Friedman’s ANOVA test across all bacterial 
groups with Dunn’s Multiple Comparison test p-values for the two age groups 16 to 18 years old 
compared to 19 to 22 years old: 
Bacterial comparisons Age Group p-values 
16-18 years old 19-22 years old 
L. gasseri vs L. jensenii 0.2457 >0.9999 
L. gasseri vs L. crispatus >0.9999 >0.9999 
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L. jensenii vs L. crispatus 0.0419
*
 0.0582 






























L. iners vs G. vaginalis 0.8223 >0.9999 
L. iners vs P. bivia 0.0117
*
 0.1348 







 The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval.  
2.3.1 Prevotella bivia 
We compared the quantified copies/ng of P. bivia between the age groups. The 16-18 years old 
age group and the 19-22 years old age group had no difference in log copies/ng (p=0.2629) 
(Figure 2.3.1). Although the P. bivia age data follows the same trend as the other bacteria, this 
































Figure 2.3.1: Comparison of the quantities of P. bivia (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
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study, between the two 16-18 years old and 19-22 years old, age groups. All p-value 
comparisons were based on an unpaired, non-parametric Mann-Whitney t-test statistic. Each 
point in the figure represents an individual participant. The three horizontal bars represent the 
median value (middle bar), upper interquartile range (top bar) and lower interquartile range 
(bottom bar). 
 
2.4 Association levels between the quantities (copies/ng) of vaginal bacteria and hormonal 
contraceptives 
The hormonal contraceptive that each participant was using was recorded at the first visit of the 
WISH Cohort study process. The three hormonal contraceptives of particular interest within this 
study include DMPA, the Implanon and Nur Isterate.  
Table 2.4: Comparison of the non-parametric paired Friedman’s ANOVA test across all bacterial 
groups with a Dunn’s Multiple Comparison test for the DMPA, Implanon and Nur Isterate 
hormonal contraceptive groups: 
Bacterial comparisons Hormonal Contraceptive p-values 
DMPA Implanon Nur Isterate 
L. gasseri vs L. jensenii 0.8817 >0.9999 >0.9999 
L. gasseri vs L. crispatus >0.9999 >0.9999 0.1923 

















L. jensenii vs L. crispatus 0.5144 >0.9999 0.0065
*
 








































L. iners vs G. vaginalis >0.9999 >0.9999 >0.9999 
L. iners vs P. bivia >0.9999 >0.9999 0.0015
*
 









The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval.  
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2.4.1 Prevotella bivia 
We compared the quantified log copies/ng of P. bivia, and found no significant differences 









































Figure 2.4.1: Comparison of the quantities of P. bivia (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the hormonal contraceptives DMPA, Nur Isterate and the Implanon. All p-value 
comparisons were based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each 
point in the figure represents an individual participant. The three horizontal bars represent the 
median value (middle bar), upper interquartile range (top bar) and lower interquartile range 
(bottom bar). 
 
2.5 Association levels between the quantities (copies/ng) of the bacteria of interest and the 
absence or presence of any once STI in the WISH cohort 
The STI status was determined based on the absence or presence of any one bacterial 
(Chlamydia trachomatis, Neisseria gonorrhea, and Mycoplasma genitalium), viral (Herpes 
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Simplex Virus 2, and Human Papilloma Virus) or parasitic (Trichomonas vaginalis) STI for each 
participant. 
Table 2.5: Comparison of the non-parametric, paired Friedman’s ANOVA test across all 
bacterial groups with a Dunn’s Multiple Comparison test for the absence or presence of any one 
STI of interest in the WISH study. 
Bacterial comparisons STI Status Group p-values 
Absent Any one Present 
L. gasseri vs L. jensenii 0.918 0.436 
L. gasseri vs L. crispatus >0.9999 >0.9999 















L. jensenii vs L. crispatus 0.1534 0.0079
*
 






























L. iners vs G. vaginalis >0.9999 0.9398 
L. iners vs P. bivia 0.1884 0.0079
*
 







 The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval. 
2.5.1 Prevotella bivia 
We compared the quantified log copies/ng of P. bivia and found no significant differences 
between the participants with and without any one STI (p=0.1905) (Figure 2.5.1). Although this 
follows the trend of the other bacterium within this cohort, due to the lack of accuracy of the 
primers this data should not be taken as reliable.  
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Figure 2.5.1: Comparison of the quantities of P. bivia (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on absence or presence of any one of the 
WISH cohort STIs present. All p-value comparisons were based on an unpaired, non-parametric 
Mann-Whitney t-test statistic. Each point in the figure represents an individual participant. The 
three horizontal bars represent the median value (middle bar), upper interquartile range (top bar) 
and lower interquartile range (bottom bar).  
 
2.6 Association levels between the quantities (copies/ng) of the bacteria of interest and the 
presence of bacterial or viral STI’s in the WISH cohort 
The STI status was determined based on the sum value of the presence or absence of all bacterial 
(Chlamydia trachomatis, Neisseria gonorrhea, and Mycoplasma genitalium), or viral (Herpes 
Simplex Virus 2, and Human Papilloma Virus) for each participant within the WISH cohort.  
Asterisk stars were used in the following figures where one start (*) indicates a p-value lower 
than 0.05, two stars (**) indicate a p-value lower than 0.01 and three stars (***) indicate a p-
value lower than 0.001.  
Table 2.6.1: Comparison of the non-parametric, paired Friedman’s ANOVA test across all 
bacterial groups with a Dunn’s Multiple Comparison test for the three STI groups, none, one and 
two or more bacterial STI’s of interest in the WISH study is present.  
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Bacterial comparisons Bacterial STI grouping p-values 
None One Two< 
L. gasseri vs L. jensenii 0.5221 >0.9999 0.6815 
L. gasseri vs L. crispatus >0.9999 0.9595 >0.9999 

















L. jensenii vs L. crispatus 0.2835 0.0294
*
 >0.9999 








































L. iners vs G. vaginalis >0.9999 >0.9999 >0.9999 
L. iners vs P. bivia 0.129 0.1043 0.4769 









The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval.  
The absence of any bacterial STI group (Figure 2.6.1A) had significantly different copies/ng of 
G. vaginalis and L. iners in comparison to L. gasseri (p<0.0001), L. jensenii (p<0.0001) and L. 
crispatus (p<0.0001). This trend was followed by the group with one bacterial STI present 
(Figure 2.6.1B) except G. vaginalis and L. iners had a significance of p=0.0001 and p=0.0117 in 
comparison to L. crispatus respectively, with L. crispatus having significantly different copies/ng 
in comparison to L. jensenii (p=0.0294). In the presence of two or more bacterial STIs (Figure 
2.6.1C), G. vaginalis and L. iners had significantly higher copies/ng in comparison to L. jensenii 
(p<0.0001, p=0.0095) with G. vaginalis further having higher copies/ng in comparison to L. 
crispatus (p=0.0437). The absence of, or presence of one bacterial STI, show similar trends in 
bacterial copies/ng with the presence of two or more bacterial STIs having fewer differences 
between the bacterial copies/ng.  
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Figure 2.6.1A: Box-plot of the absence of any one bacterial STI for L. gasseri (red), L. jensenii 
(orange), L. crispatus (green), L. iners (blue), G. vaginalis (purple) reported as log transformed 
copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) 
of the data set and the ‘whiskers’ which are the two  lines (bottom and top) extending from the 
box component of each block that end with a horizontal stroke, indicate the range from the 
smallest and largest non-outliers to the 25% and 75% percentile components, respectively. The 
middle line indicates the median value for each data set. 
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Figure 2.6.1B: Box-plot of the presence of any one bacterial STI for L. gasseri (red), L. jensenii 
(orange), L. crispatus (green), L. iners (blue), G. vaginalis (purple) reported as log transformed 
copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) 
of the data set and the ‘whiskers’ which are the two  lines (bottom and top) extending from the 
box component of each block that end with a horizontal stroke, indicate the range from the 
smallest and largest non-outliers to the 25% and 75% percentile components, respectively. The 
middle line indicates the median value for each data set. 
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Figure 2.6.1C: Box-plot of two or more bacterial STIs for L. gasseri (red), L. jensenii (orange), 
L. crispatus (green), L. iners (blue), G. vaginalis (purple) reported as log transformed copies/ng 
total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) of the data 
set and the ‘whiskers’ which are the two  lines (bottom and top) extending from the box 
component of each block that end with a horizontal stroke, indicate the range from the smallest 
and largest non-outliers to the 25% and 75% percentile components, respectively. The middle 
line indicates the median value for each data set. 
Table 2.6.2: Comparison of the non-parametric, paired Friedman’s ANOVA test across all viral 
groups with a Dunn’s Multiple Comparison test for the three STI groups, none, one or two viral 
STI’s of interest in the WISH.  
Bacterial comparisons Viral STI grouping p-values 
None One Two 
L. gasseri vs L. jensenii 0.4463 0.4859 >0.9999 
L. gasseri vs L. crispatus >0.9999 >0.9999 0.6729 















L. jensenii vs L. crispatus 0.0083
*
 0.3777 0.6729 
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L. iners vs G. vaginalis >0.9999 >0.9999 >0.9999 
L. iners vs P. bivia 0.6725 0.0054
*
 >0.9999 
G. vaginalis vs P. bivia >0.9999 0.5104 >0.9999 








The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval.  
In the presence of one viral STI (Figure 2.6.2A), G. vaginalis and L. iners had significantly 
different copies/ng in comparison to L. gasseri (p<0.0001), L. jensenii (p<0.0001) and L. 
crispatus (p<0.0001). A similar pattern was followed in the absence of any viral STI (Figure 
2.6.2B), except G. vaginalis and L. iners had a significance of p=0.0011 and p=0.0184 in 
comparison to L. crispatus, respectively. Further, L. crispatus had significantly different 
copies/ng in comparison to L. jensenii (p=0.0083). The presence of two viral STIs (Figure 
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Figure 2.6.2A: Box-plot of the absence of any one viral STI for L. gasseri (red), L. jensenii 
(orange), L. crispatus (green), L. iners (blue), G. vaginalis (purple) reported as log transformed 
copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) 
of the data set and the ‘whiskers’ which are the two  lines (bottom and top) extending from the 
box component of each block that end with a horizontal stroke, indicate the range from the 
smallest and largest non-outliers to the 25% and 75% percentile components, respectively. The 
































































Figure 2.6.2B: Box-plot of the presence of any one viral STI for L. gasseri (red), L. jensenii 
(orange), L. crispatus (green), L. iners (blue), G. vaginalis (purple) reported as log transformed 
copies/ng total DNA. The ‘box’ component of each plot indicates the interquartile range (IQR) 
of the data set and the ‘whiskers’ which are the two  lines (bottom and top) extending from the 
box component of each block that end with a horizontal stroke, indicate the range from the 
smallest and largest non-outliers to the 25% and 75% percentile components, respectively. The 
middle line indicates the median value for each data set. 
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Figure 2.6.2C: Box-plot of two viral STIs for L. gasseri (red), L. jensenii (orange), L. crispatus 
(green), L. iners (blue), G. vaginalis (purple) reported as log transformed copies/ng total DNA. 
The ‘box’ component of each plot indicates the interquartile range (IQR) of the data set and the 
‘whiskers’ which are the two  lines (bottom and top) extending from the box component of each 
block that end with a horizontal stroke, indicate the range from the smallest and largest non-
outliers to the 25% and 75% percentile components, respectively. The middle line indicates the 
median value for each data set. 
2.6.3 Prevotella bivia 
We compared the quantified log copies/ng of P. bivia between those with none, one or two (or 
more) bacterial or viral STI groups s. The bacterial STI groups had no significant difference in P. 
bivia (Kruskal-Wallis ANOVA p=0.5566). The copies/ng of P. bivia in the viral STI group with 
no STI differed significantly from the presence of two viral STIs (p=0.0488). There was no 
significant difference in P. bivia between the viral STI groups (Kruskal-Wallis ANOVA 
p=0.0526) (Figure 2.6.3). This data should not be taken as reliable due to the primer errors 
discussed previously.  
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Figure 2.6.3: Comparison of the quantities of P. bivia (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, where the samples have been separated based on none, one, two (or more <) of the WISH 
cohort Bacterial (B) versus Viral (V) STIs being present. All p-value comparisons were based on 
an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
2.7 Association levels between the quantities (copies/ng) of bacteria of interest and the 
absence or presence of low and high risk HPV subtypes in the WISH cohort 
The HPV status was considered negative in the absence of all HPV subtypes amplified by the 
Roche linear array, low risk if 6, 11, 40, 42, 54, 55, 61, 62, 64, 67, 69, 70, 71, 72, 81, 83, 84, 
89(CP6109) and IS39 HPV subtypes were present, and high risk if 16, 18, 26, 31, 33, 35, 39, 45, 
51, 52, 53, 56, 58, 59, 66, 68, 73 and 82 HPV subtypes were present.  
Table 2.7: Comparison of the non-parametric paired Friedman’s ANOVA test across all bacterial 
groups with a Dunn’s Multiple Comparison test for the HPV groups. 
Bacterial comparisons HPV Group p-values 
Negative Low Risk High Risk 
L. gasseri vs L. jensenii 0.4845 >0.9999 >0.9999 
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*
 The asterisk indicates a p-value lower than the standardized p-value of 0.05 with a 95% 
confidence interval.  
2.7.1 Prevotella bivia 
We compared the quantified log copies/ng of P. bivia between the HPV groups. There was no 
significant difference in P. bivia between the HPV groups (Kruskal-Wallis ANOVA p=0.7775) 
(Figure 2.7.1). The lack of difference between the copies/ng in each group has been attributed to 
the inaccurate primers and thus the results are unreliable until validated with new, accurate 
primers.  
L. gasseri vs L. crispatus >0.9999 >0.9999 0.6674 















































L. crispatus vs L. iners 0.4845 <0.0001
*
 0.0881 












L. iners vs G. vaginalis >0.9999 >0.9999 >0.9999 
L. iners vs P. bivia >0.9999 >0.9999 >0.9999 


















































Figure 2.7.1: Comparison of the quantities of P. bivia (log transformed copies/ng DNA) 
measured in the DNA extracted from vaginal lateral wall swabs from participants in the WISH 
study, between the negative, low risk and high risk HPV groups. All p-value comparisons were 
based on an unpaired, non-parametric Dunn’s Multiple Comparison test. Each point in the figure 
represents an individual participant. The three horizontal bars represent the median value (middle 
bar), upper interquartile range (top bar) and lower interquartile range (bottom bar). 
 
 
 
 
 
 
 
